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Combining Computational And Experimental Approaches To Study Disordered
And Aggregation Prone Proteins
Abstract
Over the past two decades disordered proteins have become more widely recognized, challenging the
canonical structure-function paradigm associated with proteins. These highly dynamic proteins have
been identified across a wide range of species and play a variety of functional roles. Furthermore, the
structural plasticity of these proteins gives way to their increased aggregation susceptibility, compared to
canonical, well-folded proteins, placing disordered proteins at the center of many neurodegenerative
diseases. Despite the increased recognition of the abundance and complexity of disordered proteins, their
structural features and the mechanisms by which they transit between functional and pathological roles
remains elusive. The efforts described herein focus on leveraging both experimental and computational
approaches to study the structure and dynamics of these proteins. Fluorescence-based experiment have
proven useful for studying these systems as the intrinsic heterogeneity of this class of proteins, which
precludes the use of many traditional structural biochemistry techniques, can be accommodated.
Therefore, initial efforts focused on developing new minimally perturbing fluorescence probes and
coupling these probes with site-selective labeling strategies. Subsequent efforts focused on identifying
methods which could predict where these probes would be tolerated to boost protein yield and avoid
structural perturbation. These and other fluorescence probes were employed in Förster Resonance
Energy Transfer (FRET) experiments, to study the conformational ensemble of α-synuclein, a disordered
protein whose aggregation is implicated in Parkinson’s Disease pathogenesis. Experimental FRET data
was paired with molecular modeling in PyRosetta to simulate the conformational ensembles of αsynuclein in the presence and absence of 2 M TMAO. The accuracy of the resultant ensembles was
corroborated by comparison to other experimental data. Following this initial success using
experimentally constrained simulations, attention was directed towards the development of algorithms
capable of generating accurate structural representations of both disordered and ordered proteins de
novo. Lastly, this work showcases the utility of a high-throughput in-silico screening approach in
identifying a compound that binds selectively to α-synuclein fibrils with nanomolar affinity. Overall this
work highlights several computational and experimental approaches which are broadly applicable to the
study of disordered and aggregation prone proteins
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ABSTRACT

COMBINING COMPUTATIONAL AND EXPERIMENTAL APPROACHES TO STUDY
DISORDERED AND AGGREGATION PRONE PROTEINS
John J. Ferrie
Professor E. James Petersson
Over the past two decades disordered proteins have become more widely recognized,
challenging the canonical structure-function paradigm associated with proteins. These highly
dynamic proteins have been identified across a wide range of species and play a variety of
functional roles. Furthermore, the structural plasticity of these proteins gives way to their increased
aggregation susceptibility, compared to canonical, well-folded proteins, placing disordered proteins
at the center of many neurodegenerative diseases. Despite the increased recognition of the
abundance and complexity of disordered proteins, their structural features and the mechanisms by
which they transit between functional and pathological roles remains elusive. The efforts described
herein focus on leveraging both experimental and computational approaches to study the structure
and dynamics of these proteins. Fluorescence-based experiment have proven useful for studying
these systems as the intrinsic heterogeneity of this class of proteins, which precludes the use of
many traditional structural biochemistry techniques, can be accommodated. Therefore, initial
efforts focused on developing new minimally perturbing fluorescence probes and coupling these
probes with site-selective labeling strategies. Subsequent efforts focused on identifying methods
which could predict where these probes would be tolerated to boost protein yield and avoid
structural perturbation. These and other fluorescence probes were employed in Förster Resonance
Energy Transfer (FRET) experiments, to study the conformational ensemble of α-synuclein, a
disordered protein whose aggregation is implicated in Parkinson’s Disease pathogenesis.
Experimental FRET data was paired with molecular modeling in PyRosetta to simulate the
conformational ensembles of α-synuclein in the presence and absence of 2 M TMAO. The accuracy
of the resultant ensembles was corroborated by comparison to other experimental data. Following
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this initial success using experimentally constrained simulations, attention was directed towards
the development of algorithms capable of generating accurate structural representations of both
disordered and ordered proteins de novo. Lastly, this work showcases the utility of a highthroughput in-silico screening approach in identifying a compound that binds selectively to αsynuclein fibrils with nanomolar affinity. Overall this work highlights several computational and
experimental approaches which are broadly applicable to the study of disordered and aggregation
prone proteins.

vii

TABLE OF CONTENTS
ACKNOWLEDGMENT ........................................................................................ iii
ABSTRACT ......................................................................................................... vi
LIST OF TABLES ............................................................................................... xi
LIST OF ILLUSTRATIONS ............................................................................... xiii
CHAPTER 1: INTRODUCTION............................................................................ 1
§ 1.1 The Role of Amlyoidogenic Proteins in Neurodegenerative Disease ... 2
§ 1.2 The Utility of Fluorescence and FRET in Studying Protein Structure . 11
§ 1.3 Computational Methods for Modeling Disordered Proteins ................ 23
CHAPTER 2: MULTICOLOR PROTEIN FRET WITH TRYPTOPHAN,
SELECTIVE COUMARIN-CYSTEINE LABELING, AND GENETIC
ACRIDONYLALANINE ENCODING. ................................................................. 28
§ 2.1 Introduction.............................................................................................. 29
§ 2.2 Characterization of Mcm-Mal and Mcm-Br ............................................ 31
§ 2.2 Protein Expression, Labeling and Purification ..................................... 41
§ 2.3 FRET Measurements ............................................................................... 53
§ 2.3 Results...................................................................................................... 65
§ 2.6 Conclusion ............................................................................................... 82
CHAPTER 3: IMPROVING THE FLUORESCENT PROBE
ACRIDONYLALANINE THROUGH A COMBINATION OF THEORY AND
EXPERIMENT. ................................................................................................... 84
§ 3.1 Introduction.............................................................................................. 85
viii

§ 3.2 Spectroscopic Characterization ............................................................. 89
§ 3.3 Results.................................................................................................... 101
§ 3.4 Conclusions ........................................................................................... 104
CHAPTER 4: SYSTEMATIC EVALUATION OF SOLUBLE PROTEIN
EXPRESSION USING A FLUORESCENT UNNATURAL AMINO ACID
REVEALS NO RELIABLE PREDICTORS OF TOLERABILITY. ..................... 105
§ 4.1 Introduction............................................................................................ 106
§ 4.2 Experimental and Computational Methods ......................................... 108
§ 4.3 Results and Discussion ........................................................................ 111
§ 4.3 Initial Conclusions ................................................................................. 119
§ 4.4 Further Algorithmic Development ........................................................ 120
CHAPTER 5: USING A FRET LIBRARY WITH MULTIPLE PROBE PAIRS TO
DRIVE MONTE CARLO SIMULATIONS OF A-SYNUCLEIN. ......................... 132
§ 5.1 Introduction............................................................................................ 133
§ 5.2 Protein Overexpression and Purification ............................................ 138
§ 5.3 FRET Data Collection and Analysis ..................................................... 146
§ 5.4 FCS and AFM Characterization ............................................................ 158
§ 5.5 Computational Modeling Procedures .................................................. 161
§ 5.6 Results.................................................................................................... 174
§ 5.7 Discussion ............................................................................................. 206
§ 5.8 Conclusions ........................................................................................... 213
CHAPTER 6: A UNIFIED DE NOVO APPROACH FOR PREDICTING THE
STRUCTURES OF ORDERED AND DISORDERED PROTEINS. .................. 216
ix

§ 6.1 Introduction............................................................................................ 217
§ 6.2 Methods .................................................................................................. 220
§ 6.3 Calculation of Data from Ensembles ................................................... 223
§ 6.3 Results.................................................................................................... 227
Chapter 7: HIGH-THROUGHPUT IN SILICO AND IN VITRO SCREENING FOR
COMPOUNDS THAT SELECTIVELY BIND TO ALPHA-SYNUCLEIN FIBRILS.
......................................................................................................................... 381
§ 7.1 Introduction............................................................................................ 382
§ 7.2 Methods .................................................................................................. 384
§ 7.3 Results.................................................................................................... 393
§ 7.4 Discussion ............................................................................................. 412
CHAPTER 8: FUTURE DIRECTIONS AND OUTLOOK .................................. 413
§ 8.1 Identification of Novel Compounds with Improved Therapeutic
Potential via FRET-based Screening ............................................................ 414
§ 8.2 Continued Exemplar-based Screening ................................................ 416
§ 8.3 Novel Approaches in Rosetta Targeting Experimental Optimization 418
BIBLIOGRAPHY .............................................................................................. 421

x

LIST OF TABLES

Table 2.1: Protein MALDI Masses. ................................................................... 47
Table 2.2: Trypsin Fragment MALDI Masses. ................................................... 47
Table 2.3: Percent of Cys Containing Protein Labeled by Mcm-Mal .................. 59
Table 2.4: TCSPC Fluorescence Lifetime Values .............................................. 73
Table 2.5: CaM + WpOCNC FRET .................................................................... 76
Table 2.6: CaM Structural Model Data ............................................................... 77
Table 2.7: Stopped-Flow Data Fitting................................................................. 81
Table 3.1: Calculated and Observed Photophysical Parameters of Acridone
Derivatives. ......................................................................................................... 93
Table 4.1: List of descriptors for Rosetta simulations...................................... 123
Table 5.1: MALDI Masses from Cnf-Trp Library............................................... 145
Table 5.2: MALDI Masses from Fam-Raz Library ............................................ 146
Table 5.3a: Steady-State FRET Fitting and Distance Determination ............... 153
Table 5.3b: Steady-State FRET Fitting and Distance Determination ............... 154
Table 5.4a: TCSPC Data and Fitting................................................................ 156
Table 5.4b: TCSPC Data and Fitting ............................................................... 157
Table 5.5: Calculated EFRET values from TCSPC ............................................. 158
Table 5.6: FCS Data ........................................................................................ 184
Table 5.7: Values from fits of Congo Red aggregation kinetics. ....................... 205
Table 5.8: Values from fits of fluorescence polarization aggregation kinetics. . 206
Table 6.1: Values for Computing J-Couplings. ................................................. 227
xi

Table 6.2: Comparison of Simulated αS Ensembles to Global Experimental Data.
......................................................................................................................... 242
Table 6.3: Comparison of Simulated αS Ensembles to Chemical Shift and RDC
Data. ................................................................................................................. 244
Table 6.4: Comparison of Simulated αS Ensembles to J-Coupling Data ......... 246
Table 6.5: Comparison of AbInitio and AbInitioVO Outputs to PDB Structures 353
Table 7.1: Comparison of Ki values in αS and aβ42 fibrils. .............................. 408

xii

LIST OF ILLUSTRATIONS

Figure 1.1: Structural differences between disordered and ordered proteins. ..... 3
Figure 1.2: Overview of the functional and pathological roles of αS. ................... 6
Figure 1.3: Overview of Fluorescence and FRET. ............................................. 14
Figure 1.4: Overview of unnatural amino acid mutagenesis. ............................. 21
Figure 1.5: Overview of PyRosetta. ................................................................... 26
Figure 2.1: Mcm labelling for FRET experiments.............................................. 30
Figure 2.2: Determination of Extinction Coefficient for Mcm-Mal. ...................... 32
Figure 2.3: Synthesis of Mcm-Br and Mcm-Mal. ................................................ 34
Figure 2.4: Absorbance and Fluorescence Spectra of Mcm-Br. ........................ 34
Figure 2.5: LCMS Analysis of Mcm-Br Reactions with Cys. .............................. 35
Figure 2.6: Mcm-Mal Reactions with Cys and Ac-Cys and assigned products. . 36
Figure 2.7: Absorbance and Fluorescence Spectra of Mcm-Mal. ...................... 36
Figure 2.8: LCMS Analysis of Mcm-Mal Reactions with Cys and Ac-Cys. ......... 38
Figure 2.9: Mcm-Mal Reactions with Cys and Ac-Cys after 1 and 6 h. .............. 39
Figure 2.10: Determination of Quantum Yield for Ac-Cys Mcm Product. ........... 40
Figure 2.11: MALDI MS Characterization of CaM Variants. .............................. 48
Figure 2.12: Trypsin Digest MALDI MS Characterization of CaM Variants. ....... 49
Figure 2.13: MALDI MS Characterization of αS Variants. .................................. 50
Figure 2.14: Enlarged MALDI MS of labeled αS Variants. ................................. 51
Figure 2.15: Tryspin Digest MALDI MS Characterization of αS Variants. .......... 52
Figure 2.16: Ac-CysMcm and Acd Absorption and Emission Spectra. .............. 54
xiii

Figure 2.17: Trp and Ac-CysMcm Absorption and Emission Spectra. ............... 54
Figure 2.18: Trp and Acd Absorption and Emission Spectra. ............................ 55
Figure 2.19: CaM Absorbance Measurements. ................................................. 58
Figure 2.20: αS Absorbance Measurements. .................................................... 59
Figure 2.21: Mcm-Mal turn-on experiments. ..................................................... 66
Figure 2.22: αS Fluorescence Spectra and FRET Fitting Results. .................... 69
Figure 2.23: αS TMAO FRET Experiments. ...................................................... 70
Figure 2.24a: αS Fluorescence Spectra and FRET Fitting Results. .................. 71
Figure 2.24b: αS Fluorescence Spectra and FRET Fitting Results. .................. 72
Figure 2.25: Mcm/Acd FRET Data Compared to Previous Structural Models of
αS Ensembles. ................................................................................................... 74
Figure 2.26: Fluorescence Assay to Determine Binding of Labeled CaM. ......... 75
Figure 2.27: CaM Structural Models. ................................................................. 76
Figure 2.28: CaM Peptide binding FRET. ......................................................... 78
Figure 2.29: CaM Steady State FRET Measurements. ..................................... 80
Figure 2.30: CaM Stopped-Flow FRET Measurements. .................................... 81
Figure 2.31: Three Color FRET and Rapid Mixing Measurements of Peptide
Binding Kinetics. ................................................................................................. 82
Figure 3.1: FRET experiments and fluorescent amino acids. ............................ 89
Figure 3.2: Synthesis of nitroacridones and aminoacridones. ........................... 90
Figure 3.4: Synthesis of acridones and benzoacridones. .................................. 90
Figure 3.4: Acridone Spectra. ............................................................................ 95
Figure 3.5: 2-Aminoacridone Spectra. ............................................................... 96
xiv

Figure 3.6: 4-Aminoacridone Spectra. ............................................................... 97
Figure 3.8: 2-Fluoroacridone, 2-Methoxyacridone, and 4-Methoxyacridone
Spectra. .............................................................................................................. 99
Figure 3.9: 4-Benzoacridone, 4-Fluorobenzoacridone, and 4Methoxybenzoacridone Spectra. ...................................................................... 100
Figure 3.10: Absorption and emission spectra of acridone derivatives. ........... 103
Figure 4.1: Scanning a variety of positions in LexA for Acd tolerability. ........... 112
Figure 4.2: Features associated with soluble Acd-labeled LexA proteins. ....... 113
Figure 4.3: Features associated with soluble Acd-labeled RecA proteins. ...... 116
Figure 4.4: Predicting protein solubility through simulation of Acd incorporation in
LexA. ................................................................................................................ 118
Figure 4.5: Predicting protein solubility through simulation of Acd incorporation in
RecA. ................................................................................................................ 119
Figure 4.6a: Comparison of Rosetta energy terms to the soluble fraction of Acd
mutant LexA protein expression. ...................................................................... 124
Figure 4.6b: Comparison of Rosetta energy terms to the soluble fraction of Acd
mutant LexA protein expression. ...................................................................... 125
Figure 4.6c: Comparison of Rosetta energy terms to the soluble fraction of Acd
mutant LexA protein expression. ...................................................................... 126
Figure 4.6d: Comparison of Rosetta energy terms to the soluble fraction of Acd
mutant LexA protein expression. ...................................................................... 127
Figure 4.7a: Comparison of Rosetta energy terms to the total expression of Acd
mutant LexA proteins. ....................................................................................... 128
xv

Figure 4.7b: Comparison of Rosetta energy terms to the total expression of Acd
mutant LexA proteins. ....................................................................................... 129
Figure 4.7c: Comparison of Rosetta energy terms to the total expression of Acd
mutant LexA proteins. ....................................................................................... 130
Figure 4.7d: Comparison of Rosetta energy terms to the total expression of Acd
mutant LexA proteins........................................................................................ 131
Figure 5.1: Scheme for labeled protein production. ......................................... 139
Figure 5.2: Determination of Optimal Thermodynamic Constraint Value. ........ 166
Figure 5.3a: Effect of Constraints on Interresidue Distance Heat Maps. ......... 167
Figure 5.3b: Effect of Constraints on Interresidue Distance Heat Maps. ......... 168
Figure 5.4: Flory Scaling Plots. ........................................................................ 169
Figure 5.5: 0 M TMAO EFRET Plots ............................................................... 172
Figure 5.6: 2 M TMAO EFRET Plots. .............................................................. 172
Figure 5.7: Diffusion Coefficients. .................................................................... 174
Figure 5.8: Steady-state Fluorescence Spectra of Free Fluorophores. ........... 176
Figure 5.9: Determination of EFRET. .............................................................. 177
Figure 5.10: Comparison of experimental and simulated data......................... 178
Figure 5.11a: Intermolecular FRET Lifetime Decays and Fits. ........................ 180
Figure 5.11b: Intermolecular FRET Lifetime Decays and Fits. ........................ 181
Figure 5.11c: Intermolecular FRET Lifetime Decays and Fits. ........................ 182
Figure 5.12: Autocorrelation plots from FCS Data. .......................................... 183
Figure 5.13: The effect of TMAO on the aggregation of wild type αS. ............. 185
Figure 5.14: Distance from Polymer-Scaled Förster Equation. ........................ 186
xvi

Figure 5.14a: Global structural summary for 0 M TMAO ensembles. .............. 189
Figure 5.14b: Global structural summary for 0 M TMAO ensembles. .............. 190
Figure 5.15a: Global structural summary for 2 M TMAO ensembles. .............. 191
Figure 5.15b: Global structural summary for 2 M TMAO ensembles. .............. 192
Figure 5.15c: Global structural summary for 2 M TMAO ensembles. .............. 193
Figure 5.16: Analysis of αS structural ensembles. ........................................... 195
Figure 5.17: Contact maps from experimentally constrained ensembles. ....... 197
Figure 5.18: Average interresidue distance heat map. .................................... 198
Figure 5.19: Experimentally constrained ensemble Flory scaling plot. ............ 198
Figure 5.20: Experimentally constrained ensemble DSSP analysis. ............... 199
Figure 5.21: Intensity ratios from PRE measurements. ................................... 201
Figure 5.22: Flory scaling plot comparison to previously published ensemble. 202
Figure 5.23: CD spectra of αS in varying concentrations of TMAO. ................ 203
Figure 5.24: Aggregation kinetics of αS monitored by Congo Red. ................. 204
Figure 5.25: Aggregation kinetics of αS monitored by fluorescence polarization
......................................................................................................................... 205
Figure 6.1: Determination of optimal new Rg score term weight. .................... 240
Figure 6.2a: Plots of Percent Helicity. .............................................................. 247
Figure 6.2b: Plots of Percent Helicity. ............................................................. 248
Figure 6.3a: Histograms of Radii of Gyration. .................................................. 249
Figure 6.3b: Histograms of Radii of Gyration................................................... 250
Figure 6.4a: Comparison of Simulated EFRET with Experimental EFRET. ..... 251
Figure 6.4b: Comparison of Simulated EFRET with Experimental EFRET. .... 252
xvii

Figure 6.5a: Comparison of Simulated Distance with Experimental Distances.
......................................................................................................................... 253
Figure 6.5b: Comparison of Simulated Distance with Experimental Distances.
......................................................................................................................... 254
Figure 6.6: Comparison of Simulated Beta_PP PRE Values and Experimental
PRE Values. ..................................................................................................... 255
Figure 6.7: Comparison of Simulated Beta_PPFI PRE Values and Experimental
PRE Values. ..................................................................................................... 256
Figure 6.8: Comparison of Simulated Beta_PPFISC PRE Values and
Experimental PRE Values. ............................................................................... 257
Figure 6.9: Comparison of Simulated Beta_PPSC PRE Values and Experimental
PRE Values. ..................................................................................................... 258
Figure 6.10: Comparison of Simulated CenStd_PP PRE Values and
Experimental PRE Values. ............................................................................... 259
Figure 6.11: Comparison of Simulated CenStd_PPFI PRE Values and
Experimental PRE Values. ............................................................................... 260
Figure 6.12: Comparison of Simulated CenStd_Ext_PP PRE Values and
Experimental PRE Values. ............................................................................... 261
Figure 6.13: Comparison of Simulated CenStd_Ext_PPFI PRE Values and
Experimental PRE Values. ............................................................................... 262
Figure 6.14: Comparison of Simulated CenNath PRE Values and Experimental
PRE Values. ..................................................................................................... 263

xviii

Figure 6.15: Comparison of Simulated SimAnn_PP PRE Values and
Experimental PRE Values. ............................................................................... 264
Figure 6.16: Comparison of Simulated SimAnn_PPFI PRE Values and
Experimental PRE Values. ............................................................................... 265
Figure 6.17: Comparison of Simulated SimAnn_PPFISC PRE Values and
Experimental PRE Values. ............................................................................... 266
Figure 6.18: Comparison of Simulated SimAnn_PPSC PRE Values and
Experimental PRE Values. ............................................................................... 267
Figure 6.19: Comparison of Simulated VDW_PP PRE Values and Experimental
PRE Values. ..................................................................................................... 268
Figure 6.20: Comparison of Simulated VDW_PPFI PRE Values and
Experimental PRE Values. ............................................................................... 269
Figure 6.21: Comparison of Simulated VDW_PPFISC PRE Values and
Experimental PRE Values. ............................................................................... 270
Figure 6.22: Comparison of Simulated FloppyTail_score12 PRE Values and
Experimental PRE Values. ............................................................................... 271
Figure 6.23: Comparison of Simulated FloppyTail_ref2015 PRE Values and
Experimental PRE Values. ............................................................................... 272
Figure 6.24: Comparison of Simulated FloppyTail_Quota PRE Values and
Experimental PRE Values. ............................................................................... 273
Figure 6.25: Comparison of Simulated FloppyTail_NoFrags PRE Values and
Experimental PRE Values. ............................................................................... 274

xix

Figure 6.26: Comparison of Simulated FloppyTail_Loops PRE Values and
Experimental PRE Values. ............................................................................... 275
Figure 6.27: Comparison of Simulated FloppyTail PRE Values and Experimental
PRE Values. ..................................................................................................... 276
Figure 6.28: Comparison of Simulated FloppyTail_Relax PRE Values and
Experimental PRE Values. ............................................................................... 277
Figure 6.29: Comparison of Simulated FloppyTail_Rot PRE Values and
Experimental PRE Values. ............................................................................... 278
Figure 6.30: Comparison of Simulated FloppyTail_Rot_Relax PRE Values and
Experimental PRE Values. ............................................................................... 279
Figure 6.31: Comparison of Simulated FastFloppyTail PRE Values and
Experimental PRE Values. ............................................................................... 280
Figure 6.32: Comparison of Simulated FastFloppyTail PRE Values and
Experimental PRE Values. ............................................................................... 281
Figure 6.33: Comparison of Simulated AbInitio PRE Values and Experimental
PRE Values. ..................................................................................................... 282
Figure 6.34: Comparison of Simulated AbInitioVO PRE Values and Experimental
PRE Values. ..................................................................................................... 283
Figure 6.35: Comparison of Simulated DeNovoIDP PRE Values and
Experimental PRE Values. ............................................................................... 284
Figure 6.36: Comparison of Simulated Beta_PP and Experimental NMR
Chemical Shift Data. ......................................................................................... 285

xx

Figure 6.37: Comparison of Simulated Beta_PPFI and Experimental NMR
Chemical Shift Data. ......................................................................................... 286
Figure 6.38: Comparison of Simulated Beta_PPFISC and Experimental NMR
Chemical Shift Data. ......................................................................................... 287
Figure 6.39: Comparison of Simulated Beta_PPSC and Experimental NMR
Chemical Shift Data. ......................................................................................... 288
Figure 6.40: Comparison of Simulated CenStd_PP and Experimental NMR
Chemical Shift Data. ......................................................................................... 289
Figure 6.41: Comparison of Simulated CenStd_PPFI and Experimental NMR
Chemical Shift Data. ......................................................................................... 290
Figure 6.42: Comparison of Simulated CenStd_Ext_PP and Experimental NMR
Chemical Shift Data. ......................................................................................... 291
Figure 6.43: Comparison of Simulated CenStd_Ext_PPFI and Experimental
NMR Chemical Shift Data. ................................................................................ 292
Figure 6.44: Comparison of Simulated CenNath and Experimental NMR
Chemical Shift Data. ......................................................................................... 293
Figure 6.45: Comparison of Simulated SimAnn_PP and Experimental NMR
Chemical Shift Data. ......................................................................................... 294
Figure 6.46: Comparison of Simulated SimAnn_PPFI and Experimental NMR
Chemical Shift Data. ......................................................................................... 295
Figure 6.47: Comparison of Simulated SimAnn_PPFISC and Experimental NMR
Chemical Shift Data. ......................................................................................... 296

xxi

Figure 6.48: Comparison of Simulated SimAnn_PPSC and Experimental NMR
Chemical Shift Data. ......................................................................................... 297
Figure 6.49: Comparison of Simulated VDW_PP and Experimental NMR
Chemical Shift Data. ......................................................................................... 298
Figure 6.50: Comparison of Simulated VDW_PPFI and Experimental NMR
Chemical Shift Data. ......................................................................................... 299
Figure 6.51: Comparison of Simulated VDW_PPFISC and Experimental NMR
Chemical Shift Data. ......................................................................................... 300
Figure 6.52: Comparison of Simulated FloppyTail_score12 and Experimental
NMR Chemical Shift Data. ................................................................................ 301
Figure 6.53: Comparison of Simulated FloppyTail_ref2015 and Experimental
NMR Chemical Shift Data. ................................................................................ 302
Figure 6.54: Comparison of Simulated FloppyTail_Quota and Experimental NMR
Chemical Shift Data. ......................................................................................... 303
Figure 6.55: Comparison of Simulated FloppyTail_NoFrags and Experimental
NMR Chemical Shift Data. ................................................................................ 304
Figure 6.56: Comparison of Simulated FloppyTail_Loops and Experimental NMR
Chemical Shift Data. ......................................................................................... 305
Figure 6.57: Comparison of Simulated FloppyTail and Experimental NMR
Chemical Shift Data. ......................................................................................... 306
Figure 6.58: Comparison of Simulated FloppyTail_Relax and Experimental NMR
Chemical Shift Data. ......................................................................................... 307

xxii

Figure 6.59: Comparison of Simulated FastFloppyTail and Experimental NMR
Chemical Shift Data. ......................................................................................... 308
Figure 6.60: Comparison of Simulated FastFloppyTail_Relax and Experimental
NMR Chemical Shift Data. ................................................................................ 309
Figure 6.61: Comparison of Simulated FloppyTail_Rot and Experimental NMR
Chemical Shift Data. ......................................................................................... 310
Figure 6.62: Comparison of Simulated FloppyTail_Rot_Relax and Experimental
NMR Chemical Shift Data. ................................................................................ 311
Figure 6.63: Comparison of Simulated AbInitio and Experimental NMR Chemical
Shift Data. ......................................................................................................... 312
Figure 6.64: Comparison of Simulated AbInitioVO and Experimental NMR
Chemical Shift Data. ......................................................................................... 313
Figure 6.65: Comparison of Simulated DeNovoIDP and Experimental NMR
Chemical Shift Data. ......................................................................................... 314
Figure 6.66a: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. .................................................................................................. 315
Figure 6.66b: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. .................................................................................................. 316
Figure 6.66c: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. .................................................................................................. 317
Figure 6.66d: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. .................................................................................................. 318

xxiii

Figure 6.66d: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. .................................................................................................. 319
Figure 6.66e: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. .................................................................................................. 320
Figure 6.66f: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. .................................................................................................. 321
Figure 6.66g: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. .................................................................................................. 322
Figure 6.67: Comparison of Simulated Beta_PP and Experimental J-Coupling
Data. ................................................................................................................. 323
Figure 6.68: Comparison of Simulated Beta_PPFI and Experimental J-Coupling
Data. ................................................................................................................. 324
Figure 6.69: Comparison of Simulated Beta_PPFISC and Experimental JCoupling Data. .................................................................................................. 325
Figure 6.70: Comparison of Simulated Beta_PPSC and Experimental J-Coupling
Data. ................................................................................................................. 326
Figure 6.71: Comparison of Simulated CenStd_PP and Experimental J-Coupling
Data. ................................................................................................................. 327
Figure 6.72: Comparison of Simulated CenStd_PPFI and Experimental JCoupling Data. .................................................................................................. 328
Figure 6.73: Comparison of Simulated CenStd_Ext_PP and Experimental JCoupling Data. .................................................................................................. 329

xxiv

Figure 6.74: Comparison with α-Synuclein PRE Data Comparison of Simulated
CenStd_Ext_PPFI and Experimental J-Coupling Data. .................................... 330
Figure 6.75: Comparison of Simulated CenNath and Experimental J-Coupling
Data. ................................................................................................................. 331
Figure 6.76: Comparison of Simulated SimAnn_PP and Experimental J-Coupling
Data. ................................................................................................................. 332
Figure 6.77: Comparison of Simulated SimAnn_PPFI and Experimental JCoupling Data. .................................................................................................. 333
Figure 6.78: Comparison of Simulated SimAnn_PPFISC and Experimental JCoupling Data. .................................................................................................. 334
Figure 6.79: Comparison of Simulated SimAnn_PPSC and Experimental JCoupling Data. .................................................................................................. 335
Figure 6.80: Comparison of Simulated VDW_PP and Experimental J-Coupling
Data. ................................................................................................................. 336
Figure 6.81: Comparison of Simulated VDW_PPFI and Experimental J-Coupling
Data. ................................................................................................................. 337
Figure 6.82: Comparison of Simulated VDW_PPFISC and Experimental JCoupling Data. .................................................................................................. 338
Figure 6.83: Comparison of Simulated FloppyTail_score12 and Experimental JCoupling Data. .................................................................................................. 339
Figure 6.84: Comparison of Simulated FloppyTail_ref2015 and Experimental JCoupling Data. .................................................................................................. 340

xxv

Figure 6.85: Comparison of Simulated FloppyTail_Quota and Experimental JCoupling Data. .................................................................................................. 341
Figure 6.86: Comparison of Simulated FloppyTail_NoFrags and Experimental JCoupling Data. .................................................................................................. 342
Figure 6.87: Comparison of Simulated FloppyTail_Loops and Experimental JCoupling Data. .................................................................................................. 343
Figure 6.88: Comparison of Simulated FloppyTail and Experimental J-Coupling
Data. ................................................................................................................. 344
Figure 6.89: Comparison of Simulated FloppyTail_Relax and Experimental JCoupling Data. .................................................................................................. 345
Figure 6.90: Comparison of Simulated FastFloppyTail and Experimental JCoupling Data. .................................................................................................. 346
Figure 6.91: Comparison of Simulated FastFloppyTail_Relax and Experimental
J-Coupling Data. ............................................................................................... 347
Figure 6.92: Comparison of Simulated FloppyTail_Rot and Experimental JCoupling Data. .................................................................................................. 348
Figure 6.93: Comparison of Simulated FloppyTail_Rot_Relax and Experimental
J-Coupling Data. ............................................................................................... 349
Figure 6.94: Comparison of Simulated AbInitio and Experimental J-Coupling
Data. ................................................................................................................. 350
Figure 6.95: Comparison of Simulated AbInitioVO and Experimental J-Coupling
Data. ................................................................................................................. 351

xxvi

Figure 6.96: Comparison of Simulated DeNovoIDP and Experimental J-Coupling
Data. ................................................................................................................. 352
Figure 6.97: Radii of Gyration of Ordered Proteins.......................................... 354
Figure 6.98: Radii of Gyration of Partially-Ordered Proteins. ........................... 355
Figure 6.99: Radii of Gyration of Disordered Proteins. .................................... 356
Figure 6.100: Folding Funnel Comparison for 1bka......................................... 357
Figure 6.101: Folding Funnel Comparison for 1bq9. ....................................... 357
Figure 6.102: Folding Funnel Comparison for 1enh. ....................................... 358
Figure 6.103: Folding Funnel Comparison for 1hz6......................................... 358
Figure 6.104: Folding Funnel Comparison for 1pgx......................................... 359
Figure 6.105: Folding Funnel Comparison for 1r69. ........................................ 359
Figure 6.106: Folding Funnel Comparison for 1shf.......................................... 360
Figure 6.107: Folding Funnel Comparison for 1ubi.......................................... 360
Figure 6.108: Folding Funnel Comparison for 5cro. ........................................ 361
Figure 6.109: Folding Funnel Comparison for 1b3a. ....................................... 361
Figure 6.110: Folding Funnel Comparison for 1d7q. ....................................... 362
Figure 6.111: Folding Funnel Comparison for 1ejf........................................... 362
Figure 6.112: Folding Funnel Comparison for 1fox.......................................... 363
Figure 6.113: Folding Funnel Comparison for 1ghc......................................... 363
Figure 6.114: Folding Funnel Comparison for 1lwm. ....................................... 364
Figure 6.115: Folding Funnel Comparison for 1vzs. ........................................ 364
Figure 6.116: Folding Funnel Comparison for 2l42.......................................... 365
Figure 6.117: Folding Funnel Comparison for 2lsu. ......................................... 365
xxvii

Figure 6.118: Folding Funnel Comparison for asyn. ........................................ 366
Figure 6.119: Folding Funnel Comparison for dsh3......................................... 366
Figure 6.120: Folding Funnel Comparison for ntal........................................... 367
Figure 6.121: Folding Funnel Comparison for paaa. ....................................... 367
Figure 6.122: Folding Funnel Comparison for sic1. ......................................... 368
Figure 6.123: Folding Funnel Comparison for tauk.......................................... 368
Figure 6.124: 1bk2 Lowest RMSD Structures.................................................. 369
Figure 6.125: 1bq9 Lowest RMSD Structures. ................................................ 369
Figure 6.126: 1enh Lowest RMSD Structures. ................................................ 369
Figure 6.127: 1hz6 Lowest RMSD Structures.................................................. 370
Figure 6.128: 1pgx Lowest RMSD Structures.................................................. 370
Figure 6.129: 1r69 Lowest RMSD Structures. ................................................. 371
Figure 6.130: 1shf Lowest RMSD Structures................................................... 371
Figure 6.131: 1ubi Lowest RMSD Structures................................................... 371
Figure 6.132: 5cro Lowest RMSD Structures. ................................................. 372
Figure 6.133: 1b3a Lowest RMSD Structures. ................................................ 372
Figure 6.134: 1d7q Lowest RMSD Structures. ................................................ 372
Figure 6.135: 1ejf Lowest RMSD Structures.................................................... 373
Figure 6.136: 1fox Lowest RMSD Structures................................................... 373
Figure 6.137: 1ghc Lowest RMSD Structures.................................................. 373
Figure 6.138: 1lwm Lowest RMSD Structures. ................................................ 374
Figure 6.139: 1vzs Lowest RMSD Structures. ................................................. 374
Figure 6.140: 2l42 Lowest RMSD Structures................................................... 375
xxviii

Figure 6.141: 2lsu Lowest RMSD Structures. .................................................. 375
Figure 6.142: 1b3a Lowest RMSD Full Structures........................................... 376
Figure 6.143: 1d7q Lowest RMSD Full Structures........................................... 376
Figure 6.144: 1ejf Lowest RMSD Full Structures. ............................................ 376
Figure 6.145: 1fox Lowest RMSD Full Structures. ........................................... 377
Figure 6.146: 1ghc Lowest RMSD Full Structures. .......................................... 377
Figure 6.147: 1lwm Lowest RMSD Full Structures. ......................................... 377
Figure 6.148: 1vzs Lowest RMSD Full Structures. 10 ..................................... 378
Figure 6.149: 2l42 Lowest RMSD Full Structures. ........................................... 378
Figure 6.150: 2lsu Lowest RMSD Full Structures. ........................................... 378
Figure 6.151: Asyn Lowest RMSD Full Structures........................................... 379
Figure 6.152: Dsh3 Lowest RMSD Full Structures. ......................................... 379
Figure 6.153: Ntal Lowest RMSD Full Structures. ........................................... 379
Figure 6.154: Paaa Lowest RMSD Full Structures. ......................................... 380
Figure 6.155: Sic1 Lowest RMSD Full Structures............................................ 380
Figure 6.156: Tauk Lowest RMSD Full Structures........................................... 380
Figure 7.1: Exemplar-based in-silico screening. .............................................. 395
Figure 7.2: Radioligand Structure and Initial Binding Assay. ........................... 396
Figure 7.3. Molecular structures of 17 compounds from the Exemplar screening.
......................................................................................................................... 397
Figure 7.4: Site 2 Exemplar from PDB 2N0A fibril. .......................................... 398
Figure 7.6: Site 9 Exemplar from PDB 2N0A fibril. .......................................... 400
Figure 7.7: Top Hits from ZINC15 database for Site 9 Exemplar..................... 401
xxix

Figure 7.8: Photocrosslinking of radioligand analog to αS fibrils. .................... 403
Figure 7.9: Impact of identified molecule on αS fibril aggregation and stability.
......................................................................................................................... 404
Figure 7.10: SAR screen based on exemplar compound (6). .......................... 406
Figure 7.11. Molecular structure of the 39 compounds from the similarity search.
......................................................................................................................... 407
Figure 7.12: Synthesis route towards 61 and [125I]61. ................................... 409
Figure 7.13: Characterization of the lead compound. ...................................... 410
Figure 7.14: In vitro autoradiography on mouse brain tissue sections to assess
[125I]61 binding. ............................................................................................... 411

xxx

CHAPTER 1: INTRODUCTION
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§ 1.1 The Role of Amlyoidogenic Proteins in Neurodegenerative Disease
Introduction to Disordered Proteins
Proteins are macromolecular biopolymers that carry out a variety of tasks
that give rise to cellular function. Each protein carries out a specific function or set
of functions which is often correlated with its structure. The specific composition of
amino acids and their arrangement, termed primary structure, allows for various
secondary structures, three-dimensional structural elements which dictate the
overall topology of a protein. Often, proteins can adopt multiple conformations,
each required for a specific task, and can move between these states to serve
several functional roles.1 Despite the longstanding view that a protein’s function is
tied to its structure via a specific sequence of amino acids, the emergence of
disordered proteins over the past two decades has urged this canonical model to
be refined.2 Intrinsically disordered proteins (IDPs) do not readily adopt a defined
architecture, but instead populate a variety of folds and conformations.2-4 This
ensemble of states is usually highly sensitive to stimuli, including changes in pH,
ionic strength and the presence of protein partners.3 These can modulate the
overall size, or radius of gyration, of a disordered protein and influence the
propensity of intramolecular contact formation.3 Furthermore, in specific cases,
these stimuli have been shown to elicit structural transitions by which a canonically
disordered protein adopts a stable fold.2-4 Partially ordered proteins, which contain
both well folded, ordered, domains in addition to intrinsically disordered regions
(IDRs) also exist with many combinations of ordered and disordered domains in a
single protein.2-4 Ultimately, IDPs and IDRs have been demonstrated to serve a
2

variety of both physiological and pathogenic roles over the past two decades,
which has prompted their study and encouraged a more robust comprehension of
how their structural lability gives rise their functionality.2-4

Figure 1.1: Structural differences between disordered and ordered proteins. Top:
Differences between the structure and rigidity of ordered and disordered proteins
as described by conformational energy landscapes. Bottom: Modulations of
disordered protein ensembles.

Functional Role of Disorder
IDPs and IDRs serve a variety of physiological functions in the cell which
are reliant on their ability to interact with several partners, respond to stimuli and
stabilize functional conformations.2 Recently, as much as 30% of the eukaryotic
proteome and 50% of the human proteome have been hypothesized to be partially
or fully disordered.5-6 As structural components, IDRs present sites on a protein
surface that can be modified by post-translational modifications (PTMs) or serve
as spacers between folded domains of a protein.2-3,

7

IDRs have been long

recognized in histones for their ability to be modified by a host of PTMs which elicit
3

various functional and signaling consequences.7 Furthermore, a variety of IDPs
contain molecular recognition features (MoRFs), allowing a disordered region,
upon interaction with a protein or DNA partner, to transition from a disordered to
an ordered state.3 For example, many transcription factors adopt helical folds when
interacting with their partner DNA motif but are otherwise disordered when not
complexed with DNA.4 Additionally, conformational ordering is also not required
for interaction and many IDPs and IDRs interact through the formation of fuzzy
complexes.3 These highly dynamic complexes, which have been theorized to be
held together by charge complementarity and cation-π interactions, give rise to the
formation of phase condensates and protein hubs. 8-10 Despite these dynamics,
these complexes can exist with exceptionally high affinities such as the
prothymosin α – histoneH1 interaction which has a sub-nanomolar binding
affinity.11 Functionally, these complexes serve as the basis for many important
cellular processes including transcription, DNA repair, signal transduction and
assembly of the ribosome.12-14 Therefore, a more robust understanding of the
underlying structure and dynamics of IDPs and IDRs will allow us to not only to
better understand which architectural aspects primes them to perform these duties,
but will likely also elucidate how mutations and misregulation can lead to disease.

Misfolding in Disease
Although the conformational fluidity of disordered proteins allows them to
perform a wide range of tasks, this often results in the exposure of hydrophobic
patches. This exposure makes this class of proteins notably aggregation prone
4

and amyloidogeneic.5 Proteins fold into their canonical active structures
sporadically or with the assistance of chaperones and other molecular machinery.1
However, the folding process is tightly regulated as adoption of an incorrect
topology can not only disrupt function but can serve as the basis of disease.5
Misfolding, or the adopt of an incorrect and sometimes pathogenic structure is
often associated with protein aggregation which is implicated in several
neurodegenerative diseases.5,

15

Prion diseases, including bovine spongiform

encephalopathy, or mad cow disease, and Creutzfeldt-Jakob disease, are likely
the most widely recognized protein misfolding diseases.15 Ingestion or exposure
to brain tissue from a specimen containing misfolded prion protein leads to further
misfolding of the prion protein endogenous to the patient, resulting in disease
propagation.15 Much like prions, amyloids are proteins whose topologies allow for
the template-based recruitment of other copies of the protein, generally resulting
in the formation of a β-sheet rich architecture known as an amyloid fibril.16 These
fibrils, along with the β-sheet rich oligomers that can form on- and off-pathway to
fibril formation, are cytotoxic and have been implicated in a variety of diseases. 5,
16

In neurodegeneration, amyloid fibrils consisting of the Huntington protein,

amyloid β, α-synuclein (αS) and tau have been implicated in Huntington’s Disease,
Parkinson’s Disease (PD), Alzheimer’s Disease and Chronic Traumatic
Encephalopathy (CTE), respectively.5,

16

Moreover, non-neurodegenerative

diseases such as Type II Diabetes, associated with islet amyloid polypeptide, and
cardiac amyloidosis, associated with transthyretin, are also caused by the
aggregation of amyloidogenic proteins.16-18 Although it is well understood that the
5

aggregation of these proteins leads to disease, the exact mechanisms of their
pathology and the processes that trigger their aggregation are not in many cases
elucidated.

Figure 1.2: Overview of the functional and pathological roles of αS. Top: Cartoon
representations of (left) helical morphologies associated with the membrane bound
forms, (middle) the disordered state and (right) toxic oligomeric and fibrillar forms
of αS. Middle: (left) Schematic representation of the functional role of αS and (right)
histological staining of LBs and LNs. Figures adapted from Laushel et. al. 19 Bottom:
Bullet point summaries of the functional (left) and pathological (right) roles of αS)

Physiological Role of Alpha-Synuclein
αS is member of a protein family consisting of three members and is a 140
amino acid long disordered protein.19-20 It consists of three domains, the first being
a 60 residue N-terminal domain (NTD) containing several imperfect 11 amino acid
6

amphipathic, KTKEGV motif, repeats.21 This domain is largely conserved across
the other two synuclein family members, β- and γ-synuclein, and adopts a helical
conformation when associated with membranes and vesicles. 21 Following the
NTD, the central domain of the protein, comprised of residues 61-94, is referred to
as the non-amyloid β component of Alzheimer’s disease amyloid plaque (NAC)
domain.19-21 This name originates from the identification of fragments of this
domain within plaques comprised primarily of amyloid β in the brains of Alzheimer’s
Disease patients.19-20 The largely hydrophobic NAC domain has been shown to be
essential for αS aggregation and adopts a variety of β-sheet rich architectures in
the oligomers and fibrils.19-21 The final C-terminal domain (CTD) of αS boasts a
significant enrichment in acidic residues and is found to be consistently disordered,
regardless of the structure of the NTD or NAC domain.19-21
Despite its long-recognized role in the pathogenesis of PD, the functional
role of αS has remained far more elusive.22 αS is primarily localized at the synaptic
termini of neurons and is purported to serve a variety of functions and interact with
several protein partners.19-20 Although αS is primarily disordered in the cytosol,
single-molecule FRET, nuclear magnetic resonance (NMR) and electron
paramagnetic resonance (EPR) studies have revealed that αS can adopt a variety
of helical conformations when interacting with membranes and vesicles. 23-25
Moreover, these conformations are modulated by the curvature of the
membrane.24 On high curvature vesicles, αS adopts a bent helix conformation
consisting of two helical stretches connected by a disordered loop, and on low
curvature membranes the protein adopts a single extended helix. 24 Additionally,
7

the final C-terminal third of the protein remains disordered, regardless of the
specific helical conformer.

23-25

In the helical membrane-bound state, αS

contributes to synaptic plasticity, vesicle recycling, neurotransmitter release and
other phenomena.19-20 Soluble N-ethylmaleimide-sensitive factor Attachment
Protein Receptor (SNARE) proteins facilitate membrane fusion which leads to
neurotransmitter release at synapses.26 In vitro and cellular studies have revealed
that interactions between αS and SNARE proteins, specifically VAMP-2 and
synaptobrevin, promote SNARE complex formation and vesicle docking. 27-29
These studies, along with knockouts of α-, β-, and γ-synuclein, suggest that αS is
a nonessential component of the larger set of machinery responsible for vesicle
reserve pool regulation and neurotransmitter release.19

Role of Alpha-Synuclein in Parkinson’s Disease
Insoluble deposits, comprised of fibrillar αS, found in the brain have long
served as a post-mortem hallmark of PD. These in soluble deposits, known as
Lewy Bodies (LBs) and Lewy Neurites (LBs), are found primarily in the substantia
nigra pars compacta of PD patients. 19, 22 LBs and LNs are linked with dopaminergic
neuronal death which leads to the well-recognized clinical presentations of the
disease.30 Aggregates of αS are theorized to spread from this initial location
throughout the brain over the course of disease progression. 31-32 Additionally, αS
aggregates have been associated with other neurodegenerative diseases, termed
synucleinopathies.33 αS aggregates take the form of LBs in dementia with Lewy
Bodies, however in other synucleinopathies, such as multiple systems atrophy
8

(MSA), aggregates present as glia cell inclusion (GCIs).34 These different
aggregate morphologies are often associated with different regions of the brain, as
GCIs are often found in oligodendrocytes of white matter tracts. 34 Although the
presence of αS containing plaques is long recognized, there still exists some
debate as to whether these features are causative or emerge later in disease
progression, playing a potentially protective role.35 However, direct administration
of fibrillar αS prepared in vitro to cultured neurons, or intrastriatally injected into the
brains of model mice, has demonstrated that the presence of fibrillar αS is sufficient
to elicit disease phenotypes associated with PD.36-38 Lastly, several familial
mutations within the gene responsible for αS production have been identified with
increased risks for PD.39-46 These mutations either increase the copy number of
αS, thus enhancing aggregation propensity, or result in alteration of the protein
sequence.39-40 Of the latter, five mutations to date (A30P, E446K, H50Q, G51D,
and A53T) have been observed in patients and greatly increase their risk for PD. 4146

These results together substantiate the need to better understand the

mechanisms behind the aggregation of αS and other amyloidogenic proteins and
their role in pathogenesis.

Impetus for Dissertation Studies
Despite the long-recognized role of αS aggregates in PD pathogenesis,
structural and mechanistic understandings of αS aggregation and toxicity have
been lacking. This gap in knowledge has not only hindered our comprehension of
disease progression and onset but has also limited our ability to therapeutically
9

target PD or monitor the disease using molecular probes. Since the start of the
work presented herein, solid-state NMR, and most impactfully cryo-electron
microscopy (cryoEM), have emerged as powerful techniques for capturing the
complex architectures associated with the fibrillar forms of αS.47-50
The work presented herein focuses on combing computational and
experimental approaches to understand the unfolded state of αS and how the
unfolded conformational ensemble can be modulated. Initially, this work highlights
the development of novel minimally perturbing fluorophores, which can be
employed in a variety of fluorescence-based assays.51-52 Subsequently, in-line with
the long-term goal, this thesis work demonstrates how fluorescence spectroscopy
can be leveraged to gain sufficient information to generate accurate experimentally
constrained molecular models of the disordered state of αS. 53 These initial efforts
led not only to improved experimental methods, but to the development of new
computational approaches, capable of accurately predicting the structure of both
ordered and disordered protein systems from their sequence. Lastly, this work
explores the use of in silico screening methods, which use the recently available
fibrillar structure of αS as inputs, to generate compounds which can be useful as
radiolabelled imaging agents. Overall, the work described herein consists of a
variety of experimental and computational method designed to gain better
mechanistic and structural understanding of disordered and aggregation prone
proteins.
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§ 1.2 The Utility of Fluorescence and FRET in Studying Protein Structure
Several different methods have been employed to study the conformations
of proteins and track protein dynamics. Most of our understanding of protein
structure to date has come from x-ray crystallography, NMR and, more recently,
cryo-EM.1-2, 54-55 However, these techniques are incapable of producing structures
for highly dynamic and heterogeneous systems and are generally not well-suited
to cellular studies.2, 54, 56 Alternatively, fluorescence-based experiments boast both
the ability to be performed in cells and can be used to monitor complex systems.57
However, these advantages are juxtaposed by a steep reduction in the amount of
structural detail obtained. Therefore, fluorescence-based experiments have
proven as a highly useful complement to these more data rich approaches for
watching protein systems in action.

Overview of Fluorescence and FRET
Fluorescence occurs when a photon interacts with a molecule resulting in
the emission of a photon of a different wavelength from the molecule. As depicted
in Fig. 1.3, a molecule can absorb the energy of an incident photon provided the
wavelength

of

the

light

matches

the

energy

of

allowed

molecular

electronic/vibrational transitions. This places the molecule into an excited state.
Once in an excited state, a portion of the energy is often dissipated through various
non-radiative decay processes, which are often associated with molecular motion.
Ultimately, fluorescence occurs when the molecule returns to the ground state,
emitting the remaining energy as a photon, which is now shifted in wavelength from
11

the initial absorbed photon. This shift is known as the Stokes Shift, and is
principally dictated by the vibrational modes of the molecule but can be affected
by the molecule’s surrounding environment. In addition to fluorescence, a variety
of relaxation processes can result in the dissipation of energy, returning a molecule
in the excited stated to the ground state. By transferring energy into the
surrounding environment, or through intersystem crossing, where the molecule
enters the triplet state via an electronic spin flip, a molecule can relax to the ground
state in the absence of fluorescence. The probability with which a photon absorbed
by a molecule results in a fluorescent event is termed the quantum yield and is
governed by the rates of radiative and non-radiative decay intrinsic to the molecule.
Additionally, the fluorescence or excited state lifetime of a molecule is the time the
molecule spends in the excited state, following an initial excitation, before emitting
a photon. Much like the Stokes shift, the lifetime and quantum yield associated
with a molecule’s fluorescence can be modulated by the molecule’s surrounding
environment.57
One photophysical phenomenon that can greatly enhanced the amount of
information which can be gleaned from fluorescence-based experiment is Förster
Resonance Energy Transfer (FRET). Initially described by Theodor Förster in
1948, FRET involves the distance-dependent resonance energy transfer between
two molecules.58 During FRET, a donor fluorophore in the excited stated is
quenched, or returned to the ground state, by non-radiatively transmitting energy
to an acceptor chromophore. Two major criteria dictate whether two molecules can
be in resonance and therefore participate in FRET. First, the specific three12

dimensional orientation of the molecules’ absorption and emission dipoles governs
the dipole coupling. Second, there must exist an energetic overlap between the
transition energy associated with the donor’s relaxation and the excitation energy
of the acceptor. This is most easily visualized as an overlap between the donor
fluorophore’s emission spectra and the acceptor chromophore’s absorbance
spectra, as is shown in Fig. 1.3. The energy transfer probability, also referred to as
the FRET efficiency, has a sixth-order dependency on the intermolecular
separation.

57-58

Molecular pairs are often defined by their Förster radius, or

distance at which the FRET efficiency is one-half, which is largely ascribed to the
wavelengths associated with the pair’s spectral overlap. These dependencies are
mathematically defined in the latter part of this thesis.57
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Figure 1.3: Overview of Fluorescence and FRET. Left: Jablonski diagram
depicting vertical transitions associated with absorbance (upward arrows) and
fluorescence (downward solid arrows) along with non-radiative relaxations
(downward dashed arrows) and FRET (dashed grey arrows) between a donor
(fluorescein, chemical structure, green) and acceptor (tetramethylrhoadamine,
chemical structure, red) fluorophore. Right Top: Absorbance (blue: fluorescein,
orange: tetramethylrhoadamine) and fluorescence (green: fluorescein, red:
tetramethylrhoadamine) spectra corresponding to Jablonski diagram transitions.
Right Bottom: Plot depicting the relationship between FRET efficiency and interprobe difference, with the coloration representing the associated fluorophore
emission.

Description of FRET’s use in Monitoring Conformational Changes
The sensitivity of FRET, coupled with the ability of fluorescence-based
experiments to be employed in a wide variety of contexts, has supported its
employment to observe the structure and motions of various biopolymers (DNA,
RNA, proteins). FRET had been used to track changes in protein conformation,
assembly and disassembly of protein complexes, interactions between protein
14

partners and many other phenomena.59 Recently, FRET has become a useful
modality for studying disordered proteins, as various features associated with the
heterogeneity of these systems preclude their study by several other methods. 60
X-ray crystallography, which is reliant on the formation of protein crystals, requires
sampling to be highly homogenous thereby eliminating it as an option for studying
disordered systems.55-56 Although cryo-EM is inherently a single-molecule
technique, where data from discreet molecules can be combined, the features
required for robust particle averaging prevent it from reporting on disordered
structural ensembles.54 Furthermore, in solution-phase NMR, the multiplicity of
conformers, coupled with the lack of environmental distinction between residues,
results in significant signal broadening and overlap.2 In most cases this makes
assignment of chemical shifts to individual residues difficult and, when possible,
does not deliver as detailed information as would be acquired for a well-folded
protein.2, 56 Like FRET, EPR and paramagnetic relaxation enhancement (PRE) can
be used to obtain inter-residue distance information.3,

61

PRE experiments

measure distances between a single residue and all other residues in a protein. 61
Although this technique delivers significantly more data than FRET, complexities
assigning chemical shifts and a working distance of < 30 Å, which would likely not
capture the more extended structural conformations generally associated with
disordered systems, hinder application of this technique.61 EPR provides
information about the distance between two spin labeled residues on a protein
along with the distribution of distances populated.61 However, much like other
techniques, the significant heterogeneity and breadth of the distance distribution
15

between spin labels results in inaccuracies in analysis. 61 Lastly, all of these
techniques are either inherently in vitro methods or are extremely challenging to
implement in a cellular context.55, 62 Therefore, FRET’s ability to capture pairwise,
inter-residue distance information, though seemingly limited, is one of the few
approaches well suited to track changes in IDP conformation.

Application of FRET to IDPs
Ensemble FRET, and more often single-molecule FRET (smFRET), has
been used to study a variety of disordered and unfolded protein systems.59-60, 63 By
combining the photophysical phenomena of FRET with time-correlated single
photon counting (TCSPC) and the use of microscopes, FRET measurements can
be made on molecules one at a time, allowing subpopulations, which are often lost
in ensemble experiments, to emerge.60 This has been used to measure the overall
size, or radius of gyration, of disordered and unfolded systems and track the effects
of PTMs, mutations and environmental factors on protein size.59-60 Despite several
years of debate, the accuracy of these measurements has recently been
corroborated by small-angle x-ray scattering (SAXS), following technical and
analytical improvements to both methods.64-66 Additionally, since smFRET-based
techniques can be performed on millisecond timescales, conformational switching
and other dynamic processes can be observed. 59 For example, the previously
described folding phenomena associated with the interaction of αS with lipid
membranes has been tracked by smFRET, as has the formation of oligomeric
species en-route to fibril formation.24, 67 Lastly, smFRET has been utilized in a
16

variety of protein unfolding studies, which many researchers have used as models
of disordered systems.60
Despite the utility of FRET in studying disordered systems, the
heterogeneity associated with IDPs and IDRs presents unique hurtles for analyzing
FRET data.60 Traditionally, the interpretation of FRET data for folded proteins is
hindered by the assumption that the attached fluorophores are capable of diffusing
isotropically.57 This presents a challenge in accurately determining the distance
between the two probes, due to inaccuracies in the computed orientation factor
which impacts the transfer efficiency between two probes. However, FRET for
disordered systems suffers from the opposite problem. Although these highly
dynamic proteins relieve concerns associated with the orientation factor, they give
rise to a new concern regarding the implicit assumption in the canonical Förster
equation that the fluorophores are separated by a single distance. 60, 65 This is not
a concern for folded proteins where breadth of the distribution of any inter-residue
distance is negligible but presents a clear problem for proteins which populate
multiple conformations or whose populations span a significant distribution of
distances.57, 60, 65 In part, this issue can be combatted by performing smFRET, in
place of ensemble FRET, which can report on the presence of distinct
subpopulations.59-60 However, this does not fully alleviate the problem as the
millisecond measurement timescale is not rapid enough, nor is the signal-to-noise
generally high enough, to capture information regarding the distribution breadth of
sub-ensembles.60 Therefore, most researchers utilize a modified version of the
Förster equation, shown in detail in the latter parts of this thesis, adding a
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probability distribution to the traditional equation.60,

65

Although this appears to

remedy the issue, allowing a single FRET efficiency to be correlated with a
distribution of states, these probability distributions often need to be supplied by
the researcher.60, 65 Due to the topological similarities between disordered proteins
and polymers, distributions from polymer physics are often employed. 60, 65, 68 The
work presented herein demonstrates how the use of multiple FRET probe pairs
can facilitate distribution selection and how these distributions and FRET data can
be utilized to construct molecular models of disordered proteins.

Development of Novel, Minimally Perturbing Fluorescent Probes
Depending on the experimental requisites, the effectiveness of most FRET
experiments relies on the choice of appropriate fluorophores. Quantities such as
quantum yield and extinction coefficient inform the overall “brightness” of the
molecule, which is important in cellular and single-molecule experiments.69
Additionally, the specific spectral range over which the pair of molecules absorb
and fluoresce, not only informs their Förster Radius and ability to serve as a FRET
pair, but also allows the measurement to circumvent any background signal which
can complicate the measurement.57 However, beyond the photophysical
characteristics of the molecule, the overall molecular size, composition and
attachment site may hinder the measurement efficacy by perturbing the system. 7071

Many cell-based experiments, as well as some in vitro experiments, leverage

the use of fluorescent fusion proteins, such as green fluorescent protein (GFP).72
Although these are currently the field standard, these fluorescent proteins often
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lack the photophysical criteria optimal for most experiments.73 Moreover, their size
is typically on the order of the size of the systems they are used to measure. This
often significantly complicates the interpretation of the measurement or can perturb
the systems, preventing the biomolecule’s normal function. Ultimately, several
groups have focused on replacing the use of GFP with Halo- and SNAP-tag fusion
proteins, which can be subsequently specifically labeled with fluorophores that
boast improved photophysical characteristics to enhance measurement quality. 7275

However, these fusion proteins still rival, and in some cases surpass, the size of

GPF, making the potential for perturbation non-trivial.71, 74-75
With this is mind, the Petersson Laboratory has focused on developing
fluorescent probes which are minimally perturbing to the protein conformation and
dynamics. This has been accomplished by focusing on small fluorescent scaffolds
which can be modified by appending molecular handles, lowering the barrier for
their use, and derivatizing these scaffolds to improve their photophysical
characteristics.52, 76-78 To date, the bulk of this effort has been focused on the use
of thioamides, single atom oxygen-to-sulfur substitutions, as fluorescence
quenching motifs.79-81 Additionally, the group has developed a derivative of
acridone, acridon-2-lyalanine (Acd), which allows this small fluorophore to be
directly incorporated within the primary structure of a protein via unnatural amino
acid (UAA) mutagenesis.77 These two efforts, along with the derivatization of other
base

scaffolds

such

as

dimethylaminoquinoline

(DMAQ),

have

been

supplemented by identifying additional fluorophores which can serve as FRET
donors or acceptors for these probes.51-52, 76-77 These developments, along with
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the employment of UAA mutagenesis, are described in part in this thesis work and
have provided several novel fluorescent tools which are minimally perturbing to
protein structure.
Methods for Introducing Fluorescent Probes (UAA Mutagenesis)
One of the major techniques used in this work to generate fluorescently
labeled protein constructs is unnatural amino acid (UAA) mutagenesis. This
method is used herein to incorporate both natively fluorescent amino acids and
amino acids that serve as biorthogonal handles for chemical labeling with synthetic
dyes.51, 53, 78 The utility of this technique is based on the concept that by hijacking
the native machinery of the cell, one can ensure precise labeling of a protein with
a given probe by encoding it at the DNA level. Although more non-specific
approaches are also used herein (cysteine labeling, tryptophan fluorescence, etc.)
they are exclusively employed in systems where they can be leveraged sitespecifically.53, 78
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Figure 1.4: Overview of unnatural amino acid mutagenesis. Incorporation of two
plasmids, one containing a protein of interested with a TAG codon and a second
containing a UAA specific synthetase (UAARS) and cognate tRNA (tRNACUA)
which recognizes the TAG codon, allows for site specific incorporation of an
unnatural amino acid (UAA) which is supplied directly in the cellular media. Boxed:
Depiction of some of the UAA used in this work which are endogenously
fluorescent (Cnf, Acd) and others (Ppy) that can be labeled after being
incorporated within a protein of interest.

Site-specific UAA mutagenesis was first reported by Peter Schultz and
colleagues in 1989 using in vitro methods, and its current implementation relies on
the incorporation of new machinery into the cell that has been evolved to be
orthogonal to the existent components.82-85 During protein synthesis, each amino
acid is recognized by an aminoacyl tRNA synthetase (aaRS) which is responsible
for charging this amino acid to a specific tRNA.82-83 This process allows the genetic
code to be converted into a protein sequence by assuring that each triplet of bases
in mRNA, which is transcribed from the DNA, is read by a single tRNA that carries,
and results in the translation of, a single amino acid.1, 83 Therefore, by encoding for
incorporation of a fluorescent amino acid at the DNA level, and developing the
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appropriate orthogonality of the requisite machinery, we can ensure specific
incorporation of the desired probe at an exact location in a protein of interest. 78
Due to the requisite specificity, development of the aaRSs utilizes directed
evolution and a new aaRS often needs to be generated for each new amino acid
derivative.86-87 The directed evolution process combines positive screens, where
aaRSs which can charge the appropriate tRNA are selected for and retained. 88
Subsequently, negative selections are performed where aaRSs are screened for
their specificity for the desired UAA against all native or undesired amino acids. 88
Lastly, due to the multiplicity of effective orthogonal synthetases developed to date,
many efforts simply screen new UAAs against libraries of existing aaRSs.89
Although other methods exist such as the use of auxotrophic cell lines,
which lack a specific amino acid, or the employment of quadruplet codons, most
UAA incorporation efforts rely on suppression of an amber stop codon. 90-91 The
amber stop codon is endogenously recognized by release factor 1 (RF1), triggering
release of the growing polypeptide chain from the ribosome. 92 Therefore, binding
of the appropriate charged tRNA to mRNA on the ribosome is always in
competition with RF1, resulting in a mixture of truncated protein and full-length
protein containing the desired UAA.92-93 To circumvent this issue, researchers
have developed RF1 knockout cell lines, and Church and colleagues have
engineered an E. Coli cell line which both lacks RF1 and has a full genomic
replacement of amber stop codons with ochre (UAA) stop codons.93-94 However,
Petersson and colleagues developed an alternative strategy to ensure that
following protein expression, only purification of the desired, full-length protein
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occurs.95 This method leverages Ni-affinity chromatography procedures via the
fusion of a C-terminal intein-His6 fusion to the protein of interest. This allows for
isolation of the protein by affinity chromatography exclusively in the situation where
the amber stop codon is effectively suppressed and an amino acid is incorporated.
Subsequently, the intein can undergo self-excision which is triggered by the
addition of β-mercaptoethanol, resulting in the generation of the native C-terminal
carboxylic acid at the end of the protein of interest.95-96 Overall, the methods for
developing and introducing minimally perturbing fluorescence probes have
provided the necessary constructs for all of the fluorescence-based experiments
described herein.

§ 1.3 Computational Methods for Modeling Disordered Proteins
Since the conformational ensembles populated by disordered proteins have
remained elusive and no clear single experimental approach has been identified
that can report on the multitude of states, a significant effort has been put forth to
supplement experimental data with computational simulations. Initially, structural
ensembles were generated from self-avoiding walk and other polymer-physics
based simulations. By utilizing experimental data from PRE, residual dipolar
coupling and other NMR-based experiments, models containing little to no
chemical information could be refined to match input data. These initial randomcoil simulations generally treated proteins as self-avoiding polymers with bonding
geometries serving as the only chemical consideration. Since these initial
developments, a significant amount of effort has been devoted to developing both
23

molecular dynamics (MD) and Monte Carlo (MC) based methods to provide
improved platforms that accurately capture disordered systems.

Description of previous efforts in Molecular Dynamic
MD methods, which utilize Newtonian physics to simulate molecular
motions, are among the most widely employed for the study of protein dynamics.
Although the force-fields and atomic parameters have been refined over many
years to accurately capture protein motions in folded protein systems, initial
simulations of disordered structures were far from accurate.97-100 These
inaccuracies generally manifest as an over-population of secondary structural
elements, usually helices, and over-compaction of the protein.97-100 Several groups,
including Shaw and colleagues, focused on developing not only new force-fields
but also new water models, which vastly improved the state-of-the-art.97,

99, 101

Despite these improvements, the required hardware and compute times for MD
simulations present a high barrier to entry, limiting the use of these methods to
short trajectories unless elaborate computational resources are employed.102-103
Furthermore, simulations that predict the fold of a protein in its native threedimensional architecture have been largely intractable in MD simulations outside
of a limited number of small, fast-folding proteins.99 Overall, the requisite for
sophisticated hardware, along with an inability to produce accurate folded
structures from sequence, limits the utility of MD for predicting protein structure
despite being the current state-of-the-art for disordered systems.
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Alternatives to Molecular Dynamics
Outside of MD, there have been similar efforts to update existing tools as
well as develop new packages for handling disordered proteins. In addition to the
initially described, largely polymer-based, modeling approaches used to refine
ensembles from experimental data, there have been several efforts to develop
methods which adequately capture the complexities of various IDPs.104-108 Several
packages, such as AWSEM-IDP, have developed improved course-grained forcefields and sampling approaches to circumvent the computational time and
hardware requirements for sufficient sampling.109-110 CAMPARI, developed by
Pappu and colleagues, utilizes Metropolis MC sampling alongside ABSINTH, an
implicit solvent model, and has proven to be the most widely accepted non-MD
method to date for producing accurate disordered protein ensembles. 101,

110-111

Although there currently exist several packages, many of which were developed
during this thesis work, no package to date boasts the ability to predict the structure
of both ordered and disordered proteins from primary sequence in a unified
architecture.
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Figure 1.5: Overview of PyRosetta. Left: Depiction of the three primary
components that serve as the basis for Monte-Carlo sampling in PyRosetta. Right:
Examples of each of the core components of PyRosetta.112

The Rosetta Modeling Suite
One software package that has demonstrated considerable success in
predicting the structure of a folded protein from its sequence is the Rosetta
Modeling Suite. The Rosetta Modeling Suite was initially developed by Baker and
colleagues but has continued to be improved and maintained by the over 150
developers from 60 laboratories at 23 universities that contribute to Rosetta
Commons.112 Although initially conceived with the goal of protein design in mind,
methods in Rosetta include de novo protein structure prediction, protein and ligand
docking, modeling with experimental data and more.112-113 Rosetta operates off of
a relatively simplistic underlying architecture by which sampling methods, termed
movers, are applied to given molecule, generally a protein, called a pose, with the
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efficacy of each sampling step captured by sets of energy terms, referred to as
score functions.112 Although the bulk of Rosetta exists as compiled C++ packages
consisting of previously devised algorithms, new algorithms can be facilely devised
using PyRosetta.114 PyRosetta, written by Gray and colleagues, provides Python
wrappers for the underlying functionalities in Rosetta, allowing users to rapidly
develop new methods in Python, without needing to compile.114 Therefore, by
using existing features of Rosetta, as well as incorporating novel methods for
improving sampling and scoring using functionalities in Python, the work detailed
herein has focused on developing a unified architecture for the de novo prediction
of both folded and unfolded proteins. Lastly, the latter portion of this thesis work
focuses on how a sub-package of Rosetta, designed for identifying pockets on a
protein surface, can be leveraged to identify potential molecular probes that bind
to αS fibril structures.
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CHAPTER 2: MULTICOLOR
SELECTIVE

PROTEIN FRET WITH TRYPTOPHAN,

COUMARIN-CYSTEINE

LABELING,

AND

GENETIC

ACRIDONYLALANINE ENCODING.
The content of this chapter was originally published in Chemical Communications.
It is adapted here with permission from the publisher:
Multicolor protein FRET with tryptophan, selective coumarin-cysteine labeling, and
genetic acridonylalanine encoding. J. J. Ferrie, N. Ieda, C. M. Haney, C. R.
Walters, I. Sungwienwong, J. Yoon and E. J. Petersson, Chem. Commun.,
2017, 53, 11072 DOI: 10.1039/C7CC05492K – Reproduced by permission of The
Royal Society of Chemistry.
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§ 2.1 Introduction
Site-specific fluorescence probes can be used to measure distances within
proteins when used as part of a Förster resonance energy transfer (FRET) pair.
Here we report the synthesis of a coumarin maleimide (Mcm-Mal) that is
fluorogenic upon reaction with cysteine.

We demonstrate that cysteine,

acridonylalanine (Acd) double mutant proteins can be produced by unnatural
amino acid mutagenesis and reacted with Mcm-Mal to generate Mcm/Acd labeled
proteins for FRET studies. The Mcm/Acd FRET pair is minimally-perturbing, easy
to install, and well-suited to studying protein distances in the 15-40 Å range.
Furthermore, Mcm/Acd labeling can be combined with tryptophan fluorescence in
three color FRET to monitor multiple interactions in one experiment.
Fluorescence spectroscopy methods can be valuable ways of studying
protein folding and dynamics, as they allow one to observe protein motions in real
time under physiological conditions.115-116 If two probes can be attached to the
protein, one can obtain structural information using distance-dependent
interactions such as Förster resonance energy transfer (FRET) and quenching by
photo-induced electron transfer.57 The development of probes that can be easily
installed for these applications is an important area of bioorganic chemistry. Here,
we report the synthesis of methoxycoumarin maleimide (Mcm-Mal, Fig. 2.1), a
probe that can be used as part of a FRET pair with acridonylalanine (Acd). We
further demonstrate that Mcm/Acd labeling can be combined with a single Trp
mutant for three color FRET experiments, which can be used to simultaneously
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monitor two interactions, such as a protein/protein interaction and a conformational
change within one of the proteins.

Figure 2.1: Mcm labelling for FRET experiments. Protein expressed with Cys and
acridonylalanine (Acd, ) mutants is harvested as an intein fusion and reacted with
methoxycoumarin maleimide (Mcm-Mal) for two color FRET experiments. Inset:
Three color FRET between Trp (purple), Mcm (pink), and Acd (cyan) can be used
to detect binding (Trp excitation) and conformational change (Mcm excitation)
simultaneously.

The fluorescent labeling of proteins for FRET studies has been greatly
enabled by recent advances in site-specific protein modification, particularly
through incorporation of unnatural amino acids (Uaas) and biorthogonal
reactions.117 However, there are still limitations to commonly used fluorophores
such as fluorescein and rhodamine that can hamper FRET experiments. Their
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large size can be disruptive to protein folding, and their working range for FRET
may not be suited to distance changes in the proteins. The fluorescein/ rhodamine
FRET pair has a Förster radius (R0, the distance of half-maximal energy transfer)
of ~50 Å, making it useful for studying distances in the 30-90 Å range. Since many
important intraprotein distances are shorter than 30 Å, small short-range FRET
pairs are better suited to studying these protein regions.
Our laboratory has worked to develop non-perturbing, short/medium-range
probe pairs that can be selectively excited in proteins. These include fluorescent
Uaas such as Acd.77, 118 Acd is excited at 380-400 nm with emission at 420-450
nm.

We have shown that Acd can be a valuable FRET acceptor from

methoxycoumarin (Mcm, excited at 325 nm) with a working range of 15-40 Å.77
Mcm is an excellent FRET donor to Acd since it has a high extinction coefficient
with a peak in the absorption spectrum that coincides with a minimum in the Acd
absorption spectrum (Fig. 2.16).

However, in previous studies, Mcm was

introduced as 7-methoxycoumarin-4-yl-alanine, which must be incorporated by
solid phase peptide synthesis.77 We wished to introduce Mcm through selective
Cys modification in order to more easily generate Mcm/Acd labelled proteins.

§ 2.2 Characterization of Mcm-Mal and Mcm-Br
Determination of Mcm-Mal Extinction Coefficient.
Mcm-Mal, Ac-Cys and Mcm-AcOH (~2 mg) were weighted on an analytical
balance. Mcm-Mal and Mcm-AcOH were dissolved in 100 μL DMSO while Ac-Cys
was dissolved in 900 μL 20 mM Tris 100 mM NaCl pH 7.5. Mcm-Mal was reacted
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with a 100-fold excess of Ac-Cys (resulting solutions < 1 % DMSO) and allowed to
react for 6 hour. Following reaction, multiple dilutions were prepared of Mcm-Mal
+ Ac-Cys and Mcm-AcOH and the UV-Vis absorbance of each sample was
measured. The absorbance at 325 nm of each sample was plotted as function of
concentration based on mass calculation and fit to a line with the extinction
coefficient determined by the slope (εMcm-AcOH = 14440 M-1 cm-1, εMcm-Mal = 19010
M-1 cm-1).

Figure 2.2: Determination of Extinction Coefficient for Mcm-Mal. Top Left:
Absorbance spectra of varying concentration of Mcm-AcOH in 20 mM Tris 100 mM
NaCl pH 7.5. Top Right: Absorbance spectra of varying concentration of Mcm-Mal
+ Ac-Cys in 20 mM Tris 100 mM NaCl pH 7.5. Bottom: Absorbance at 325 nm for
varying concentrations of Mcm-Mal + Ac-Cys and Mcm-AcOH in 20 mM Tris 100
mM NaCl pH 7.5, with linear correlation for determination of extinction coefficient.
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Reactions of Cys and Ac-Cys Monitored by UV/Vis, Fluorescence, and LCMS.
Stocks of Mcm-Mal and Mcm-Br were prepared in DMSO and stocks of Cys
and Ac-Cys were prepared in 100 mM Tris pH 7.0 or 20 mM Tris 100 mM NaCl pH
7.5, respectively. Mcm-Mal and Mcm-Br were mixed with buffer, Cys, or Ac-Cys
to final concentrations of 10 μM of both Mcm derivative and Cys/Ac-Cys for UVVis absorbance, steady-state fluorescence and LRMS measurements. Reactions
were allowed to take place for 6 hours following vortexing for 10 seconds prior to
measurement. Mcm-Br [M+H]+ Calcd. 269.0/271.0, Obs. 269.0/271.0; Mcm-Mal
[M+H]+ Calcd. 286.1, Obs. 286.2; Mcm-Mal + Cys (S4 or S5) [M+H]+ Calcd. 407.1,
Obs. 407.2; Mcm-Mal + Ac-Cys (S6) [M+H]+ Calcd. 449.1, Obs. 449.4
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Figure 2.3: Synthesis of Mcm-Br and Mcm-Mal. a) Ethyl acetoacetate, H2SO4,
65%; b) 1. Ac2O, HNO3; 2) H2 (g), Pd/C, 32% (over two steps); c) Maleic anhydride,
84%; d) NBS, NH4OAc, 78%

Figure 2.4: Absorbance and Fluorescence Spectra of Mcm-Br. Left: Absorbance
Spectra: 10 µM Mcm-Br in Tris buffer (100 mM, pH 7.0, DMSO 1%) alone, or mixed
with 10 µM Cys. Right: Fluorescence Spectra: 10 µM Mcm-Br in Tris buffer (100
mM, pH 7.0, DMSO 1%) alone, or mixed with 10 µM Cys. Fluorescence excitation
at 330 nm, emission monitored at 390 nm.
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Figure 2.5: LCMS Analysis of Mcm-Br Reactions with Cys. 10 µM Mcm-Br or
Mcm-Mal in Tris buffer (100 mM, pH 7.0, DMSO 1%) alone or mixed with 10 µM
Cys. LC chromatogram monitored at 330 nm. MS spectrum obtained for largest
peak in LC chromatogram.
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Figure 2.6: Mcm-Mal Reactions with Cys and Ac-Cys and assigned products.
Inset: Mcm-AcOH.

Figure 2.7: Absorbance and Fluorescence Spectra of Mcm-Mal. Left: Absorbance
Spectra: 10 µM Mcm-Mal in Tris buffer (10 mM, pH 7.0, DMSO 1%) alone, or mixed
with 10 µM Cys or Ac-Cys. Right: Fluorescence Spectra: 10 µM Mcm-Mal in Tris
buffer (100 mM, pH 7.0, DMSO 1%) alone, or mixed with 10 µM Cys or Ac-Cys.

Fluorescence measurements were obtained using the PTI Quantamaster in
20 mM Tris, 100 mM NaCl pH 7.5 buffer with an excitation wavelength of 325 nm,
measuring the emission from 350-450 nm, with 2 nm excitation and emission slit
widths, a step size of 1 nm, and an integration time of 0.25 seconds per step.
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Reaction Timecourses of Cys and Ac-Cys Monitored by Fluorescence.
For timecourse measurements, 2 μM dilutions were prepared for all
components from DMSO stocks of Mcm-Br/Mcm-Mal and stocks of Cys and AcCys in 20 mM Tris 100 mM NaCl pH 7.5. Buffer, Cys or Ac-Cys were added to
aliquots of Mcm-Mal or Mcm-Br in a 96-well plate immediately prior to
measurement in a Tecan M1000 plate reader producing final concentrations of 1
μM for all reaction components. Samples were excited at 325 nm and measured
and the emission was monitored at 400 nm with excitation and emission slit widths
of 5 nm. Measurements were taken every 20 seconds.
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Figure 2.8: LCMS Analysis of Mcm-Mal Reactions with Cys and Ac-Cys. 10 µM
Mcm-Mal in Tris buffer (100 mM, pH 7.0, DMSO 1%) alone or mixed with 10 µM
Cys or Ac-Cys. Cys reactions were incubated for 1 minute or 6 hours. LC
38

chromatogram monitored at 330 nm. MS spectrum obtained for largest peak in LC
chromatogram.

Figure 2.9: Mcm-Mal Reactions with Cys and Ac-Cys after 1 and 6 h. 10 µM McmMal in Tris buffered saline (20 mM Tris, 100 mM NaCl, pH 7.5, DMSO 1%) alone
or mixed with Cys or Ac-Cys. Fluorescence excitation at 325 nm, emission 350500 nm and acquired after 1 hour (left) or 6 hours (right).

Determination of Mcm-Mal post-reaction Quantum Yield.
Mcm-Mal was reacted with 10-fold excess Ac-Cys in 20 mM Tris 100 mM
NaCl pH 7.5 ( < 1% DMSO) for 6 hour. Six dilutions of reacted Mcm-Mal and 7methoxycoumarin-4-yl-acetic acid (Mcm-AcOH, see Fig 2.6, Scheme S2 inset)
ranging in absorbances from 0.05 to 0.02 were prepared. Fluorescence emission
spectra were measured at an excitation of 325 nm over an emission range of 335
to 550 nm with 5 nm slit widths, a 1 nm step width and a 0.25 second integration
time. The quantum yield was subsequently calculated for each Mcm-Mal/McmAcOH pair by multiplying the quantum yield of Mcm-AcOH (ΦMcm-AcOH = 0.18) by
the ratio of the sum of the fluorescence emissions of Mcm-Mal to Mcm-AcOH,
resulting in an average quantum yield of ΦMcm-Mal-Ac-Cys = 0.22.
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Figure 2.10: Determination of Quantum Yield for Ac-Cys Mcm Product. Top left:
Absorbance spectra of aliquots of Mcm-AcOH in 20 mM Tris 100 mM NaCl pH 7.5
ranging from 0.05 to 0.02. Top right: Absorbance spectra of aliquots of Ac-Cys
Mcm-Mal in 20 mM Tris 100 mM NaCl pH 7.5 ranging from 0.05 to 0.02. Middle
left: Fluorescence emission spectra of Mcm-AcOH dilutions in 20 mM Tris 100 mM
NaCl pH 7.5 at an excitation wavelength of 325 nm. Middle right: Fluorescence
emission spectra of Ac-Cys Mcm-Mal dilutions in 20 mM Tris 100 mM NaCl pH 7.5
at an excitation wavelength of 325 nm. Bottom left: Calculated quantum yield
values for each sample combination.
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§ 2.2 Protein Expression, Labeling and Purification
Cloning of CaM Constructs.
The gene encoding full-length calmodulin was previously cloned into the
pTXB1 vector containing a C-terminal MxeGyrA intein, followed by a His6
purification tag.95 A ‘TAG’ codon for the incorporation of Acd at Leu112 via amber
stop codon suppression and a ‘TGC’ codon encoding Cys at Phe12 for Mcm-Mal
labelling were inserted using the following sets of primers in QuikChange® PCR.
In the case of the F12C-L112δ double mutant, the CaM-F12C mutant was obtained
first, before using the TAG112 primers in a second round of PCR to obtain the
desired plasmid.

Expression of CaM C12-GyrA-H6.
A plasmid encoding CaM F12C-GyrA was transformed into BL21-Gold (DE3)
E. Coli cells and grown against ampicillin (Amp, 100 μg/mL) on an LB-agar plate.
Single colonies were picked and grown in liquid LB media (2 x 5 mL, 100 μg/mL
ampicillin) with shaking (250 RPM) at 37 C until saturation. Both primary cultures
were then added to a secondary culture of autoclaved M9 media (500 mL, 100
μg/mL Amp) and grown at 37 C, with shaking (250 RPM) until OD600= 0.8 (3-4 h).
Isopropyl β-D-1-thiogalactopyranoside (IPTG) was then added (final concentration
= 1 mM) and the temperature and shaking speed were reduced to 25 C and 225
RPM respectively for 16 h of additional incubation.
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Expression of CaM-δ112 and CaM-C12δ112.
Plasmids encoding CaM-δ112-GyrA-H6 and CaM-C12δ112-GyrA-H6 were
separately transformed into BL21 cells that also contain a plasmid encoding for an
orthogonal Acd synthetase 2b (AcdRS2b, also referred to as clone A9) and
tRNACUA pair described in detail elsewhere.95,
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These transformations were

grown against streptomycin (Strep, 100 μg/mL) and Amp (100 μg/mL) on an LBagar plate. Single colonies were picked and grown in liquid LB media (2 x 5 mL
each, 100 μg/mL each of Strep and Amp) with shaking (250 RPM) until saturation.
Both primary cultures were then added to a secondary culture of autoclaved M9
media (500 mL, 100 μg/mL each of Strep and Amp) and grown at 37 C with
shaking (250 RPM) until OD600=0.7 (3-4 hours). IPTG and Acd were then added
(1 mM and 0.5 mM final concentrations, respectively) and the temperature and
shaking speed were reduced to 18 C and 225 RPM, respectively. These cultures
were then incubated at these conditions for 20 hours.

Purification of CaM Constructs.
Cells were harvested by centrifugation at 5,000 RPM in a GS3 rotor and
Sorvall RC-5 centrifuge for 15 minutes at 4 C. The supernatant was discarded
and the cell pellet was suspended in 20 mL lysis buffer (50 mM HEPES, pH 7.5)
containing a broad spectrum protease inhibitor tablet. Resuspended cells were
then lysed on ice by sonication (30 amps power, 2 second pulse, 2 second rest, 4
minutes total sonication time) and then pelleted at 13,000 RPM in an SS-34 rotor
(Sorvall RC-5 centrifuge) for 15 minutes at 4 C. The supernatant was collected
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and incubated with Ni2+-NTA resin (2 mL column volume) for 1 h on ice with
shaking. The slurry was then added to a fritted column and the liquid was allowed
to flow through. The resin was then washed with 3 x 10 mL of buffer (50 mM
HEPES, pH 7.5) and 3 x 10 mL of wash buffer (50 mM HEPES, 10 mM imidazole,
pH 7.5). Each CaM construct was then eluted from the resin in 5 fractions each
containing 3 mL of elution buffer (50 mM HEPES, 300 mM imidazole, pH 7.5). The
pooled fractions were immediately subjected to intein cleavage conditions by
adding β-mercaptoethanol to a final concentration of 200 mM and incubated on a
rotisserie at RT for 20 hours. The resulting cleavage solution was then dialyzed
against 20 mM Tris pH 8.0 (2L) overnight in preparation for anion exchange
purification via FPLC. Prior to FPLC purification, 10 μL of 0.5 M TCEP Bond
Breaker™ was added to the CaM-C12 and CaM-C12δ112 constructs to reduce any
aberrant disulfides formed between CaM proteins and/or βME.

Each CaM

construct was purified over a HiTrap Q column using a 120 min NaCl gradient (0.1
M to 0.8 M NaCl in 20 mM Tris, pH 8.0). Fractions containing the product peak
were confirmed by MALDI and dialyzed twice against water at 4 C (2 L, 2 hours
each). These samples were then flash frozen in liquid N2 and lyophilized to a
powder.

CaM Labelling with Mcm-Mal.
A stock solution of ~25 mM Mcm-Mal was prepared by dissolving 4.6 mg of
Mcm-Mal solid in 645 μL DMSO.

CaM-C12 and CaM-C12δ112 samples were

dissolved in 1 mL of 20 mM Tris, pH 7.5. To each sample was added 10
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equivalents of Mcm-Mal (based off UV-Vis quantification of protein solutions) and
the samples were incubated at 37 C with shaking (200 RPM) for 3 hours. Each
sample was then diluted in 2 mL of 20 mM Tris pH 8.0 and subjected to a second
round of FPLC purification using the gradient described above. Fractions were
analyzed by MALDI MS and fractions containing the desired mass for Cys-Mcm
conjugated product were pooled and dialyzed (2 x 2 L) against water before being
flash frozen in N2 and lyophilized to a powder.

αS-Q62C and αS-E114C Expression.
α-Synuclein (αS) mutant plasmids (pTXB1_S-C62_Mxe-H6 or pTXB1_SC114_Mxe-H6) were transformed into competent E. coli BL21(DE3) cells and plated
on LB agar plates supplemented with Amp overnight at 37 °C.119 Single colonies
were used to inoculate 5 mL of LB media supplemented with Amp (100 µg/mL).
The primary culture was incubated at 37 °C with shaking at 250 rpm for 4 h. A
single primary culture was used to inoculate 1 L of LB media containing Amp (100
mg/L) which was then grown at 37 °C with shaking at 250 rpm until it reached OD
~0.7. Expression was induced with IPTG (1 mM) and the temperature was reduced
to 18 °C overnight.

αS-δ94, αS-C62δ94, and αS-δ94C114 Expression.
αS

mutant

plasmids

(pTXB1_S-TAG94_Mxe-H6,

pTXB1_S-

C62TAG94_Mxe-H6, or pTXB1_S-TAG94C114_Mxe-H6, generated using plasmids
in Haney et al.) and an AcdRS2b/ tRNA plasmid were transformed into competent
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E. coli BL21(DE3) cells and plated on LB agar plates supplemented with Amp
overnight at 37 °C.78, 118 Single colonies were used to inoculate 5 mL of LB media
supplemented with Amp and streptomycin (Strep, 100 μg/mL of each).

The

primary culture was incubated at 37 °C with shaking at 250 rpm for 4 h. A single
primary culture was used to inoculate 1 L of LB media containing Amp and Strep
(100 mg/L) which was grown at 37 °C with shaking at 250 rpm until it reached OD
~0.7. Expression was induced by adding IPTG and Acd (concentrations of 1 mM
and 140 mg/L, respectively) which was then incubated overnight at 18 °C with
shaking at 250 rpm.

Purification of αS Constructs.
Cells were harvested by centrifugation at 4,000 RPM in a GS3 rotor and
Sorvall RC-5 centrifuge for 20 minutes at 4 C. The supernatant was discarded
and the cell pellet was suspended in 15 mL lysis buffer (40 mM Tris, 5 mM EDTA,
pH 8.0) containing one Roche protease inhibitor cocktail pill (cOmplete mini
tablets, EDTA-free, Easy Pack, Roche Cat. #04693159001). Resuspended cells
were then lysed on ice by sonication (30 amps power, 1 second pulse, 1 second
rest, 5 minutes total sonication time) and then pelleted at 14,000 RPM in an SS34 rotor (Sorvall RC-5 centrifuge) for 20 minutes at 4 C. The supernatant was
collected and incubated with Ni2+-NTA resin (3 mL column volume) for 1 h on ice
with shaking. The slurry was then added to a fritted column and the liquid was
allowed to flow through. The resin was then washed with 3 x 5 mL of buffer (50
mM HEPES, pH 7.5) and 2 x 10 mL of wash buffer (50 mM HEPES, 10 mM
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imidazole, pH 7.5). Constructs were then eluted from the resin in 4 fractions each
containing 3 mL of elution buffer (50 mM HEPES, 300 mM imidazole, pH 7.5). The
pooled fractions were immediately subjected to intein cleavage conditions by
adding β-mercaptoethanol to a final concentration of 200 mM and incubated on a
rotisserie at RT for 20 hours. The resulting cleavage solution was then dialyzed
against 20 mM Tris pH 8.0 overnight. Prior to FPLC purification, 10 μL of 0.5 M
TCEP Bond Breaker™ was added to the Cys constaining constructs to reduce any
aberrant disulfides formed between αS proteins and/or βME. Each construct was
purified by ion-exchange chromatography using a HiTrap Q HP column (5 mL) on
an ÄKTA FPLC using a 100 minutes NaCl gradient (0 to 500 mM NaCl in 20 mM
Tris, pH 8.0). The fractions containing the product were identified by MALDI MS.
αS-δ94 mutant was dialyzed at 4 °C against αS buffer (20 mM Tris, 100 mM NaCl,
pH 7.5) overnight and stored at –80 °C in 1.5 mL aliquots and thawed once for
experiments. Cys containing mutants were carried directly into the labelling step
following purification.

αS Labelling with Mcm-Mal.
The protein solution after FPLC (ca. 10–20 mL) was treated with 20 μL Bond
Breaker solution. To the protein solution was added 25 mM Mcm-Mal solution in
DMSO (200–300 μL). Each reaction step was monitored by MALDI MS. After
labelling with Mcm-Mal, the solution was dialyzed at 4 °C against Tris buffer (20
mM, pH 8.0) overnight. The dialyzed solution was concentrated by centrifugation
with a 3 kDa cutoff filter (milliporesigma #UFC900324). The concentrated solution
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was purified by HPLC with a protein C4 column (Vydac #214TP1010).

After

concentration by centrifugation with a 3 kDa cutoff filter, the solution was dialyzed
against αS buffer (20 mM Tris, 100 mM NaCl, pH 7.5) overnight.

Following

dialysis, αS in buffer was stored at –80 °C in 1.5 mL aliquots and thawed once for
experiments.

Table 2.1: Protein MALDI Masses.
Protein

Calc. [M+H]+or [M+Na]+

Obs. [M+H]+or [M+Na]+

αS-CMcm62

14721

14731

αS-CMcm62δ94

14838

14844

αS-CMcm114

14720

14727

αS-δ94CMcm114

14837

14844

αS-δ94

14757

14757

CaM-CMcm

16950

16947

CaM-δ112

16881

16889

CaM-CMcm12δ112

17123

17133

12

Table 2.2: Trypsin Fragment MALDI Masses.
Protein

Fragment

Calc.
[M+H]+

[M +
Na]+

Obs.
[M+H]+

[M+Na]+

αS-CMcm62

61-80

2207

2229

2206

2228

61-80

2207

2229

2206

2228

αS-CMcm

62δ94

81-96

1596

1618

1595

1618

αS-CMcm114

103-140

4564

4586

4562

4584

αS-δ94CMcm114

81-96

1596

1618

1596

1618

103-140

4564

4586

4561

4564

81-96

1596

1618

1596

1618

1-13

1763

1785

1761

1783

107-115

1179

1201

1180

1201

1-13

1763

1785

1762

1784

107-115

1179

1201

1179

1201

αS-δ94
CaM-CMcm

12

CaM-δ112
CaM-CMcm

12δ112
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Figure 2.11: MALDI MS Characterization of CaM Variants. On each plot matrix
adduct peaks are marked with * The plots show CaM-C12 (First Row Left), CaMCMcm12 (First Row Right), CaM-C12δ112 (Second Row Left), CaMCMcm12δ112 (Second Row Right) and CaM-δ112 (Third Row Left). An enlarged
spectrum of the region of interest for the CaM-CMcm12δ112 shown where the
labeled and unlabeled protein masses are indicated with † and ‡ respectively
(Fourth Row Left). Fluorescence emission at 390 nm from excitation at 325 nm
was monitored after mixing 35 µM CaM-C12 with 3 equiv Mcm-Mal in Tris buffer,
pH 7.5 (Third Row Right, Green: CaM-C12, Grey: Buffer control).
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Figure 2.12: Trypsin Digest MALDI MS Characterization of CaM Variants. On
each plot, the M+H peak of the fragment of interest is marked with * and the M+Na
peak is marked with **, while the M+H peak corresponding to unlabeled Cys
containing protein is denoted with ‡ and the M+Na peak is marked with †.. The
plots show the fragments of CaM1-13-C12 of CaM-C12 (Top Left), CaM1-13CMcm12 of CaM-CMcm12 (Top Right), CaM1-13-CMcm12 of CaM-CMcm12δ112
(Middle Left) and CaM107-115- δ112 of CaM-CMcm12δ112 (Middle Right),
CaM107-115-δ112 of CaM-δ112 (Bottom Left).
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Figure 2.13: MALDI MS Characterization of αS Variants. On each plot matrix
adduct peaks are marked with *. The plots show αS-C62 (Row 1 Left), αS-CMcm62
(Row 1 Right), αS-C114 (Row 2 Left), αS-CMcm114 (Row 2 Right), αS-C62δ94 (Row 3
Left), αS-CMcm62δ94 (Row 3 Right), αS-δ94C114 (Row 4 Left), αS-δ94CMcm114 (Row 4
Right) and αS αS-δ94 (Row 5 Left). Fluorescence emission at 400 nm from
excitation at 325 nm was monitored after mixing 1 µM αS-C62 or αS-C114 with 1
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equiv Mcm-Mal in 20 mM Tris buffer, pH 7.5 (Bottom Right, Green: αS-C62,
Orange: αS-C114, Grey: Buffer control).

Figure 2.14: Enlarged MALDI MS of labeled αS Variants. Spectra where the
region of interest is enlarged for αS-CMcm62 (Top Left), αS-CMcm62δ94 (Top Right),
αS-CMcm114 (Middle Left) and αS-δ94C114 (Middle Right) where the labeled and
unlabeled protein masses are indicated with † and ‡ respectively. MALDI MS of
αS-CMcm62 before (blue) and after 3 hr labeling reaction (red) showing extend of
labeling (Bottom Left).
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Figure 2.15: Tryspin Digest MALDI MS Characterization of αS Variants. On each
plot, the M+H peak of the fragment of interest is marked with * and the M+Na peak
is marked with **. The mass corresponding to unlabeled Cys containing protein is
denoted with ‡. The plots show the fragments αS61-80-CMcm62 of αS-CMcm62 (Top
Left), αS103-140-CMcm114 of αS-CMcm114 (Top Right), αS103-140-CMcm114 of αS-δ94C114
(Upper Middle Left), αS81-94- δ94 of αS-δ94C114 (Upper Middle Right), αS61-80-CMcm62
of αS-CMcm62δ94 (Bottom Middle Left), αS81-94-δ94 of αS-CMcm62-δ94 (Bottom Middle
Right), and αS81-94-δ94 of αS-δ94 (Bottom Left).
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§ 2.3 FRET Measurements
FRET Calculations
For FRET measurements, the Förster distance, R0, is given in Å by Equation
(S1)
𝑹𝟔𝟎 =

𝟗𝟎𝟎𝟎(𝒍𝒏 𝟏𝟎)𝜿𝟐 𝜱𝑫 𝑱
𝟏𝟐𝟖𝝅𝟓 𝒏𝟒 𝑵𝑨

(Eq. 2.1)

where 2 is a geometrical factor that relates the orientation of the donor and
acceptor transition moments, D is the quantum yield of the donor, n is the index
of refraction of the solvent, NA is Avogadro’s number, and J is the spectral overlap
integral defined in units of M-1•cm-1•nm4. J is formally defined as
∞

𝐽 = ∫0 𝑓𝐷 (𝜆)𝜀𝐴 (𝜆)𝜆4 𝑑𝜆

(Eq. 2.2)

where εA(λ) is the molar extinction coefficient of the acceptor at each
wavelength λ and fD(λ) is the normalized donor emission spectrum given by
𝑓𝐷 (𝜆) =

∞

𝐹𝐷 (𝜆)

∫0 𝐹𝐷 (𝜆)𝑑𝜆

(Eq. 2.3)

where FDλ(λ) is the fluorescence of the donor at each wavelength λ.
Substituting these results into Equation 2.1, as well as the donor (Mcm) quantum
yield, 1.33 for the index of refraction of water, and 2/3 for 2 gives the Förster
distance. These R0 values were used to calculate FRET efficiency (EFRET) as a
function of distance using Equation 2.4.
𝐸𝐹𝑅𝐸𝑇 =

1
1+(

(Eq. 2.4)

𝑅 6
)
𝑅0

Here, EFRET is the FRET efficiency and R is the separation between the
chromophores. These values are reported in Table 2.5.
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Figure 2.16: Ac-CysMcm and Acd Absorption and Emission Spectra. Ac-CysMcm
(puple) and Acd (blue) absorption spectra (solid lines) were measured in 20 mM
Tris 100 mM NaCl, pH. 7.5. Ac-CysMcm (purple) and Acd (blue) fluorescence
emission spectra (dashed lines) were measured with excitation at 325 nm for AcCysMcm and 386 nm for Acd. Spectral overlap between Ac-CysMcm emission and
Acd absorption is indicated by the shaded area.

Figure 2.17: Trp and Ac-CysMcm Absorption and Emission Spectra. Ac-CysMcm
(purple) and Trp (black) absorption spectra (solid lines) were measured in 20 mM
Tris 100 mM NaCl, pH. 7.5. Ac-CysMcm (purple) and Trp (black or grey)
fluorescence emission spectra (dashed lines) were measured with excitation at
325 nm for Mcm-Mal and 295 nm for Trp in the WpOCNC peptide in the absence
(black) and presence (grey) of wild-type CaM to illustrate the change in overlap
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due to solvation environment. Spectral overlap between Trp emission and AcCysMcm absorption is indicated by the shaded areas.

Figure 2.18: Trp and Acd Absorption and Emission Spectra. Trp (black) and Acd
(blue) absorption spectra (solid lines) were measured in 20 mM Tris 100 mM NaCl,
pH. 7.5. Trp (black and grey) and Acd (blue) fluorescence emission spectra
(dashed lines) were measured with excitation at 386 nm for Acd and 295 nm for
Trp in the WpOCNC peptide in the absence (black) and presence (grey) of wildtype CaM to illustrate the change in overlap due to solvation environment. Spectral
overlap between Trp emission and Acd absorption is indicated by the shaded
areas.
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CaM FRET Measurements
Following preparation, dried CaM mutants along with pOCNC and
WpOCNC peptides were re-dissolved in 15 mM HEPES, 140 mM KCL, and 6 mM
CaCl2, pH 6.70. Concentrations of CaM mutants were determined based on Mcm
(εMcm325 = 19010 M-1cm-1) or Acd (εAcd386 = 5700 M-1cm-1) absorbance while
pOCNC and WpOCNC peptide concentrations were determined based on Phe
(εPhe259 = 189 M-1cm-1) or Trp (εTrp276 = 5579 M-1cm-1) absorbance. Fluorescence
measurements were taken on a PTI QuantaMaster 40 system. Trp emission
spectra were collected with an excitation wavelength at 295 nm over an emission
range of 305-600 nm, Mcm emission spectra were collected with an excitation
wavelength at 325 nm over an emission range of 335-600 nm, and Acd emission
spectra were collected with an excitation wavelength at 386 nm over an emission
range of 396-600 nm. All spectra were collected with excitation and emission
wavelengths set to 5 nm with a 0.25 second integration time and a 1 nm step size.
CaM mutants were measured at a concentration of 0.5 μM in the absence of
peptide, and the presence of pOCNC or WpOCNC peptide at a concentration of 1
μM. A single control measurement to determine the fluorescence spectrum of the
bound WpOCNC peptide was taken at a 1 μM concentration of peptide and a 2 μM
concentration of wild-type CaM.
To confirm that the binding affinity of CaM was not perturbed by the
introduction of fluorescent probes, the binding affinity was determined for CaMCMcm12δ112. This was performed by mixing labeled and wild-type CaM in varied
concentrations with 1 μM WpOCNC at concentration ratios of 0.125:1, 0.25:1,
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0.5:1, 1:1 and 1.5:1 of protein to peptide. Trp emission specta were collected as
previously described. For the wild-type protein, the wavelength of the maximum of
the Trp fluorescence was used to quantitatively determine the amount of bound
peptide, while for CaM-CMcm12δ112 the amount of bound protein was determined via
the quenching in the emission at 350 nm. The normalized values were then fit with
Equation 2.5 to determine Kd as in previous publications.77
𝑦=𝑅

(𝐾𝑑 +[𝑃]+[𝑃][𝐿])−√(𝐾𝑑 +[𝑃]+[𝑃][𝐿])2 −4[𝑃]2 [𝐿]
2[𝑃]

(Eq. 2.5)

In Equation 2.5 [P] and [L] are the total concentrations of the protein and
peptide respectively The Kd for the wild-type and CaM-CMcm12δ112 proteins
were 7.44±6.89 and 21.8±20.5 nM respectively. Given the high affinity of the
WpOCNC peptide and the 1 µM concentration in our assay, these represent only
estimates of the actual Kd, with significant error.

However, we take the

stoichiometric binding observed in both cases to indicate that CaM labeling does
not substantially disrupt peptide binding.
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Figure 2.19: CaM Absorbance Measurements. Absorbance spectra of CaMCMcm12 (Top Left), CaM-δ112 (Top Right) and CaM-CMcm12δ112 (Bottom Left)
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Figure 2.20: αS Absorbance Measurements. Absorbance spectra of αS-CMcm62
(Top Left), αS-CMcm114 (Top Right) αS-CMcm62 δ 94 (Middle Left), αS-CMcm114 δ 94
(Middle Right) and αS-δ 94 (Bottom Left).

Table 2.3: Percent of Cys Containing Protein Labeled by Mcm-Mal

Percent Labeled

CaM-CMcm12δ112

αS-CMcm62 δ 94

αS-CMcm114 δ 94

90.1 %

77.3 %

67.2 %

The percent of Cys containing protein labeled by Mcm-Mal was determined
from the ratio of the concentrations of Mcm and Acd calculated from UV
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absorbance spectra (Figs 2.19 and 2.20), using the previously described extinction
coefficients. These values likely deviate from the true labeling percentage due to
background and scattering profiles within the obtained spectra.

Stopped-Flow Measurements.
Stopped-flow experiments were performed with 1 μM Mcm/Acd labelled
CaM and 2 μM pOCNC peptide.

Each measurement was taken in triplicate

following mixing of 20 μL of protein and 20 μL of peptide. For each mixing event
the fluorescence emission of Acd (440 ± 40 nm) following excitation of Trp at 295
nm or Mcm at 325 nm. For each measurement, 15000 points were collected over
a time range of 30 milliseconds. Nonlinear fits were performed in GraphPad Prism
7.00 where each measurement was fit over the entire time window to the equation
Y = Y0 + Y𝑀 × exp(-k × 𝑥)

(Eq. 2.6)

In Eq. 2.6, Y is the fluorescence intensity as a function of time, x, where Y0
is the maximum intensity and YM is the difference between the maximum intesnity
and intensity at time zero. The resulting fit values for each curve and the resulting
averages are seen in

Comparison of CaM FRET Data to Other Structural Data.
The calculated distances obtained from the experimental Mcm/Acd FRET
measurements can be compared to published NMR structures of CaM in the
peptide-bound (PDB ID 1SY9) and free (PDB ID 1X02) forms.120-121 We selected
three representative substructures from the ensembles of 20 low energy structures
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reported for each PDB entry. Rather than simply calculate the distances between
residues 12 and 112 from Cα to Cα, we manually placed into these PDB structures
models of the CMcm chromophore (both R and S adducts) and Acd chromophore
(two sidechain rotamers designated A and B in Fig. 2.26) generated from AM1
minimized structures in Gaussian 09.122 For Acd, the sidechain orientation was
determined by making a Phe mutation at positon 112 in PyMol and aligning the
Acd chromophore with the Phe sidechain. For CMcm, a Cys mutant was made at
position 12 in PyMol and the sulfur atom in the Mcm model was aligned with the
Cys sulfur.

The Mcm chomophore was then rotated about the C-C-S-C

maleimide bond to minimize steric clashes. The Mcm and Acd models used are
shown in Figure 2.26. The distances between the highlighted (black arrows) atoms
were determined and averaged to identify the center-to-center distance between
the two chromophores. The values from the two Acd rotamers and the R and S
adducts of the Mcm chromophore are reported in Table 2.6. Ranges for these
values were reported in the main text.

αS FRET Measurements
Purified CMcm-labelled, -labelled, and CMcm/ double-labelled αS proteins
were dialyzed into αS buffer.

Protein concentrations were determined by

absorption spectroscopy (CMcm: ε325 = 19,010 M-1cm-1 Acd: ε386 = 5,700 M-1cm-1).77,
123

Background corrections were performed using a|e 1.2.124

Fluorescence

steady-state spectra were obtained at protein concentrations of ~0.5 μM while
fluorescence lifetimes were acquired at ~2 μM.
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Buffers containing varying

concentrations of trimethylamine N-oxide (TMAO) in 20 mM Tris and 100 mM NaCl
were prepared on the day of the spectroscopy experiments, and the pH of each
buffer was readjusted to 7.5 following the addition of TMAO. Both steady-state
and lifetime measurements were performed at concentrations of 0, 2, and 4 M
TMAO. Steady-state measurements were performed with direct excitation of Mcm
at 325 nm, measuring emission from 335-600 nm, with all slit widths set to 5 nm,
a step size of 1 nm, and an integration time of 0.25 s per step. Direct excitation of
Acd was performed at 386 nm, measuring from 396-600 nm with the same slit
width, step size, and integration time.

Steady State Fluorescence Data Fitting and FRET Calculation.
Due to the significant overlap of the Mcm and Acd emission spectra,
deconvolution was required to determine the relative Mcm quenching due to FRET.
Fitting of spectra containing Mcm and Acd double-labelled protein was performed
by minimizing the square difference between the spectra from the double-labelled
protein and a sum of linearly weighted single-labelled spectra using the following
equation

2

∑∑
(𝐴𝐼(𝜆)𝐷 − 𝐵𝐼(𝜆)𝐴 )) → 𝑚𝑖𝑛
𝜆 (𝐼(𝜆)𝐷𝐴 −

(Eq. 2.7)

Here, I(λ)DA, I(λ)D and I(λ)A represent the fluorescence intensity at a given
wavelength from protein which was double-labelled, single-labelled with only the
FRET donor, and single-labelled with only the FRET acceptor, respectively. A and
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B are linear weights of the donor and acceptor spectra and are wavelength
invariant. The Solver function in Microsoft Excel was used to vary the values of A
and B to minimize the sum of this square difference across all emission
wavelengths. The FRET efficiency (EFRET) was then directly obtained from the
linear weight of donor spectrum, A, where A = 1-EFRET.
For CaM experiments, distances were determined using the
canonical Förster equation (Eq. 2.4).

Error bars for CaM experiments were

obtained via propagation of error through the determination of A and the canonical
Förster equation.

Interfluorophore distance values for αS experiments were

calculated using a polymer scaled version of the Förster equation of the form

𝐸𝐹𝑅𝐸𝑇 = ∑𝑟 𝑃(𝑟)⁄(1 + (𝑟⁄𝑅0 )6 )

(Eq. 2.8)

were the probability distribution was set to the functional form for a
Gaussian chain.

3

𝑃(𝑟) = 4𝜋𝑟 2 (2𝜋⟨𝑟 2⟩)

3⁄2

3 𝑟2

𝑒𝑥𝑝 (− 2 ⟨𝑟 2⟩)

(Eq. 2.9)

Error bars were obtained via propagation of experimental error through both
determination of A and distance determination using the Gaussian-chain scaled
Förster equation.
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Fluorescence Lifetime Data Fitting and FRET Calculation.
Fluorescence lifetime measurements were acquired via time-correlated
single photon counting using a 340 nm LED light source. Lifetime spectra were all
acquired at 380 nm with slit widths ≤ 8 nm and collection over a 199 ns time
window, which was divided into 4096 lifetime bins. Collection was terminated
when a single bin reached a count of 10,000 photons. TCSPC data were fit to
single or bi-exponential decays using PowerFit-10. The FRET efficiency (EFRET)
was calculated as one minus the ratio of the Mcm lifetime in the presence of Acd
to the Mcm lifetime in the absence of Acd.

Comparison of αS FRET Data to Other Structural Data.
The calculated distances obtained from the experimental Mcm/Acd FRET
measurements were compared to published structural ensembles.

The two

ensembles were previously published in Allison et al. and Nath et al., derived from
a molecular dynamics simulation restrained with paramagetic relaxation
enhancement data and a Monte Carlo simulation with constraints from FRET,
respectively.68, 125-126 To obtain distances for comparisons, the distances between
Cα atoms for every residue pair in the sequence were extracted from each
structure within each ensemble. Since αS is intrinsically disordered, it is unlikely
that the structural ensembles represent the full distribution of states, therefore
distances were averaged in a Flory-scaling like protocol similar to the analysis in
Nath et al.68 For each ensemble, the inter-residue distances were averaged over
all residue pairs spaced by the same primary sequence separation over all
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structures, rather than just averaging over a single specific residue pair over all
structures. The average and standard deviation of the inter-residue distance as a
function of primary sequence separation is shown in Figure 2.25, along with the
probe separation distance calculated from the experimental Mcm-Acd FRET
efficiency via the gaussian chain polymer-scaled version of the Förster equation.
Since there are no published ensembles for the structure of αS in the presence of
TMAO, this comparison could only be performed for measurements in the absence
of TMAO.

§ 2.3 Results
Characterization of Mcm-Mal and Mcm-Br
We considered two ways of installing Mcm, either through conjugate
addition of a 3-maleimide derivative (Mcm-Mal) or through an SNAr reaction of a 3bromo derivative (Mcm-Br, Fig. 2.3). Mcm-Br and Mcm-Mal were synthesized by
Naoya Ieda as detailed in Figure 2.3.
We tested the reaction of Mcm-Mal and Mcm-Br with Cys in aqueous buffer
and found that reactions of Mcm-Mal were much faster (complete within a few
seconds at 10 µM), with a >20-fold increase in fluorescence at 390 nm (Figs. 2.4
and 2.7).

High performance liquid chromatography (HPLC) and mass

spectrometry (MS) analysis indicated that the very rapid reaction initially yielded
the conjugate addition product shown in Fig. 1, without maleimide ring opening
(Figs. S3 and S5). This product then isomerizes on a timescale of hours to a
compound of identical mass, which we attribute to the lactam form S5 (Figs. 2.6
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and 2.8). This is similar to reactions recently reported for detection of Cys in its
amino acid form by Tong et al.127

The authors ascribed the high levels of

fluorogenicity that they observed to relief of two quenching mechanisms, one by
conjugate addition, and the other by opening of the maleimide ring. Since this
second step involves the Cys -amine, we also tested the reaction of Mcm-Mal
with N-acetyl cysteine (Ac-Cys), which is more representative of Cys in proteins.
The resulting >20-fold turn-on of fluorescence was comparable to that seen in
reactions with Cys (Fig. 2.21) These Ac-Cys/Mcm-Mal data, together with our
observations of the faster fluorescence turn-on relative to ring-opening in
Cys/Mcm-Mal reactions, imply that the conjugate addition is the primary
determinant of fluorescence turn-on.

Figure 2.21: Mcm-Mal turn-on experiments. Fluorescence intensity of 10 µM
Mcm-Mal in Tris buffer (100 mM, pH 7.0, DMSO 1%) alone or mixed with 1 equiv
Cys or Ac-Cys. Fluorescence excitation at 325 nm, emission monitored at 400nm;
background corrected data are shown, see raw data in Fig. 2.9. Inset:
Fluorescence spectra acquired after 6 h of incubation.
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Following these trial reactions with small molecules, we evaluated the turnon of Mcm-Mal fluorescence in reactions at a Cys residue in two proteins,
calmodulin (CaM) and -synuclein (S). CaM is a calcium sensor protein that
undergoes a dramatic conformational change in the presence of calcium and
helical peptide binding partners.128-129 S is a disordered protein that contributes
to the pathogenesis of Parkinson’s disease.19, 130 These provide examples of the
value of FRET to monitor conformational change and protein/protein interactions.
Cys mutants of CaM and S (CaM-C12, S-C62, S-C114) were reacted with McmMal, and fluorescence emission was monitored at 390 nm. In all cases, we
observed a turn-on of fluorescence, but this was significantly less than what was
observed with Cys or Ac-Cys, due in part to higher background fluorescence in
protein reactions because of the need to keep the protein Cys reduced. Matrixassisted laser desorption ionization (MALDI) MS analysis of whole proteins and
trypsin digests confirmed that modification took place exclusively at the Cys,
without ring-opening. (Fig. 2.11-2.15)

Use of Mcm-Acd as a FRET Pair
In order to perform FRET measurements, one must doubly label the protein
with a donor/acceptor probe pair. We installed the Mcm/Acd FRET pair by using
site-directed mutagenesis and amber codon suppression to generate constructs
with single Cys and Acd mutations, followed by reaction of Cys with Mcm-Mal. (Fig.
2.1)

The reaction progress was monitored using the turn-on of Mcm-Mal

fluorescence and MALDI MS. (Figs. 2.11 and 2.13) We commonly use C-terminal
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intein-His6 tags to facilitate isolation of full-length proteins containing unnatural
amino acids from truncated proteins.95

His6 tags can be cleaved with β-

mercaptoethanol either before or after Mcm-Mal labelling.

Due to the highly

sensitive nature of FRET measurements, we typically perform a second
purification pass by FPLC or HPLC.
We have used our doubly labeled S and CaM constructs in proof-ofprinciple FRET experiments to demonstrate the value of the Mcm/Acd pair. For
S, we monitored a conformational change of the monomer induced by addition of
the compacting osmolyte trimethylamine N-oxide (TMAO). TMAO is a naturally
occuring osmolyte that is abundant in aquatic organisms, and counteracts the
denaturing effects of urea required for osmotic pressure regulation. 131-132 Previous
work has demonstrated that αS undergoes successive compaction with exposure
to increasing amounts of TMAO.133-135
Here, we chose to monitor TMAO-induced conformational changes in S
by introducing Cys residues at positions 62 or 114 and Acd at position 94. Singlelabelled constructs containing either Mcm or Acd and the double-labelled
constructs were prepared as described above. Fluorescence spectra for all of the
single and double-labelled constructs were collected in 0, 2, and 4 M TMAO.
Singly-labelled spectra were used to analyse the double-labelled spectra to
determine FRET efficiency (EFRET). This was performed by linearly weighting the
singly-labelled spectra and minimizing the squared difference between the doublylabelled spectrum and the sum of the linearly weighted single-labelled spectra at
each wavelength. (Fig. 2.23) This allows one to correct for changes in quantum
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yield or spectral overlap when the chromophore changes environment, and directly
affords the relative Mcm quenching (A in Fig. 2.23) and EFRET (EFRET = 1-A) to
determine the FRET distance through application of an appropriate form of the
Förster equation.

Figure 2.22: αS Fluorescence Spectra and FRET Fitting Results. Donor-only
(CMcm, solid blue line), acceptor-only (, solid red line), or double-labelled (CMcm/,
solid black line) spectra are shown overlayed with the results of fitting the doublelabelled spectra to a weighted sum of the single-labelled spectra (light blue dashed
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line). The weighted component spectra are shown in dashed blue (donor-only)
and dashed red (acceptor-only) lines. Spectra were acquired in buffer containing
0, 2, or 4 M TMAO with excitation at 325 nm.

Figure 2.23: αS TMAO FRET Experiments. Left: Incubation of S with TMAO
causes protein compaction, which can be monitored by FRET. Top Right:
Fluorescence emission spectra (325 nm excitation) of 1 µM concentrations of SCMcm6294 and the corresponding singly-labelled S-CMcm6294 and S-CMcm6294
constructs in 0 M TMAO. Deconvolution of the doubly labelled spectrum by fitting
to a weighted sum of the singly-labelled spectrum are shown. Bottom Right: EFRET
and corresponding inter-fluorophore distances for S constructs under varying
conditions determined using spectral deconvolution.
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Figure 2.24a: αS Fluorescence Spectra and FRET Fitting Results. TCSPC data
sets in 0 M or 2 M TMAO are shown for donor-only (CMcm, dark blue line) or double
labelled (CMcm/, dark red line). Bi-exponential fits to the data are shown in light
blue (donor only) or pink (double labelled); the instrument response function (IRF)
is shown in black. Weighted residuals are shown in corresponding colors above
each fluorescence lifetime plot.
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Figure 2.24b: αS Fluorescence Spectra and FRET Fitting Results. TCSPC data
sets in 4 M TMAO are shown for donor-only (CMcm, dark blue line) or double
labelled (CMcm/, dark red line). Bi-exponential fits to the data are shown in light
blue (donor only) or pink (double labelled); the instrument response function (IRF)
is shown in black. Weighted residuals are shown in corresponding colors above
each fluorescence lifetime plot.
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Table 2.4: TCSPC Fluorescence Lifetime Values
Protein

TMAO

τ1

τ2

Amp. 1

Amp. 2

αS-CMcm62

0M

3.10

-

2.47

-

3.10 0.90

-

2M

3.12

-

3.03

-

3.12 1.16

-

4M

2.80

0.86

0.79

0.55

2.01 0.93

-

0M

2.85

0.95

1.01

0.25

2.47 1.20

-

2M

3.03

0.96

1.00

0.32

2.53 0.83

-

4M

3.01

1.13

0.68

0.76

2.12 0.96

-

0M

2.74

1.29

0.93

0.50

2.23 0.84

0.28

2M

2.60

1.01

1.02

0.78

1.92 0.95

0.39

4M

1.90

0.39

0.17

2.81

0.48 0.97

0.76

0M

2.17

0.71

0.70

0.71

1.43 1.07

0.42

2M

0.82

2.31

0.67

1.10

1.38 1.04

0.45

4M

2.07

0.42

0.28

2.68

0.57 0.99

0.73

αSCMcm114

αSCMcm62δ94

αSδ94CMcm114

τAvg.

κ2

EFRET

The 0 M data are consistent with Flory scaling models of inter-residue
distances in disordered proteins. (Fig. 2.25) Moreover, we observe compaction
for both label positions with increasing amounts of TMAO, as previously observed
in this system with other FRET pairs.134, 136 These results were corroborated by
measuring the change in Mcm fluorescence lifetime for the two double-labelled
pairs relative to the analogous Mcm single-labelled proteins.
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Figure 2.25: Mcm/Acd FRET Data Compared to Previous Structural Models of αS
Ensembles.

For CaM, we monitored the conformational change induced by peptide
binding. Acd-labelled CaM was expressed and reacted with Mcm-Mal to give
CaM-CMcm12112.

Based on existing crystal and NMR structures of CaM, we

expected that a significant change in EFRET would occur due to a decrease in
distance between positions 12 and 112 upon peptide binding. (Fig. 2.28) We note
that in several CaM crystal structures, an extended conformation is observed,
making the 12/112 inter-residue distance >50 Å. However, NMR studies have
shown that the N- and C-terminal lobes of CaM are dynamic, and that the
conformations sampled in solution are more compact.137
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Figure 2.26: Fluorescence Assay to Determine Binding of Labeled CaM.
Fluorescence spectra of WpOCNC binding to CaM-CMcm12δ112 (Top Left and Right)
and CaM-WT (Middle Left) with the relative concentration of CaM:WpOCNC
indicated in the legend. Plots of fraction of WpOCNC bound for both CaMCMcm12δ112 and CaM-WT shown as a function of the concentration ratio of
CaM:WpOCNC with fits from Equation (S5) (Middle Right and Bottom Left).
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Table 2.5: CaM + WpOCNC FRET
Free

Bound

ΦD

0.16

0.17

J (M-1•cm-1•nm4)

7.042 x 1013

7.137 x 1013

R0 (Å)

24.6

24.3

EFRET

0.676 ± 0.002

0.405 ± 0.001

Distance (Å)

25.9 ± 0.1

21.8 ± 0.1

Figure 2.27: CaM Structural Models. Left: Chromophore structures used in
modelling Acd or CMcm in CaM structures. Acd rotamers were superimposed on
the lowest energy rotamer of a Phe112 mutant in each CaM structure. R- or SMcm-Mal thiol adducts were docked onto Cys12 mutants in each CaM structure.
The distances between the atoms indicated by arrows were computed and
averaged to determine the chromophore separation for comparison to FRET data.
Right: Example of the four models of Mcm/Acd-labelled CaM generated from PDBID 1X02 structure 14, corresponding to Acd rotamer A or B with R- or S-CMcm.
Other structures used in the analysis reported in Table 2.5 were generated in a
similar fashion from structures in PDB ID 1X02 or 1SY9.
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Table 2.6: CaM Structural Model Data
PDB ID

Distance

PDB ID

Distance

(Å)
1X02 –
14AS
1X02 –
14BS

28.8

1X02 –
14BR

3AS

36.7

3BS

33.8

3AR

36.6

11AS

3BR

33.6

1SY9 –
11BS
1SY9 –
11AR
1SY9 –
11BR

3AS

21.9

3BS

15.2

42.3

7BR

40.7
38.8 ± 3.3

17AS

20.2

17BS

18.1

1SY9 –

3AR

21.7

1SY9 –
15.8

7AR

1SY9 –

1SY9 –
16.2

34.9

1SY9 –

1SY9 –
15.5

7BS

35.2 ± 1.7
1SY9 –

16.5

37.3

1X02 –

26.9 ± 3.4
1SY9 –

7AS

1X02 –

1X02 –
23.1

(Å)

1X02 –

1X02 –
25.3

Distance

1X02 –

1X02 –

1X02 –
14AR

(Å)
1X02 –

30.5

PDB ID

17AR

20.0

1SY9 –

3BR

19.8

16.0 ± 0.4

19.1 ± 1.1

17BR

18.3
19.6 ± 3.1

Structure names correspond to PDB ID, followed by substructure number, Acd A
or B rotamer, and CMcm R or S stereochemistry at starred carbon in Fig. 2.27.
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Figure 2.28: CaM Peptide binding FRET. Left: Fluorescence emission spectra of
CaM-CMcm12112 (325 nm excitation) obtained in the presence and absence of the
WpOCNC binding peptide. Note: The apparently small FRET change is the result
of an opposing increase in Mcm emission upon binding. This can be accounted
for by comparison to CaM-CMcm12 emission with and without WpOCNC. Full
spectral deconvolution to obtain EFRET values is described in ESI. Right: Images
of CaM in the presence an absence of the pOCNC peptide rendered from PDB
entries 1X02121 and 1SY9,120 respectively. Distances obtained from EFRET
measurements are consistent with the CaM conformations in these NMR studies
when models of CMcm and Acd are included.

Fluorescence spectra of CaM-CMcm12112 were obtained in Ca2+-buffered
solutions, and indeed we observed significant Mcm-to-Acd FRET, evidence that
positions 12 and 112 were closer than 40 Å. Upon addition of WpOCNC, a Trp
derivative of a known high-affinity CaM binding peptide,120, 138 we observed an
increase in FRET. As in our S studies, we also obtained spectra for singlylabelled CaM-CMcm12 and CaM-112 under identical conditions, and fit a sum of
these spectra to the CaM-CMcm12112 spectrum to quantitatively determine EFRET.
The resulting inter-residue distances of 26 Å and 22 Å in the absence and presence
of the WpOCNC peptide, respectively, are in reasonable agreement with Mcm78

and Acd-labelled CaM models based on existing NMR structures (Fig. 2.27 and
2.28).120-121 These studies demonstrate the value of Mcm/Acd FRET in monitoring
a binding induced conformational change.

Trp-Mcm-Acd Three Color FRET
The longer wavelength excitation (325 nm) and emission of Mcm and
Acd allowed us to selectively observe these changes in the presence of the Trp
residue in WpOCNC.

However, we can also take advantage of the spectral

overlap of Trp emission with both Mcm and Acd to perform three color FRET
experiments, monitoring binding and conformational change events in the same
experiment. Although deconvolution to extract distance information is not reliable,
FRET can still be used to measure binding kinetics.

Using a stopped-flow

fluorometer, we observed rapid binding of WpOCNC through 295 nm excitation,
monitoring Acd emission at 420 nm. In the same experimental setup, we excited
at 325 nm to monitor the conformational change in CaM alone. We found that the
rates of binding (Ex295: 338 ± 93 s-1) and conformational change were nearly
identical (Ex325: 306 ± 40 s-1), implying that the two processes are concerted. This
is consistent with previous experiments showing that CaM populates compact
structures even in the absence of peptide.121, 137 Our data support the idea that
WpOCNC stabilizes existing compact CaM conformations rather than binding and
then inducing a large conformational change. We note that the rates of binding
and conformational change are also consistent with previous data for CaM binding
of several peptides (~500 s-1 at 1 µM peptide and CaM).139-141
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Figure 2.29: CaM Steady State FRET Measurements. Plots display the
background subtracted (solid) and fit (dashed) spectra for CaM-CMcm12δ112
(Top Left) following excitation at 325 nm, CaM-CMcm12δ112 bound to WpOCNC
(Top Right) following excitation at 325 nm, WpOCNC bound to wild-type CaM
(Middle Left) following excitation at 295 nm, CaM-CMcm12 bound to WpOCNC
(Middle Right) following excitation at 295 nm, CaM-δ112 bound to WpOCNC
(Bottom Left) following excitation at 295 nm and CaM-CMcm12δ112 bound to
WpOCNC (Bottom Right) following excitation at 295 nm. WpOCNC-Free spectra
were obtained from measurement of WpOCNC in buffer, while the WpOCNCBound spectrum was obtained from measuring WpOCNC bound to wild-type CaM
at a 2:1 ratio of protein to peptide with final peptide concentration of 1 μM.
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Figure 2.30: CaM Stopped-Flow FRET Measurements. Acd emission of CaMCMcm12δ112 during binding of WRRIAR was monitored following excitation of Mcm
at 325 nm (left) or Trp at 295 nm (right). Acd emission was monitored at 440 ± 40
nm using an Edmund Optics filter. Each plot contains three single stopped-flow
shots which were collected following four wasted shots. Protein and peptide were
mixed in a 1:2 concentration ratio producing final concentrations of 0.5 μM protein.

Table 2.7: Stopped-Flow Data Fitting
Parameter

Ex. 295 nm

Std. Dev.

Ex. 325 nm

Std. Dev.

Y0

4.814

0.028

5.821

0.027

YM

-0.517

0.072

-0.531

0.051

k

0.338

0.093

0.306

0.040
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Figure 2.31: Three Color FRET and Rapid Mixing Measurements of Peptide
Binding Kinetics. Left: Emission spectrum of CaM-CMcm12112/WpOCNC complex
(295 nm excitation) shown deconvoluted with Trp, Mcm, and Acd components.
Right: Overlay of fits to stopped flow fluorescence data for binding of WpOCNC to
0.5 µM CaM-CMcm12112. Red: 295 nm excitation, 420 nm emission; Blue: 325 nm
excitation, 420 nm emission. See Figs. 2.29 and 2.30 for raw data and additional
steady state spectra for FRET experiments.

§ 2.6 Conclusion
Using a combination of Cys labeling by Mcm-Mal and Acd incorporation
allows one to easily introduce a FRET pair that is selectively excitable and
minimally perturbing in proteins (WpOCNC Kds are nearly identical for CaM and
CaM-CMcm12112, Fig. 2.26).

Mcm/Acd FRET pairs can be used to monitor

conformational changes of 15-40 Å, a useful scale for tracking motions within
protein domains or among domains of moderately sized proteins. We have shown
that spectra of Mcm- or Acd-only proteins can be used to correct for changes in
quantum yield or spectral shape to accurately determine E FRET and interchromophore distance. While background signal from reducing agents hindered
its demonstration here, the fluorescence turn-on of Mcm-Mal gives it the potential
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to be used for in situ FRET with Acd. Additionally, Trp FRET with both Mcm and
Acd can be used in combination with Mcm/Acd FRET to monitor the kinetics of two
processes simultaneously. We note that previous three color (or “two step”) FRET
studies have primarily been single molecule experiments using bulky probes or
even fluorescent proteins.142-145 An example using cyanophenylalanine, Trp, and
7-azatryptophan by Gai uses smaller probes, but these are all UV wavelength
probes.146

The Trp/Mcm/Acd trio balances small probe size with selective

excitation, and we are working to develop complementary red-shifted, minimalist
fluorescence probes.
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CHAPTER

3:

IMPROVING

THE

FLUORESCENT

PROBE

ACRIDONYLALANINE THROUGH A COMBINATION OF THEORY AND
EXPERIMENT.
The content of this chapter was originally published in the Journal of Physical
Organic Chemistry. It is adapted here with permission from the publisher:
Copyright 2018 Wiley. Used with permission from Itthipol Sungwienwong, John J.
Ferrie, Joomyung V. Jun, Chunxiao Liu, Taylor M. Barrett, Zachary M. Hostetler,
Naoya Ieda, Amara Hendricks, Anand K. Muthusamy, Rahul M. Kohli, David M.
Chenoweth, George A. Petersson and E. James Petersson, Improving the
fluorescent probe acridonylalanine through a combination of theory and
experiment, Journal of Physical Organic Chemistry John Wiley & Sons, Ltd.
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§ 3.1 Introduction
Fluorescence spectroscopy can be a valuable tool for studying the structural
dynamics of proteins and protein/protein interactions.116

There are several

common types of protein experiments that employ fluorescence spectroscopy:
folding/conformational change experiments, binding experiments, and proteolysis
experiments (Fig. 3.1).147-148 Changes in fluorescence can be used to track protein
structural change on the ns timescale using distance dependent chromophore
interactions: either Förster resonance energy transfer (FRET) or quenching by
photo-induced electron transfer (eT).149-151

Such studies require fluorescent

probes that enable accurate measurement on a variety of distance ranges between
the two chromophores. FRET ranges are characterized by the Förster radius, R0,
the distance of half-maximal energy transfer for any chromophore pair.152 For
example, the common FRET pair fluorescein (Fam)/ tetramethylrhodamine (Tmr)
has an R0 of 47 Å and is useful to measure distances in the 30 to 90 Å range. 153
Since many inter-residue distances in proteins are shorter than this, one needs to
complement the Fam/Tmr FRET pair with other probe pairs that are better suited
to shorter interactions. With this in mind, the Petersson laboratory has developed
a methoxycoumarinylalanine (Mcm, 1)/ acridonylalanine (Acd, 2) FRET pair for
monitoring distances in the 15 to 40 Å range, and thioamide/Mcm or thioamide/Acd
eT quenching pairs for short distance (<15 Å) measurements. 51, 154
In addition to being better suited to short distance ranges than Fam or Tmr,
Acd is small enough to be directly genetically incorporated, rather than posttranslationally attached, and is less likely to disrupt protein folding.155 This allows
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one to place a chromophore on the interior of a protein and to label proteins that
cannot be reversibly unfolded and refolded (e.g., our published labeling of
LexA).118 Having the chromophore attached by a short sidechain rather than a
Cys maleimide or “click” chemistry triazole linker also reduces the positional
uncertainty of the FRET probe with respect to the protein backbone.

Thus,

distance measurements from FRET should more reliably report on changes in
protein conformation. We and others have previously shown that Acd can be a
valuable probe for protein study because of its small size (222 Å3), high quantum
yield in water (Φ = 0.95), unusually long fluorescence lifetime (τ ~15 ns), and high
photostability.77,

123, 156

We have developed an engineered aminoacyl tRNA

synthetase (RS)/ orthogonal tRNA pair for selective Acd incorporation by unnatural
mutagenesis.77

This has allowed us to label proteins and peptides with

methoxycoumarin/Acd FRET pairs either through Mcm incorporation by solid
phase peptide synthesis (SPPS) or by attachment of methoxycoumarin-maleimide
to a Cys residue in a protein.51 While many aspects of the Mcm/Acd FRET pair
are optimal, such as significant spectral overlap and a high Mcm extinction
coefficient at 325 nm where Acd has a minimum, one disadvantage is the small
Acd Stokes shift which leads to significant overlap of their emission spectra. This
overlap necessitates a challenging deconvolution of the Mcm/Acd spectra in order
to determine FRET efficiencies and distance measurements.

Thus, an Acd

derivative with a larger Stokes shift would be desirable for Mcm FRET.
In addition to improving Mcm FRET, we also wish to alter other fluorescent
properties of Acd, such as red-shifting excitation and emission, increasing the
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extinction coefficient, and altering solvatochromic effects to make brighter
derivatives that are better suited to microscopy or single-molecule fluorescence
applications. Sisido and coworkers have previously shown that some of these
effects can be achieved by simply homoligating Acd with a benzene ring
(benzoacridonylalanine or Bad, 3) to extend the π-system.157 However, we wish
to make derivatives that can still be incorporated by the ribosome, and Sisido’s
laboratory also showed that Bad was not incorporable during in vitro translation
with chemically-charged tRNA.

Therefore, we will use crystal structures and

computational models of our evolved AcdRS and “rules” for ribosomal permissivity
established in previous in vitro translation studies155, 158 to restrict Acd substitutions
to positions that will allow in vivo tRNA charging and incorporation into proteins.
Identifying Acd derivatives by making amino acid analogs is synthetically
laborious and unnecessary given that Acd and Bad spectroscopic properties are
identical to the properties of the respective chromophore cores.123, 156-157 Thus, to
improve Acd fluorescence, we set out to make a series of acridone (5) core
derivatives in order to identify derivatives with sufficiently improved properties to
warrant synthesis of the amino acid form for incorporation into peptides. Previous
studies of acridone derivatives have shown that many of the spectroscopic
properties can easily be modulated through substituent effects, providing strong
precedent for our work.157, 159-165 Moreover, focusing on the acridone core makes
computational modeling more tractable, with the potential to further narrow the
scope of synthetic work by predicting absorption and emission spectra.
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Here, we prepare a series of acridone derivatives in order to validate the
accuracy of our electronic structure calculations and identify a derivative,
aminoacridonylalanine (Aad, 4) with substantially red-shifted emission. In addition,
our calculations help to explain the origin of fine structure in acridone spectra, an
explanation which is in conflict with the conclusions of previous computational and
experimental Acd spectroscopy studies, but is consistent with the larger body of
acridone literature. Finally, we synthesize Aad and perform initial trials toward its
genetic incorporation.
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Figure 3.1: FRET experiments and fluorescent amino acids. Top: Protein
conformational changes, protein–protein interactions, and proteolytic cleavage can
be monitored by changes in the intra- or intermolecular distance between two
FRET (Förster resonance energy transfer) probes. Bottom: Fluorescent amino
acids based on 7-methoxycoumarin and acridone cores.

§ 3.2 Spectroscopic Characterization
Acidone core derivatives, except 2-methoxyacrione (21) which was
purchased from Sigma-Aldrich, were synthesized by Itthipole Sungweinwong
following the routes detailed below.
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Figure 3.2: Synthesis of nitroacridones and aminoacridones.

Figure 3.4: Synthesis of acridones and benzoacridones.

Prior to spectroscopic characterization, stocks of all acridone and
benzoacridone compounds were prepared in acetonitrile at a concentration of 200
or 300 μM. All absorbance and fluorescence measurements were taken in 1:1
CH3CN/buffer.

Buffers include citrate buffer (89.1 mM citric acid 21.8 mM

Na2HPO4) pH 2.6, phosphate buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 2 mM KH2PO4) pH 7.4, and 3-(cyclohexylamino)-1propanesulfonic acid (CAPS) buffer, pH 10.0. The absorbance and emission
spectra of all compounds were acquired in 1:1 CH3CN/PBS. The sensitivity of the
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absorbance and emission to pH was assessed for the parent acridone core as well
as the 4-NH2 and 2-NH2 derivatives in 1:1 CH3CN/citrate and 1:1 CH3CN/CAPS.
Absorbance measurements were acquired at concentrations of 75 and 7.5 μM for
proper visualization of the spectral profile above and below ~300 nm (4aminoacridone absorbance measurements were taken at 7.5 and 0.75 μM).
Fluorescence measurements were acquired under identical solution
conditions at concentrations of 7.5 μM for all compounds, except for the 4-NH2, 2NO2, and 4-NO2 derivatives of Acd which were obtained at 75 μM due to a lack of
brightness. Spectra were collected using excitation wavelengths matching the
maximum absorbance wavelength for each analog measured. The collection
window started 15 nm from the excitation wavelength and extended to 650 nm.
This window was truncated to no less than a total range of 150 nm for more blue
shifted chromophores. All slit widths were set to 1.5 nm and spectra were acquired
with an integration time of 0.25 sec/nm. Higher signal-to-noise spectra for the 4NH2, 2-NO2, and 4-NO2 derivatives were collected keeping all other setting the
same but adjusting all slit widths to 3 nm.
Extinction coefficients were calculated from absorbance measurements
collected on a Tecan M1000 plate reader (Mannedorf, Switzerland). Samples
containing 100, 80, 60, 40 and 20 μM chromophore were prepared in 1:1
CH3CN/PBS solution with a total sample volume of 100 μL.

Following brief

vortexing, samples were loaded into a Corning CoStar black, clear bottom, 96-well
plate.
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Absorbance and emission spectra are reported in Figures 3.2-S9. Emission
spectra are shown normalized to the acridone emission at 412 nm to approximate
quantum yields. The most prominent peak positions are reported along with
extinction coefficients and these relative emission intensities in Table 3.1.
Calculated spectra were obtained from George Petersson and were performed in
Gaussian16™ are shown for comparison. 166-168
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Table 3.1: Calculated and Observed Photophysical Parameters of Acridone
Derivatives.
Compound
Acd 5

Calculated
λem/Int.b

λex/εa

λem/Int.b

253/11.4 00411/1.00

254/5.22

412/1.00

364/1.51

382/0.72

435/0.83

434/0.45

383/2.43
2-NO2 6

4-NO2 7

2-NH2 8

4-NH2 9

4-F 15

398/0.70

235/5.32

-

230/3.33

282/2.53

296/0.87

341/1.03

356/0.76

408/1.87

402/0.37

243/6.62

-

244/2.81

292/2.56

266/0.94

331/1.27

328/0.58

464/2.06

434/0.60

252/4.93

509/0.21

256/3.38

278/2.96

278/2.46

419/0.47

420/0.52

252/5.74

492/0.59

260/4.19

299/1.20

314/0.38

400/0.61

400/0.59

248/12.8

397/0.48

365/1.19
2-OMe 21

Observed

λex/εa

251/10.0

252/4.44

-

-

527/0.16

540/0.01

412/0.65

378/0.51
444/0.47

252/5.32

271/3.61

268/5.38

400/0.95

396/0.82

447/0.63

414/0.82
4-OMe 16

249/6.62

421/0.35

375/0.62
Bz 18

4-F-Bz 19

234/1.38

495/0.31

272/12.7

302/1.40

296/2.07

446/0.81

438/0.58
496/0.24

272/14.0

268/9.96

507/0.42

508/0.21

448/0.54
512/0.25

456/0.67
aExtinction

222/1.78

269/21.7

268/15.3

431/0.37

384/0.69

446/0.61
4-OMe-Bz 20

256/6.30

coefficients () reported as

272/9.42
454/0.61

104
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M-1cm-1.

512/0.14

bEmission

intensity (Int.) normalized the intensity of the highest emission peak of
acridone for both calculated and observed spectra.
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Figure 3.4: Acridone Spectra. Experimental (solid lines) and calculated (dashed
lines) spectra and with vibronic transitions to/from lowest excited state (black bars)
of Acridone (5) at pH 7.4, and experimental spectra at pH 2.6 and 10.0.
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Figure 3.5: 2-Aminoacridone Spectra. Experimental (solid lines) and calculated
(dashed lines) spectra and with vibronic transitions to/from lowest excited state
(black bars) of 2-Aminoacridone (8) at pH 7.4, and experimental spectra at pH 2.6
and 10.0.
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Figure 3.6: 4-Aminoacridone Spectra. Experimental (solid lines) and calculated
(dashed lines) spectra and vertical transitions (black bars) of 4-Aminoacridone (9)
at pH 7.4, and experimental spectra at pH 2.6 and 10.0.
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Figure 3.7: 2-Nitroacridone and 4-Nitroacridone Spectra. Experimental (solid
lines) and calculated (dashed lines) spectra and vertical transitions (black bars) of
2-Nitroacridone (6) and 4-Nitroacridone (7) at pH 7.4.
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Figure 3.8: 2-Fluoroacridone, 2-Methoxyacridone, and 4-Methoxyacridone
Spectra. Experimental (solid lines) and calculated (dashed lines) spectra and
vertical transitions (black bars) of 2-Fluoroacridone (15), 2-Methoxyacridone (21),
and 4-Methoxyacridone (16) at pH 7.4.
99

Figure
3.9:
4-Benzoacridone,
4-Fluorobenzoacridone,
and
4Methoxybenzoacridone Spectra. Experimental (solid lines) and calculated
(dashed lines) spectra and vertical transitions (black bars) of 4-Benzoacridone
(18), 4-Fluorobenzoacridone (19), and 4-Methoxybenzoacridone (20) at pH 7.4.
100

§ 3.3 Results
Following production of the various Acd derivatives, we determined the
absorbance and emission profiles, as well as the extinction coefficient, of each
core. These data are summarized in Figure 3.10 and Table 3.1, and the spectra
of each compound are reported separately in the ESI.

The absorption and

emission spectra are normalized in Figure 3.10 for clarity, raw spectra are shown
in the ESI and extinction coefficients and emission intensities are given in Table
3.1.

Since we ultimately endeavor to utilize these derivatives as fluorescent

unnatural amino acids, we attempted to perform the spectroscopic characterization
in phosphate-buffered saline (PBS), pH 7.4. However, due to the relatively low
solubility of the benzoacridone compounds in water, all measurements were
performed in 1:1 acetonitrile/PBS. Extinction coefficients were obtained through
serial dilutions of stocks of 300 μM, which is approximately the solubility limit of
benzoacridone in acetonitrile.

Fluorescence emission spectra were acquired

under the same solvent conditions.
The parent acridone (5) absorbance spectrum features two major peaks in
the near UV region with maxima at 382 and 398 nm as well as additional features
below 300 nm. Derivatization of the acridone core resulted in changes of the
absorbance profile that were both functional group and position dependent. For
example, introducing a methoxy group in the 2 position in 21 resulted in a ~15 nm
red-shift in the absorbance maximum, with minimal modulation of the line shape,
while introduction at the 4 position in 16 resulted in a very minimal shift, with the
multi-peak profile becoming less defined. Amino modification at either the 2 or 4
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position produces a singular broad feature that is significantly red-shifted.
Moreover, the absorbance profile of 2-aminoacridone (8) is pH sensitive (Fig. 3.3).
The spectrum takes on a single broad absorbance feature very similar to that of 4aminoacridone (9) at high pH, which is dramatically reduced at low pH. It is
important to note that both the unmodified and the 4-amino Acd chromophores are
pH insensitive (Figs. 3.4 and 3.6).

Lastly, we observe that extension of the

conjugated system in the case of benzoacridone (18) results in an expected shift
of the absorbance to higher wavelengths, but displays an unexpected reduction in
the extinction coefficient. When modified with either fluoro (19) or O-methyl (20)
substituents, the absorbance profile is minimally shifted and the peaks become
less well-resolved, similar to what was observed when modifying the parent
acridone scaffold (15 and 16).
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Figure 3.10: Absorption and emission spectra of acridone derivatives. Spectra
determined in 1:1 acetonitrile/PBS, pH 7.4. Spectra are shown normalized to
enable comparison of changes in absorption and emission maxima.
Acridone substitution also elicited changes in the emission profile and
Stokes shift. The unmodified acridone emission features two major peaks at 412
and 435 nm with a minor peak around 460 nm. As in the absorbance profiles, the
maxima of these peaks move to lower energy upon modification with the O-methyl
group (21 or 16) with the multi-peak profile becoming less defined. Similarly,
introduction of the amine functionality resulted in a significant red shift as well as
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a reduction of the multi-peak line shape to a single broad emission.

Both

compounds 8 and 9 exhibited a dramatic increase in Stokes shift of ~100 nm
compared to the acridone core. Both also displayed a sensitivity to pH, manifested
as a decrease in emission intensity with decreasing pH, compared to the
unmodified core whose emission is insensitive to pH changes in the 2-10 range.
Finally, the benzo modified acridone analogs all feature a nearly identical emission
profile ~100 nm red shifted from the emission of the parent acridone compound.
The combination of benzo and fluoro or methoxy substitution further red shifts the
absorption spectrum, but does not appreciably change the emission spectrum.

§ 3.4 Conclusions
We can draw several conclusions from our results. Firstly, as anticipated
from previous literature reports, we are able to modulate the fluorescence of the
acridone core through relatively simple substitutions.

These substitutions,

introduced through direct modification of acridone or through cross-coupling and
cyclization, are compatible with eventual usage in generating Acd amino acid
derivatives. Secondly, the close correlation (% differences ex: 2.35, em: 2.40)
between our calculated and observed absorption and emission spectra give us
confidence that we can predict the spectra for acridone derivatives, providing
guidance for future synthetic efforts. This will be particularly valuable for targeting
multiply-substituted derivatives, where the number of possibilities is geometrically
larger and the synthesis will be more challenging. Finally, Aad appears to be
superior to Acd for several fluorescence applications.
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CHAPTER

4:

SYSTEMATIC

EVALUATION

OF

SOLUBLE

PROTEIN

EXPRESSION USING A FLUORESCENT UNNATURAL AMINO ACID
REVEALS NO RELIABLE PREDICTORS OF TOLERABILITY.
The content of this chapter was originally published in ACS Chemical Biology. It is
adapted here with permission from the publisher:
Reprinted with permission from Z. M. Hostetler, J. J. Ferrie, M. R. Bornstein, I.
Sungwienwong, E. J. Petersson, and R. M. Kohli. Systematic Evaluaiton of Soluble
Protein Expression Using a Fluorescent Unnatural Amino Acid Reveals No
Reliable Predictors of Tolerability. ACS Chem. Biol. 13, 10, 2855-2861. Copyright
2018 American Chemical Society
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§ 4.1 Introduction
Technological advances in genetic code expansion have encouraged the
design of proteins with a wide range of reactive residues, post-translational
modifications, photocaged groups, or intrinsic fluorophores. 169-171 Nonsense codon
suppression using orthogonal tRNA/aminoacyl-tRNA synthetase pairs enables
direct incorporation of chemically diverse unnatural amino acids (Uaas, also known
as non-canonical amino acids) into proteins in vivo. Many efforts have sought to
boost the efficiency of Uaa incorporation, including evolving more efficient
aminoacyl-tRNA synthetases and recoding the E. coli genome to remove
competing translational release factors.93, 172 Although these developments can
improve total yields of modified proteins, factors governing the position-dependent
effects of Uaa substitution on protein solubility remain understudied.
Recent reports have demonstrated that the position of a Uaa can affect the
level of total protein expressed, both in cell-free and cell-based systems.156, 173-177
Investigations of 20 positions in IFN-α and 33 positions in VSV glycoprotein
revealed varying total protein yields, from 0 to 95% of wildtype.177-178 Despite these
observations, explanations for position-dependent differences in total amounts of
Uaa-containing proteins have been limited, and no studies have explicitly
addressed UAA incorporation versus the resulting protein solubility.
Unnatural amino acid mutagenesis could hypothetically operate under wellaccepted principles that govern the effects of natural amino acid mutation. For
example, substitution of a nonpolar for a polar residue within the hydrophobic core
generally destabilizes proteins, whereas mutations on the solvent-exposed surface
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less frequently affect solubility.179-180 Unsurprisingly, evolutionarily-conserved
residues largely disfavor mutation.181-183 Substituting bulkier and more chemicallydiverse Uaas into a protein can restrict function and therefore could pose similar
burdens on folding and solubility.184 Nevertheless, the applicability of principles of
natural amino acid mutagenesis to Uaa mutagenesis remains unknown.
Suggested guidelines or approaches for choosing Uaa-tolerant sites have
been proposed. Some groups favor residues with structural similarity to the Uaa.175
Others assert that candidate positions should be first assessed for mutational
tolerability with natural amino acids or that proteins should be thoroughly screened
by random incorporation of Uaas into protein-GFP fusions to reveal positions that
label with high efficiency.176, 185-186 Nonetheless, the feasibility of using positionspecific properties to increase soluble protein expression remains untested.
To address these open questions, we aimed to explore factors that impact
Uaa incorporation and soluble protein production. By employing an intrinsically
fluorescent Uaa, acridonylalanine (Acd),77, 118, 173 we directly detect labeled protein
in cell lysate samples, overcoming the inability of past studies to measure levels
of both total and soluble expressed protein. Our systematic survey of more than
fifty sites across two proteins reveals that while incorporation efficiency is relatively
similar, protein solubility, and by extension Uaa tolerability, varies widely across
different positions. However, most position-specific physicochemical, evolutionary,
and structural properties, some of which have been previously suggested to
improve yield, were minimally predictive; instead, solubility more strongly
associated with the identity of the protein domain. After controlling for this domain
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effect, we found that only a few factors, such as a tolerance for aromatic residues,
moderately trended with protein solubility. To our knowledge, this work currently
represents the most systematic effort evaluating predictive factors for producing
soluble Uaa-containing proteins.

§ 4.2 Experimental and Computational Methods
All experiments referenced in this chapter were performed by Zachary
Hostetler, as were initial attempts to use computable characteristics (conservation,
hydrophobicity, solvent accessibility, etc.) to predict Uaa mutation tolerance.
The bacterial protein LexA, a multi-domain repressor of the DNA damage
response, has characteristics that made it well-suited to this broader survey. Wildtype E. coli LexA is well-behaved in overexpression and has previously tolerated
selective unnatural amino acid (Uaa) incorporation.22 Additionally, the availability
of protein crystal structures and a multiple sequence alignment for LexA enabled
retrieval of position-specific properties from databases or servers that require
these data as inputs. For every position in LexA, we calculated established metrics
across different classes of properties: physicochemical, such as hydrophobicity;
evolutionary, such as conservation; and structural, such as solvent accessibility.
Using these metrics, we selected 32 positions spanning both domains of LexA,
deliberately avoiding known deleterious mutants as well as the most conserved or
hydrophobic positions (Figure 4.1a). Our selected positions sample the remaining
metrics well (Figure 4.1b), indicating that this series is well-positioned to explore
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how aromatic, accessible, or poorly-conserved residues might differentially
tolerate Uaa incorporation.
Historically, measuring Uaa incorporation efficiencies in vivo has
overlooked protein solubility issues, while labeling Uaa-containing proteins in vitro
has suffered from incomplete sample recovery and detection. Crucially, we chose
to measure both total and soluble protein levels by using the fluorescent Uaa
acridonylalanine (Acd, Figure 4.1c), which already possesses an optimized
tRNA/tRNA synthetase pair for in vivo incorporation.21,22 This system offers several
advantages. First, Acd incorporation occurs during protein overexpression without
post-translational labeling. Second, measurements of Acd fluorescence at the
expected size on an SDS-PAGE gel are directly proportional to levels of protein
with successfully-incorporated Acd. Finally, gel-based detection of Acd
demonstrates a broad dynamic range, enabling us to detect quantitative
differences in the expression of Acd-containing LexA mutants.
Expression levels for a single protein can range widely due to experimental
variability, making quantitative comparison between different proteins difficult. To
overcome this challenge, we overexpressed the 32 LexA mutants in the presence
of both Acd and the Acd-specific tRNA/tRNA synthetase using autoinduction media
for consistency in the timing and duration of protein production. Following
overexpression, we measured fluorescence intensity levels of Acd-containing
LexA protein in both the whole cell lysate and soluble fraction (Figure 4.1d). The
use of purified Acd-containing LexA as a standard enabled quantitative and
reproducible comparisons of protein amounts across independent experiments.
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Simulation of Acd incorporation into LexA or RecA with Rosetta.
Prior to performing simulations, a parameter file and rotamer library were
produced for Acd following a previously described method. 187 Starting structures
for the LexA simulations were prepared from PDB 1JHE and PDB 1JHF by adding
the missing residues using the remodel application in Rosetta.188-189 A blueprint file
was prepared from each monomer and the primary sequence was modified to
match that of the LexA expression construct. After adding the missing residues to
each monomer, the dimer was reconstructed by merging the two PDB files and the
resultant structure was minimized using the Relax application. 190 The Relax
application was run by setting the jump_move, bb_move, and chi_move flags to
False and using the relax:fast flag. The starting structure was selected as the
lowest energy structure of 10 outputs. The same protocol was followed to produce
the RecA starting structures from PDB 3CMW, omitting the remodel application
step as all residues were present.191 For the Backrub-based method, a total 2,500
structures were produced from each starting structure. This was done by running
the Backrub application in Rosetta performing 10,000 trials at 0.6 kT to generate
each output structure.192 The total energy was computed for each member of the
ensemble following the single-site mutation to Acd and global repacking in
PyRosetta.114 For RecA, all mutations were performed and assessed within a
single monomeric unit (residues 967-1299) within the multimer. The total energy
was averaged across all members of the single ensemble for RecA and across all
members of both ensembles for LexA. LexA simulations based on the relax-based
algorithm were performed in PyRosetta using the same initial structures as starting
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points. The method consisted exclusively of the FastRelax mover constrained to
the starting coordinates using the 'lbfgs_armiho_nonmonotone' min_type and a
maximum of 200 iterations. A total of five output were produced for each mutation
and the energy was averaged across all outputs for both starting structures for a
given site. All methods were run using the 'beta_nov15' score function weights.

§ 4.3 Results and Discussion
Observing that the position of Acd can substantially impact protein solubility,
we next asked which of the properties that ostensibly affect Uaa tolerability might
correlate with solubility (Fig. 4.1). We fitted the soluble fraction as a response
variable to each property in individual linear regression models. For almost all of
the properties we evaluated, the explained variability (adj. R2) was about 5% or
less, indicating that if any property-specific effect exists, it is insubstantial and likely
below our ability to detect with a sample size of 32. We note that particular
properties—such as accessibility, conservation, and hydrophobicity—did not
explain any substantial variation in our data, despite past suggestions that
choosing accessible, less-conserved, and chemically-similar residues may yield
more soluble Uaa-containing protein (
Figure 4.1c).
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Figure 4.1: Scanning a variety of positions in LexA for Acd tolerability. (a) Positions
chosen for Uaa incorporation in the LexA dimer. Chosen positions are depicted in
yellow, α-helices in blue, and β-sheets in green. (b) Principal component analysis
(PCA) of LexA positions determined by multiple structural, evolutionary, and
physicochemical properties (see methods). All residues in LexA were scored and
plotted against the first two principal components, with positions chosen for Uaa
incorporation highlighted in yellow. Arrow segments represent a few notable
variables among those used in PCA loaded onto the plotted data. (c) Chemical
structure of Acd with indicated excitation and emission peaks. (d) Acd-labeled
LexA samples visualized in 15% SDS-PAGE gels by Coomassie staining (left) or
UV excitation (right). Lanes 1–3 show purified LexA standards. Lanes 4–11 show
paired total and soluble fractions from four individual mutants as representative
examples.
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Figure 4.2: Features associated with soluble Acd-labeled LexA proteins. (Previous
Page) (a) Smoothed density plots of log10-transformed amounts of total protein or
soluble protein. (b) Average log10-transformed soluble protein amounts overlaid on
average log10-transformed total protein amounts for each mutant. Error bars
indicate the standard deviation from three individual replicates each derived from
separate clones. (c) Plots of the average fraction of soluble protein as a function
of three selected parameters: conservation, hydrophobicity, and accessibility. Fits
for the entire LexA dataset to individual linear regression models yield best fit lines
(solid black) and 95% confidence intervals (shaded gray). Fits of data from each
separate LexA domain yield best fit lines for the NTD (dashed green) or CTD
(dashed blue). (d) Boxplots comparing the average fraction of soluble protein
against either domain or secondary structure, with individual averages overlaid.
Differences between groups were evaluated using Tukey’s HSD test for multiple
pairwise comparisons (** = p-value < 0.01; *** = p-value < 0.001). (e) Plot of the
average fraction of soluble protein as a function of position in the LexA sequence,
with error bars indicating the standard deviation from three replicates. Above, the
secondary and tertiary structure of LexA is indicated; α-helices are depicted as
green ovals and β-sheets as blue rectangles. (f) Separate boxplots for each LexA
domain indicating the relationship between average fraction of soluble protein and
113

evolutionary tolerance at each position to tryptophan, as one example of an
aromatic residue.

Conspicuously, several highly-correlated properties each explained around
50% of the variability in our data, including individual residue position (adj. R2 =
0.53), secondary structure (adj. R2 = 0.45), and overall protein domain (adj. R2 =
0.53) (
Figure 4.2d and
Figure 4.2e). Specifically, we obtained more soluble protein when Acd was
incorporated within the first 74 residues of LexA, which includes all three of the αhelices that comprise the N-terminal domain. By contrast, Acd incorporation within
the β-sheets of the C-terminal domain resulted in much lower proportions of
soluble protein. The nearly uniform secondary structure composition of each
domain limited our ability to interpret whether Acd tolerability is due to local
secondary structure effects or global protein domain stabilities.
Studying Acd incorporation in a distinct protein scaffold with mixed α/β
character could help dissect the similar effects we observed from the highlycorrelated domain and secondary structure factors with LexA. Thus, we extended
our survey to RecA, a bacterial ATPase that binds LexA to suppress its repressor
function.26 We selected positions in E. coli RecA that satisfied one or more criteria:
high accessibility, low conservation, few inter-residue contacts, or prior functional
tolerance to mutation (Figure 4.3a).27 After expressing these mutants with Acd and
measuring

protein

amounts,

we

again
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observed

greater

variability

in

logarithmically-transformed soluble protein levels (mean = 3.42, SD = 0.40)
compared to total protein levels (mean = 3.72, SD = 0.17) (Figure 4.3b and 4.3c).
Similar to LexA, most properties examined did not explain much variation in the
fractions of soluble protein (Figure 4.3d), with the exception that solubility modestly
trended with domain type and tolerance to aromatics. However, unlike in LexA, no
clear relationship existed between protein solubility and type of secondary
structure (Figure 4.3e), a result consistent with a more limited prior survey of GFP.8
This survey in RecA bolsters a model in which the intrinsic Uaa tolerability of a
protein domain remains the key obstacle for the production of soluble protein.
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Figure 4.3: Features associated with soluble Acd-labeled RecA proteins. (a)
Positions chosen for Acd incorporation in RecA. Chosen positions are depicted in
yellow, α-helices in blue, and β-sheets in green. (b) Smoothed density plots of
log10-transformed amounts of total protein or soluble protein. (c) Average log10transformed soluble protein amounts overlaid on average log10-transformed total
protein amounts for each mutant. Error bars indicate the standard deviation from
three individual replicates each derived from separate clones. (d) Plots of the
average fraction of soluble protein as a function of three selected parameters:
conservation, hydrophobicity, and accessibility. Fits to individual linear regression
models yield best fit lines (solid black) and 95% confidence intervals (shaded gray).
(e) Boxplots comparing the average fraction of soluble protein against domain or
secondary structure, with individual averages overlaid.

Searching for easily-determined properties that correlate with Acd
tolerability may have eliminated from consideration more complicated properties
with higher predictive ability. Additionally, linear regression modeling may have
over-simplified the inter-dependence of certain properties and protein solubility.
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Previously, Rosetta modeling has predicted the ΔΔG associated with a particular
mutation and identified tolerated mutations within a protein.192-194 Speculating that
Rosetta modeling could recapitulate our experimental results, we used the Rosetta
Modeling Suite to simulate the resulting energy associated with Acd incorporation
in LexA or RecA. However, we observed no significant correlations between
simulated energies and soluble fractions of LexA or RecA (Figure 4.4 and Figure
4.5). Incidentally, we noted that nearly all high-energy positions in LexA
experimentally yielded insoluble protein and may therefore have been useful in
filtering out those positions; however, we did not observe a similar energy
threshold effect for RecA. Accordingly, further refinement towards predicting Uaa
incorporation using Rosetta is required in order to recapitulate experimental data
and exclude higher-energy and lower-solubility mutants.
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Figure 4.4: Predicting protein solubility through simulation of Acd incorporation in
LexA. Scatterplots of the total energies in Rosetta Energy Units (REU) from
simulating Acd incorporation in LexA as a function of the soluble fraction of total
protein. Rosetta energies were obtained by performing each single mutation on a
relaxed structure of LexA derived from one of two previously published structures
(PDB: 1JHE or 1JHF), using either a Relax-based (left) or Backrub-based (right)
method. The total energy of each LexA mutant was computed following mutation
of the residue of interest to Acd either by minimizing of the energy using a relaxbased protocol or following repacking of all residues for each member of an
ensemble of LexA structures. Each point represents the average of the two
different simulations, with vertical error bars representing standard deviations. The
solid turquoise line represents the average energy of energy-minimized LexA
without any Acd mutation.
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Figure 4.5: Predicting protein solubility through simulation of Acd incorporation in
RecA. Scatterplot of the total energies in Rosetta Energy Units (REU) from
simulating Acd incorporation in RecA as a function of the soluble fraction of total
protein. Rosetta energies were obtained by performing each single mutation on
each member of a 2,500 structure RecA ensemble generated using the Backrub
application. Separate ensembles were generated from the previously published
structure (PDB: 3CMW). The total energy of each RecA mutant was computed
after mutating the residue of interest to Acd and repacking all residues in RecA.
Each point represents the average energy computed across all members of the
different simulations, with vertical error bars representing standard deviations. The
solid turquoise line represents the average energy of energy-minimized RecA
without any Acd mutation.

§ 4.3 Initial Conclusions
The expression of soluble protein is a major bottleneck for the study of
protein function. Here, we leveraged the fluorescence of Acd to study how protein
solubility is impacted by Uaa mutagenesis. In two bacterial proteins, we
demonstrated the dramatic impact that Uaa position has on protein solubility.
Surprisingly, a number of amino acid properties that purportedly contribute to Uaa
119

tolerability—including

low

evolutionary

conservation,

similar

hydrophobic

character, or high surface accessibility—were unreliable predictors of protein
solubility. Instead, these inconsistent relationships suggest that consideration of
specific amino acid features for successful Uaa mutagenesis is less critical than
previously thought. Rather, we speculate that the Uaa tolerability of a protein
domain may matter more. Our results also emphasize a continued need to explore,
through theory and experiment, the steric and chemical burdens different Uaas
pose to the expression of soluble protein. In the absence of reliable predictors or
refined simulation algorithms for Uaa tolerability, a chemical biologist pursuing Uaa
incorporation in a new protein, as of now, should broaden rather than narrow the
types of residues screened for Uaa tolerability when possible.

§ 4.4 Further Algorithmic Development
Following the previously described efforts to identify a metric or algorithm
which can adequately predict the soluble fraction of Uaa containing protein, further
attempts were made to develop an effective Rosetta-based method. The previous
simulations leveraged different sampling approaches but utilized a single common
score function. Since all Rosetta score functions are a composite of several
different energy terms which describe various physical characteristics of the
system, I sought to identify which aspects of scoring along with which isolable
energy terms best captured the variance in the data. This was accomplished by
re-performing the previously described Backrub-based and Relax-based
simulations on the LexA 1JHE PDB structure and computing the score contribution
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from each energy term across the entire protein, each monomer of the LexA dimer,
each protein domain and on a per-residue basis. Table 4.1 details the
nomenclature employed in Figures 4.6 – 4.7 comparing the results of these
simulations to the previously acquired total expression and soluble fraction
experimental data.
Although the previous methods using the fully compiled “beta_nov15”
Rosetta energy function did not have a sufficient correlation with the protein soluble
fraction data, the investigation of individual energy terms (Fig 4.6a-d) revealed that
several terms may serve as useful predictors in a threshold-based prediction
scheme. Decomposition of the “beta_nov15” score function in its constituent
energy terms revealed that the top 20 highly correlated terms, shown in Figs. 4.bad, all display a stepwise relationship with the fraction soluble data. Curiously, the
bulk of these correlates emerge on domain-level scoring, which supports the
findings of the previous work which demonstrated that domain identification was a
strong predictor in LexA of position tolerance to amino acid substitution.
Furthermore, it is important to note that almost all sampling schemes are
represented in the top 20 correlates indicating that even though different sampling
approaches lead to different energy terms which are significant, all sampling
schemes are capable of producing some form of prediction.
These findings are further reinforced when investigating the potential
correlations with the total expression values for Acd mutant LexA variants.
Compared with the soluble fraction data, the total expression data has a
significantly reduced variance and, unsurprisingly, the single-term correlates from
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Rosetta appear to perform less effectively for the total expression dataset.
However, the individual energy terms no longer show stepwise correlations (Fig
4.7a-d) demonstrating that linear regression of combined terms may deliver a
highly effective metric. Lastly, several of the top 20 correlates originate from the
energy values associated with the native residue in LexA which is selected for
mutation (Fig 4.7a-b). If a significant correlation can be gleaned from simply
scoring the input structure, a very rapid algorithm that does not require in silico
mutation and sampling may be capable of predicting components of the LexA
dataset.
Ultimately these findings encourage further investigation into the feasibility
of employing sampling and scoring methods endogenous to the Rosetta Modeling
Suite to predict which sites are more favorable for mutations to Uaas. Overall,
through the use of PyRosetta, development of new score functions through linear
regressions of exiting energy terms and the ability to make slight modifications to
current sampling schemes should lead to an effective predictive algorithm.
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Table 4.1: List of descriptors for Rosetta simulations
Backrub_Pre

Sampling Schemes
Mutation of residue to Acd is performed
prior to running 100 independent backrub
trajectories

Backrub_Post

Mutation of residue to Acd is performed
prior after running 100 independent
backrub trajectories on the unmutated
proteins

Relax_Cst

Following mutation of the residue to Acd,
the whole protein is relaxed in the
presence of constraints based on the
starting structure

Relax_No_Cst

Following mutation of the residue to Acd,
the whole protein is relaxed in the
absence of constraints

Full_Length

Scoring Granularity
All residues in the protein are used to
compute the score

Monomer_One/Monomer_Two Residues from a single chain (A/B) are
used to compute the score
Domain_One/Domain_Two

All residues in the N-terminal or Cterminal domain from a single chain (A/B),
whichever contains the amino acid of
interest, is used to compute the score

Residue

The single residue site post mutation is
used to compute the score

WT

The single residue site pre mutation is
used to compute the score

Total_score

Energy Terms
“beta_nov15”
containing
weighted
contributions from all energy terms
assayed

* All energy terms are described in detail in Alford et. al.194
123

Figure 4.6a: Comparison of Rosetta energy terms to the soluble fraction of Acd
mutant LexA protein expression. Depicted are members of the top-20 correlates
of single energy terms from Rosetta simulations to the fraction of soluble protein
from expression of single-point Acd mutants of LexA. Figure titles (experimental
data, sampling scheme, scoring granularity, energy term) shown above each plot
follow the nomenclature detailed in Table 4.1.
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Figure 4.6b: Comparison of Rosetta energy terms to the soluble fraction of Acd
mutant LexA protein expression. Depicted are members of the top-20 correlates
of single energy terms from Rosetta simulations to the fraction of soluble protein
from expression of single-point Acd mutants of LexA. Figure titles (experimental
data, sampling scheme, scoring granularity, energy term) shown above each plot
follow the nomenclature detailed in Table 4.1.
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Figure 4.6c: Comparison of Rosetta energy terms to the soluble fraction of Acd
mutant LexA protein expression. Depicted are members of the top-20 correlates
of single energy terms from Rosetta simulations to the fraction of soluble protein
from expression of single-point Acd mutants of LexA. Figure titles (experimental
data, sampling scheme, scoring granularity, energy term) shown above each plot
follow the nomenclature detailed in Table 4.1.
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Figure 4.6d: Comparison of Rosetta energy terms to the soluble fraction of Acd
mutant LexA protein expression. Depicted are members of the top-20 correlates
of single energy terms from Rosetta simulations to the fraction of soluble protein
from expression of single-point Acd mutants of LexA. Figure titles (experimental
data, sampling scheme, scoring granularity, energy term) shown above each plot
follow the nomenclature detailed in Table 4.1.
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Figure 4.7a: Comparison of Rosetta energy terms to the total expression of Acd
mutant LexA proteins. Depicted are members of the top-20 correlates of single
energy terms from Rosetta simulations to the total protein yield from expression of
single-point Acd mutants of LexA. Figure titles (experimental data, sampling
scheme, scoring granularity, energy term) shown above each plot follow the
nomenclature detailed in Table 4.1.
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Figure 4.7b: Comparison of Rosetta energy terms to the total expression of Acd
mutant LexA proteins. Depicted are members of the top-20 correlates of single
energy terms from Rosetta simulations to the total protein yield from expression of
single-point Acd mutants of LexA. Figure titles (experimental data, sampling
scheme, scoring granularity, energy term) shown above each plot follow the
nomenclature detailed in Table 4.1.
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Figure 4.7c: Comparison of Rosetta energy terms to the total expression of Acd
mutant LexA proteins. Depicted are members of the top-20 correlates of single
energy terms from Rosetta simulations to the total protein yield from expression of
single-point Acd mutants of LexA. Figure titles (experimental data, sampling
scheme, scoring granularity, energy term) shown above each plot follow the
nomenclature detailed in Table 4.1.
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Figure 4.7d: Comparison of Rosetta energy terms to the total expression of Acd
mutant LexA proteins. Depicted are members of the top-20 correlates of single
energy terms from Rosetta simulations to the total protein yield from expression of
single-point Acd mutants of LexA. Figure titles (experimental data, sampling
scheme, scoring granularity, energy term) shown above each plot follow the
nomenclature detailed in Table 4.1.
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CHAPTER 5: USING A FRET LIBRARY WITH MULTIPLE PROBE PAIRS TO
DRIVE MONTE CARLO SIMULATIONS OF ALPHA-SYNUCLEIN.
The content of this chapter was originally published in Biophysical Journal. It is
adapted here with permission from the publisher:
This article was published in Biophysical Journal, 114, John J. Ferrie, Conor M.
Haney, Jimin Yoon, Buyan Pan, Yi-Chih Lin, Zahra Fakhraai, Elizabeth Rhoades,
Abhinav Nath, and E. James Petersson, Using a FRET Library with Multiple Probe
Pairs to Drive Monte Carlo Simulations of α-Synulcein, 53-64, Copyright
Biophysical Society 2017.
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§ 5.1 Introduction
Intrinsically disordered proteins (IDPs) and proteins containing disordered
regions are exceptionally responsive to changes in solution conditions, making
them prone to misfolding and aggregation. One such IDP is α-synuclein (αS), a
140-amino acid neuronal protein the aggregation of which is implicated in
Parkinson's Disease pathogenesis

19-20.

αS is primarily expressed at presynaptic

termini and is suspected to play roles in regulating neurotransmitter release and
maintaining synaptic function and plasticity

195.

Likely the most recognized aspect

of αS is its ability to misfold and self-associate, resulting in the production of toxic
amyloid fibrils. These fibrils are the primary components of Lewy Bodies, which
have been long been recognized as a post mortem hallmark of Parkinson's
Disease

19.

The protein is comprised of three domains: the N-terminal domain

(residues 1-60), comprised of four imperfect 11-amino acid repeats featuring a
KTKEGV motif featured in amphipathic helices; the non-amyloid β component, or
NAC domain (residues 61-95), which contains two additional KTKEGV repeats and
forms the β-sheet rich core of amyloid aggregates; and the acidic C-terminal
domain, which is highly charged and considered largely disordered. The first two
domains adopt an α-helical structure in the presence of lipid membranes or
detergent micelles, while in solution the αS monomer is largely disordered
196-197.

20, 23-25,

The structural plasticity of αS, and most IDPs, is attributed to a lack of

hydrophobic residues and an excess of charged residues, producing systems that
are self-repulsive and unable to form a collapsed hydrophobic core

197.

Despite

these characteristics, α-synuclein has been shown to be partially collapsed and to
133

deviate from a true random coil structure

104, 108, 126, 198-200.

Moreover, the dynamic

structure of αS has high environmental sensitivity that has largely hindered
development of a cohesive characterization of the structural ensemble of
monomeric αS in solution64, 68, 104, 108, 126, 197, 199-202. Solution conditions including
temperature, salt concentration, and pH all have substantial effects on the partial
folding and collapse of αS. Furthermore, cosolvents and osmolytes have been
shown to drive conformational readjustment of αS

197, 203-206.

In particular, seminal

work by Uversky, Fink and coworkers demonstrated the ability of trimethylamineN-oxide (TMAO) to promote compaction and partial helical folding of αS
monomers, and in high concentrations drive the formation of helical oligomers 133.
Intriguingly, these helical conformations are morphologically distinct from the
helical structure formed on membranes, and the presence of osmolytes has been
show to affect fibril formation 134.
TMAO is a naturally occurring amphiphilic osmolyte that is found in several
aquatic organisms, where it counteracts the destabilizing effects of high
concentrations of urea required for regulation of osmotic pressure

131-132, 207.

Experimental and theoretical efforts have afforded an effective model by which
preferential exclusion of TMAO from the protein backbone and sequestration of
water by TMAO promotes the formation of intramolecular hydrogen bonds and a
reduction in exposed surface area for the protein

30, 208-213.

Solution studies of

TMAO have revealed that the large 4.67 D dipole moment prompts significant
water ordering around each molecule

214.

Comprised of a total of ~13 water

molecules, direct coordination of water to the oxygen along with formation of a
134

clathrate like structure about the methyl groups produces a first solvation shell with
a 6 Å radius and elicits an excluded volume effect that entropically drives protein
compaction

208, 214-216.

In addition to the effects of excluded volume and water

arrangement, TMAO has been proposed to act as a nanocrowder and also serves
as a poor solvent of the peptide backbone

217-218.

Single-molecule Förster

resonance energy transfer (FRET) has been previously used by Deniz and
coworkers to investigate the compact structure of αS in TMAO

134-135.

These

studies were performed with a limited set of measurements and demonstrated that
successive compaction of αS occurs with increasing concentrations of TMAO while
maintaining a single, broadly distributed conformational state. Moreover, the work
by Deniz and coworkers showed that despite the emergence of a partially helical
secondary structure, the folding pathway and resulting structure were distinct from
helices formed on membranes. Although a putative structural ensemble was not
proposed in this work, our laboratory and others have demonstrated the ability to
apply distances and distributions obtained from single molecule FRET data as
constraints for Monte Carlo (MC) simulations

68.

In the context of the present

problem of TMAO compaction of αS, we wish to further develop a method for
employing FRET constraints to generate experimentally-constrained models of
intrinsically disordered protein ensembles.
Although the use of FRET data has not been extensively explored as a
basis for generating structural ensembles of IDPs, the application of other longrange measurements has demonstrated success. Work by Forman-Kay,
Zweckstetter, Blackledge and others has shown the efficacy of utilizing data from
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paramagnetic relaxation enhancement (PRE) NMR experiments as restraints for
simulating ensembles of IDPs

61, 107-108, 199-200.

Dobson, Vendruscolo and Eliezer

have also applied NMR-based methods to study the disordered ensemble of αS
104, 126.

Moreover, efforts by Langen have demonstrated the similar usefulness of

electron paramagnetic resonance (EPR)

196, 219.

To date, most studies have

focused on the application of PRE data, which lacks description of the underlying
distribution of states

61.

Single molecule FRET has demonstrated an exceptional

ability to visualize subpopulations of disordered ensembles

60.

Furthermore, Best

and Schuler have addressed some of the major concerns surrounding distance
extraction from FRET data

64, 202.

Studies of chemically denatured ubiquitin have

shown that FRET and SAXS data afford comparable molecular sizes and that the
inclusion of large hydrophobic probe molecules does not significantly impact the
structural ensemble

202.

Moreover, recent work by Schuler has verified that

distributions extracted from single molecule FRET data display a high degree of
agreement with distributions compiled from structural ensembles generated from
molecular dynamics simulations restrained with NMR and SAXS data

64.

In this report, we focus on elucidating the structural changes associated
with TMAO induced compaction of αS by combining MC simulations in PyRosetta
with experimental constraints from ensemble FRET measurements. Although
single molecule FRET measurements provide additional information regarding the
number of distributions as well as the distribution breadth associated with a
particular average value, the photophysical requisites for these measurements
(i.e., bright, visible wavelength fluorophore pairs, which tend to have 30-70 Å
136

working ranges) generally preclude accurate measurement of distances below ~30
Å. This limitation is important, as we wish to generate atomically-detailed
computational models of αS and therefore need short distance constraints for our
simulations. Based on the aforementioned results from Deniz and coworkers, we
assume that the observed ensemble FRET efficiencies are resultant from single
distributions, well described by polymer physics models, allowing us to rely on
distances obtained from single distribution analysis

60, 134-135.

Furthermore, we

propose that the most effective set of constraints would encompass not only long
distances, such as those traditionally afforded from single molecule FRET, but also
short distances, closer to those obtained via PRE measurements, which should
more effectively limit the conformational variability within the ensemble.
Previously,

we

have

studied

αS

compaction

using

the

p-

cyanophenylalanine (Cnf) and thioamide probe pair, which has a short Förster
radius (R0, the distance of half-maximal energy transfer) of 18 Å 136, 220. We showed
that increases in FRET efficiency (EFRET) indicating compaction are observable as
αS is incubated with increasing concentrations of TMAO. However, these Cnfthioamide labeled proteins required semi-synthesis through native chemical
ligation, a method with insufficient throughput for FRET library construction.
Herein, we employ Cnf-tryptophan (Trp) as a genetically incorporable, short range
probe pair allowing for more facile production of a library of labeled constructs for
measuring distinct intramolecular distances in the presence of TMAO

221-222.

Additionally, we have incorporated a second, longer range probe pair, fluorescein5-maleimide (Fam) conjugated to cysteine (Cys) and tetramethylrhodamine azide
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(Raz) conjugated to an O-propargyl tyrosine (Ppy) unnatural amino acid

78.

The

Fam-Raz pair has a working distance around 50 Å and provides accuracy in
ranges equivalent to those accessible through single molecule FRET.
By applying measurements from these two complementary FRET libraries
as weighted constraints for atomically-detailed MC simulations in PyRosetta, we
construct model conformational ensembles that agree well with experimental data
such as fluorescence correlation spectroscopy (FCS), reporting on the overall
average size of the protein. This strategy of using FRET data to direct all atom
models in MC simulations provides a means to generate structure-guided
hypotheses for allosteric transitions in αS in order to understand the effects of
changes in environment or interactions with ligands.

§ 5.2 Protein Overexpression and Purification
Protein expression was performed in E. Coli. where unnatural amino acids
were incorporated via amber stop codon suppression and traceless purification
was facilitated via attachment of a C-terminal intein containing a C-terminal Histag (Fig. 5.1). For the Cnf-Trp library, all native tyrosine residues were mutated to
phenylalanine to assure that all energy transfer occurred exclusively between Cnf
and Trp.
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Figure 5.1: Scheme for labeled protein production. Top: Direct incorporation of pcyanophenylalanine (Cnf) and tryptophan (Trp) via unnatural amino acid
mutagenesis and conventional mutagenesis, respectively. Bottom: Incorporation
of Cysteine (Cys) and O-propargyl tyrosine (Ppy) with subsequent labeling by
fluorescein-5-maleimide (Fam) and tetramethylrhodamine azide (Raz),
respectively.
General Expression Protocol for αS-intein-H6 Fusion Proteins:
A pTXB1 plasmid encoding for the αS-intein-H6 fusion protein was
transformed into E. coli BL21-Gold (DE3) cells. The DNA GyrA intein from Mxe
fusion construct has been previously reported 78. Transformed cells were selected
based on ampicillin (Amp) (100 mg/L) resistance, encoded on the pTXB1 plasmid
containing the protein of interest. Single colonies were selected and used to
inoculate 5 mL primary cultures of LB media, and were grown at 37 °C, shaking at
250 rpm in the presence of 100 μg/mL Amp. A secondary culture of LB media
containing 100 mg/L Amp was inoculated with a single saturated primary culture,
and was grown at 37 °C while shaking at 250 rpm. After reaching an OD600 of 0.71.0, 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the
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culture to induce expression. Following induction the culture continued to grow
overnight at 18 °C overnight.
Expression of αS-intein-H6 Proteins Containing Unnatural Amino Acids:
The procedure for the expression of mutants containing Cnf or Ppy was
identical to the general protocol above with the following noted exceptions. The
pTXB1 plasmid coding for the protein of interest contained an amber stop codon
(TAG) at the intended site for unnatural amino acid introduction was cotransformed with a plasmid encoding a pDULE2-pFX plasmid containing an
orthogonal

aminoacyl

synthetase/tRNA

pair

78.

pDULE2-pFX

encodes

streptomycin (Strep) resistance, and cells containing both plasmids were selected
for based on Strep (100mg/L) resistance in addition to Amp resistance. Primary
cultures were also grown in the presence of both Strep (100 μg/mL) and Amp (100
μg/mL). In place of LB, secondary cultures were grown in M9 minimal media
containing 6 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl and 1 mL of 2 M MgSO4, 1 mL
of 1mg/mL FeCl2 (in 1.0 M HCl), 1 mL of 15 mg/mL, 2 mL of 10% Yeast Extract,
12.5 mL 40% glucose (w/v) in 1L of autoclaved water, along with 100 mg/L Amp
and 100 mg/L Strep. Lastly, once the secondary culture reached an OD 600 of 0.71.0, 0.8 mM of the unnatural amino acid was added to culture prior to induction
with IPTG. Expression was performed overnight at 18 °C.
General Purification Protocol for Cnf-Trp containing αS-intein-H6 Fusion Proteins:
Cells were harvested via centrifugation at 5000 rpm for 20 minutes at 4 °C
with a GS3 rotor on a Sorvall RC-5 centrifuge. The supernatant was decanted
away from the cell pellet, and the pellet was resuspended in 20 mL resuspension
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buffer containing 40 mM Tris, 5 mM EDTA, pH 8.3 and a protease inhibitor tablet
(Roche cOmplete mini tabs, EDTA free). Cells were lysed by sonication at an
amplitude of 30 for 5 minutes with 1 second on 1 second off. Lysate was
subsequently centrifuged at 14000 rpm for 20 minutes using an SS-34 rotor on a
Sorvall RC-5 centrifuge. His tagged protein was isolated from the supernatant via
nickel affinity. Ni-NTA resin (3 mL CV) was incubated with the supernatant on ice
for 1 hour. Following incubation the mixture was loaded into a fritted column, and
the lysate was drained. The resin was initially washed with 15 mL of 50 mM
HEPES, pH 7.5 followed by 20 mL of 50 mM HEPES, 5 mM imidazole, pH 7.5,
prior to elution of the protein of interest with 12 mL of 50 mM HEPES, 300 mM
imidazole, pH 7.5. Cleavage of the intein was performed via addition of βmecaptoethanol (βME) to a final concentration of 200 mM and incubation at room
temperature for 18 hours on a rotisserie. Following cleavage of the intein, removal
of imidazole and βME was facilitated by dialysis into 20 mM tris base pH 8.0 at 4
°C overnight. The undesired intein was removed by a second Ni column (3 mL
CV). The flow though containing the protein of interest was collected after 1 hour
incubation with the Ni resin on ice.

General Labeling Protocol for Fam-Raz containing αS-intein-H6 Fusion Proteins:
S variants containing Cys and/or Ppy were expressed as described above
and purified by Ni-NTA affinity. Following the second purification subsequent to
intein cleavage, the desired protein was dialyzed into 20 mM Tris, pH 8.0 overnight
at 4 °C. The protein was then labeled in this semi-crude state in one (donor-only
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or acceptor-only) or two (doubly-labeled) labeling steps as described below.
Proteins lacking an unnatural amino acid (S-Cys) were quantified by UV-Vis
spectroscopy using ε280 = 5120 M-1 cm-1 with the exception of S-Cys136, which
was quantified using ε280 = 3840 M-1 cm-1 223. Protein variants containing Ppy were
quantified using the BCA assay with bovine serum albumin (BSA) standards
generated by two-fold serial dilution in water from 2 mg/mL to 0.125 mg/mL.
Labeling reactions of proteins containing Cys were carried out by addition of
BondBreaker® TCEP solution to a final concentration of 1 mM and incubation at
room temperature for 10-15 minutes. Following this time, fluorescein-5-maleimide
(Fam) was added from a 25 mM stock in DMSO to a final concentration equal to
five-fold excess relative to protein (typical dye concentration was ~500-800 µM).
The labeling reaction was shielded from light by wrapping in aluminum foil and
incubated at 37 °C. The labeling reaction was monitored by MALDI-TOF MS
following 5-fold dilution of the reaction into water. Following complete
disappearance of unlabeled protein as determined by MALDI, the labeled product
was dialyzed overnight at 4 °C in 20 mM Tris pH 8.0. Proteins containing Ppy were
labeled via copper(I) catalyzed azide-alkyne cycloaddition as described below;
doubly-labeled proteins were first labeled with Fam as described above and
subsequently by Raz. Azide-alkyne labeling reactions were performed by
preparation

of

copper(I)-tris(3-hydroxypropyltriazolylmethyl)amine

(THPTA)

catalyst mixture by using 80 mM CuSO4 in water (1.25 µL/mL protein solution) to
which was added 50 mM THPTA in water (30 µL/mL protein solution) and then 100
mM sodium ascorbate in water (30 µL/mL protein solution). This solution was
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incubated at room temperature for 10-15 minutes prior to addition to the protein
solution. Protein was labeled by addition of five equivalents of Raz from a 50 mM
stock in DMSO (typical dye concentrations were ~300-500 µM), followed by
addition of the Cu(I) catalyst mixture. Labeling reactions were then shielded from
light and incubated at 37 °C and reaction progress monitored by MALDI-TOF MS
following 5-fold dilution of the reaction in water. Upon completion of the reaction,
the labeled product was dialyzed into 20 mM Tris pH 8.0 overnight at 4 °C to
remove excess dye.

Purification Protocol for All αS Proteins:
All proteins were then purified by anion-exchange chromatography on an
ÄKTA FPLC system using HiTrap Q HP columns and elution between 20 mM Tris
pH 8.0 (buffer A) and 20 mM Tris, 1 M NaCl pH 8.0 (buffer B). Fractions containing
the desired protein were identified by MALDI-TOF MS and were pooled. All
proteins from the Fam-Raz library as well as poorly expressing member of the CnfTrp library were concentrated using Amicon Ultra 3 kDa filters to a total volume of
≤ 1 mL. Further purification was then performed using a Varian HPLC system and
a Vydac C4 TP reverse-phase semi-preparative column with a flow rate of 4
mL/min and gradient between 0.1% TFA in water (solvent A) and 0.1% TFA in
acetonitrile (solvent B). Fractions containing the desired product were identified by
MALDI-TOF MS and judged to be of high purity were combined and diluted a
minimum of 5-fold by addition of 20 mM Tris, 100 mM NaCl pH 7.5 and
subsequently concentrated via Amicon µLtra 3 kDa centrifugal filters to a total
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volume of ≤ 5 mL, diluted 3-5 fold and re-concentrated; the final dilution and
concentration was repeated twice. All proteins were then assessed for purity and
integrity of the fluorescent label by MALDI-TOF analysis of whole protein and
tryptic fragments.
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Table 5.1: MALDI Masses from Cnf-Trp Library
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Table 5.2: MALDI Masses from Fam-Raz Library

§ 5.3 FRET Data Collection and Analysis
TMAO Assay:
All labeled αS variants were dialyzed into 20 mM tris, 100 mM NaCl, pH 7.5.
Buffers containing TMAO were also prepared with 20 mM tris, 100 mM NaCl, and
the pH was adjusted to 7.5 following the addition of TMAO. Concentrations for the
Cnf-Trp

library

was

determined

using

the

Sigma-Aldrich

FluoroProfile

Quantification Kit, while concentrations for Fam-Raz constructs were determined
via UV-Vis absorbance. Steady-state measurements for the Cnf-Trp library and
time correlated single photon counting (TCSPC) measurements of the Fam-Raz
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library were performed at 1 μM, while steady-state measurements for the Fam-Raz
library were performed at 100 nm. Prior to each measurement, labeled protein was
mixed with TMAO containing buffer and briefly vortexed. Measurements were
taken in triplicate at final concentrations of 0, 2 and 4 M TMAO at 20 °C. Steadystate measurements for the Cnf-Trp library were collected with an excitation of 240
nm over an emission range of 275 - 410 nm with excitation and emission slits set
to 5 nm and 1 nm step size collecting for 0.75 seconds per step, exciting primary
the Cnf fluorophore. Spectra were collected for direct excitation of Trp with an
excitation of 280 nm over an emission range of 310 - 410 nm with excitation and
emission slits set to 5 nm and 1 nm step size collecting for 0.75 seconds per step.
Measurements of the Fam-Raz library were collected with an excitation of 486 nm
over an emission range of 495 - 700 nm with excitation and emission slits set to 5
nm and 1 nm step size collecting for 0.25 seconds per step. Direct excitation of
Raz was performed by exciting at 555 and measuring over an emission range of
565 - 700 nm with a 1 nm step size and a collection time of 0.25 seconds per step.
All TCSPC measurements of fluorescence lifetime decays were collected
using a pulsed LED with a maximum emission at 486 nm. Fluorescence was
collected at 515 nm with the slit widths adjusted for each measurement to keep the
ACD value between 1 - 3 % of the SYNC value. The instrument response function
(IRF) was collected for each slit width used for collection. For these experiments
labeled αS was mixed with TMAO containing buffer to final protein concentrations
of 2 μM and 0, 2 or 4 M TMAO. Additionally, formation of aggregates in buffer or
TMAO were assayed by mixing single-labeled αS containing FAM and single147

labeled αS containing Raz in equimolar concentrations with a final protein
concentration of 2 μM in 0, 2 and 4 M TMAO.

Fitting Steady-State Data:
Following data collection, the single labeled spectra were used to quantify
the degree of energy transfer. First, the spectral overlap of the donor and acceptor
were deconvoluted by fitting the double labeled spectrum with the linear sum of
the individual donor and acceptor-labeled spectra. Fitting was performed by
minimizing the total least squared difference using the Excel Solver feature to
adjust the constants A and B:

∑𝜆(𝐼(𝜆)𝐷𝐴 − 𝐴𝐼(𝜆)𝐷 − 𝐵𝐼(𝜆)𝐴 )2 → 𝑚𝑖𝑛
𝐼(𝜆)𝐷𝐴 = 𝐴𝐼(𝜆)𝐷 + 𝐵𝐼(𝜆)𝐴

(Eq. 5.1)

(Eq. 5.2)

Here, I(λ)DA, I(λ)D and I(λ)A are the wavelength dependent fluorescence
intensities of the double-labeled, single labeled protein containing the donor, and
single-labeled protein containing the acceptor fluorophore, respectively. Solutions
to Eq. 5.2 were obtained by utilizing the Excel Solver functionality. This procedure
was performed at each TMAO concentration, thus accounting for any changes in
quantum yield or spectral shifting. The linear contributions of the single-labeled
construct containing the donor only, A, and the contribution from the single-labeled
construct containing the acceptor only, B, were both used to independently
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calculate the EFRET through Eq. 5.3 and 5.4 and combined in a weighted average
via Eq. 5.5:

𝐸𝐷 = (1 − 𝐴)

(Eq. 5.3)

𝜀

𝐸𝐴 = (𝐵 − 1) 𝜀𝐴

(Eq. 5.4)

𝐷

1

1

𝐷

𝐴

𝐸𝐹𝑅𝐸𝑇 = (𝑆 + 𝑆 )

−1 𝐸
𝐷

𝐸

( 𝑆 + 𝑆𝐴 )
𝐷

𝐴

(Eq. 5.5)

In Eqs. 5.3-5.5, ED and EA are EFRET values calculated from the donor and
acceptor weights respectively. Additionally, Eq. 5.4 requires ratio of the extinction
coefficient for the acceptor, εA, to the donor, εD, which are detailed in Tables 5.3a
and 5.3b and have been determined from the absorption spectrum of each
fluorophores scaled using published extinction coefficients (Cnf ε 240=13,921 M1cm-1 221,

Trp ε278=5700 M-1cm-1

221,

FAM ε494=68,000 M-1cm-1

224

and Raz

ε555=87,000 M-1cm-1 as indicated by the manufacturer) . The EFRET values from the
donor and acceptor were then used to compute a weighted average EFRET value
by using the inverse of the experimental error to weight each EFRET value, where
SD and SA represent the donor and acceptor propagated error respectively.

2

2

2

2

2

2

𝑆𝐴 = 𝐴 × √(𝑆𝐼𝐴 × 𝐵 ⁄𝐼𝐷 ) + (𝑆𝐼𝐷𝐿 ⁄𝐼𝐷 ) + (𝑆𝐼𝐷 × (𝐼𝐷𝐿 − 𝐵 × 𝐼𝐴 )⁄𝐼𝐷2 )
𝑆𝐵 = 𝐵 × √(𝑆𝐼𝐷 × 𝑆⁄𝐼𝐴 ) + (𝑆𝐼𝐷𝐿 ⁄𝐼𝐴 ) + (𝑆𝐼𝐴 × (𝐼𝐷𝐿 − 𝐴 × 𝐼𝐷 )⁄𝐼𝐴2 )
1

1

𝐴

𝐵

𝑆𝐸𝐹𝑅𝐸𝑇 = √2⁄(𝑆 + 𝑆 )

(Eq. 5.8)
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(Eq. 5.6)

(Eq. 5.7)

Lastly, SEFRET represents the propagated error of the calculated weighted
average EFRET value.
Accurate calculation of R0 was required for calculation of interresidue
distances from the determined EFRET. R0 was calculated using the equation:

𝑅06 = (9 𝑙𝑛(10) 𝜅 2 𝛷𝐷 𝐽)⁄(128𝜋 2 𝑁𝐴 𝑛4 )

(Eq. 5.9)

Here, NA is Avogadro's number, 2 is the dipole orientation factor,
approximated at 2/3, ΦD is the quantum yield of the donor, J is the spectral overlap
integral between the emission of the donor and the absorbance of the acceptor
and n is the refractive index of the medium. The overlap integral of the donor
fluorescence and acceptor absorbance spectra for each fluorophore pair was
determined empirically from the absorbance and emission spectra of the free
fluorophores in buffer through application of the integral:

∞

𝐽 = ∫0 𝑓𝐷 (𝜆)𝜀𝐴 (𝜆)𝜆4 𝑑𝜆

(Eq. 5.10)

where fD(λ) is the normalized donor emission, εA(λ) is the molar extinction
coefficient of the acceptor, at each wavelength (λ). The normalized donor emission
is given by:

𝑓𝐷 (𝜆) =

𝐹𝐷 (𝜆)
∞
∫0 𝐹𝐷 (𝜆)𝑑𝜆

(Eq. 5.11)
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where FD(λ) is the fluorescence emission spectrum of the donor dye. Following
determination of R0 average distance values from the polymer scaled Förster
equation (Eq. 5.12), using either Eq 5.13 or Eq 5.14 to determine Pn(r,x)), along
with the associated error and constraint weights for each constraining function,
were determined in Wolfram Mathematica.

𝐸𝐹𝑅𝐸𝑇 = ∑𝑟 𝑃𝑛 (𝑟, 𝑥)⁄(1 + (𝑟⁄𝑅0 )6 )
3

3/2

𝑃1 (𝑟, 𝑥) = 4𝜋𝑟 (2𝜋𝑥 2 )

3 𝑟2

𝑒𝑥𝑝 (− 2 𝑥 2 )

1 (𝑟−𝑥)2

1

𝑃2 (𝑟, 𝑥) = √2𝜋𝜎2 𝑒𝑥𝑝 (− 2

𝜎2

)

(Eq. 5.12)
(Eq. 5.13)
(Eq. 5.14)

Fluorescence measurements of labeled proteins have shown that the
quantum yield is sensitive to the local environment, as well as TMAO
concentration. Therefore, changes in quantum yield must also be taken into
account to effectively determine R0 via Eq. 5.9. The quantum yield was calculated
by fitting the emission spectrum of the free fluorophore in buffer, without TMAO, to
the emission spectrum of each labeled analog at each concentration of TMAO,
again using a linear least squared difference approach.

∑𝜆(𝐼𝐷 − 𝐶 × 𝐼𝐷𝑦𝑒 )

2

(Eq. 5.15)

The sum in Eq. 5.15 was minimized using the Excel solver function by
adjusting the constant, C. Here, ID and IDye represent the sum of the fluorescence
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intensity over all wavelengths of the labeled protein and the free fluorophore,
respectively. The donor quantum yield is then defined as:

𝛷𝐷 = 𝐶 × 𝛷0

(Eq. 5.16)

where Φ0 is the quantum yield of the free fluorophore.

By using this

empirically adjusted quantum yield in the calculation of R0, we effectively reduce
inaccuracies in the determined interchromophore distance arising from changes in
quantum yield. Lastly, the distance of interest, R, is determined from the above
variables as described in the main text.
Finally, error was propagated through the calculation of the interprobe
distance. This was performed by determining the inverse function of Pn(r,x), here
represented as F(EFRET), using Wolfram Mathematica as shown in Eq. 5.17.

𝐹(𝐸𝐹𝑅𝐸𝑇 ) = 𝑃𝑛−1 (𝑟, 𝑥)

(Eq. 5.17)

The error is then simply propagated following the determination of the partial
derivative of Pn-1(EFRET) with respect to the EFRET variable as shown in Eq. 5.18.

𝑆𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 = 𝑆𝐸𝐹𝑅𝐸𝑇 ×

𝛿𝐹(𝐸𝐹𝑅𝐸𝑇 )
𝛿𝐸𝐹𝑅𝐸𝑇
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(Eq. 5.18)

Table 5.3a: Steady-State FRET Fitting and Distance Determination
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Table 5.3b: Steady-State FRET Fitting and Distance Determination
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Fitting Lifetime Data:
Lifetime data were fit using PowerFit10 distributed by PTI. Each decay was
fit to a single or double exponential decay where the time regime was selected to
minimize the chi-squared values and the residuals. EFRET was determined from 1(τDA/τD) where τDA and τD are the lifetimes for double-labeled and donor-only
constructs respectively. For biexponential decays both the amplitude average and
the intensity average lifetimes were used to calculate EFRET values for comparison
to the EFRET values extracted from steady-state measurement.
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Table 5.4a: TCSPC Data and Fitting
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Table 5.4b: TCSPC Data and Fitting
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Table 5.5: Calculated EFRET values from TCSPC

§ 5.4 FCS and AFM Characterization
FCS Measurements:
FCS measurements were done at 20°C on a lab-built instrument based on
an Olympus IX71 microscope. A continuous emission 488 nm DPSS 50 mW laser
(Spectra-Physics, Santa Clara, CA) was adjusted to 4.5 W power just prior to
entering the microscope. Fluorescence was collected through the objective and
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separated from the excitation laser using a Z488rdc long pass dichroic and an
HQ600/200m bandpass filter (Chroma, Bellows Falls, VT). Fluorescence was
focused onto the aperture of a 50 m optical fiber coupled to an avalanche
photodiode (Perkin Elmer, Waltham, MA). 10 autocorrelation curves of 10 seconds
each were taken using a digital correlator (Flex03Q-12, correlator.com,
Bridgewater, NJ). Fitting was done using MATLAB (The MathWorks, Natick, MA).
Eight-well chambered coverglasses (Nunc, Rochester, NY) were cleaned
by plasma treatment followed by incubation with polylysine-conjugated
polyethylene glycol (PEG-PLL). PEG-PLL was prepared from a modified Pierce
PEGylation protocol (Pierce, Rockford, IL). After overnight incubation with PEGPLL, chambers were rinsed with Millipore water and stored until use for
measurements. Measurements were done by first replacing the water with
solutions of ~400 M wild type -synuclein in each concentration of TMAO to
prevent adsorption of labeled protein. 20 nM of Alexa Fluor 488 or labeled synuclein were added into a chamber, and each sample was mixed by pipetting
immediately before measurement. The free dye measurements were used to
obtain reference diffusion times.
The observed fluorescence fluctuations were autocorrelated and the raw
autocorrelation data was fit to the equation:

1⁄2
1

𝐺(𝜏) = 𝑁 (

1

1+

𝜏
𝜏𝛼𝑆
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𝑠2 𝜏
𝜏𝛼𝑆

)
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)

(Eq. 5.19, S15)

N is the number of molecules in the focal volume, τ is the delay time, ταS is
the time spent by the sample in the focal volume, and s represents the eccentricity
of the confocal volume, and is fixed to 0.2. The diffusion time of the protein, ταS, is
extracted from fit.

AFM Measurements:
Three droplets of αS solution were incubated on the mica substrate for 5
minutes. To remove the excess solution, the samples were blotted by Kimwipe,
gently rinsed with 2 mL Milli-Q water, and then dried using a weak nitrogen stream.
During the sample preparation, the substrate was tilted 30-45° to prevent the
solution from flowing backwards. The samples were imaged in tapping mode using
a Keysight 5500 AFM instrument (Keysight Technologies) equipped with a closedloop

scanner.

Rotated

silicon

probes

with

aluminum

reflex

coating

(BudgetSensors, Tap-300G, resonance frequency ~300 kHz, tip radius <10 nm,
force constant 40 N/m) were used to record topographic, amplitude, and phase
images with 512 x 512 pixel resolution. The AFM images were analyzed by
Gwyddion package. A third-order polynomial was used to flatten the background
for topographic images. The volumetric analyses of globular structures were
performed using Gwyddion software.
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§ 5.5 Computational Modeling Procedures
Semi-Empirical Probability Distribution:
This simulation was run utilizing the same format as the 0 M TMAO
unconstrained simulation where the score function at each step was replaced
simply with a single repulsive van der Waals term. For the combined set of outputs,
all segments which are spaced by the same number of residues in the primary
sequence were fit to a normal distribution. From this an empirical relationship was
constructed between the distance spanning any two parts of the protein and the
average breadth, σ.

PyRosetta Simulations:
All simulations were performed in PyRosetta on the University of
Pennsylvania School of Arts and Science General Purpose Cluster. The simulation
format followed a basic simulated annealing procedure detailed in the general
script attached. In short, the initial protein structure was randomized by sampling
random backbone φ/ψ angles against a score function consisting solely of
repulsive van der Waals energy terms while the protein was represented in the
course-grained centroid model. Following randomization, constraints were applied
with continued sampling of φ/ψ angles in centroid model while increasing the score
function complexity from score0-score3 ending with the score3 function as well as
long and short range hydrogen bonding terms (hbond_srbb and hbond_lrbb).
Lastly, the protein representation was switched into full-atom and backbone torsion
angles were sampled along with side-chain χ angles while the 'beta' score function
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was applied with the addition of constraints. Acceptance for a set of moves was
determined as usual in a Monte Carlo simulation by comparing the sum of the
score energy and constraint energy of the previous structure to the newly
generated structure. The lowest energy structure generated from each of these
steps was retained and used as the starting structure for the next simulation step.
The final output structure as determined from the sum of the total 'beta' score
function energy and the constraint energy.
Several different methods were employed in an attempt to capture the
influence of TMAO on the protein structure in addition to applying constraints.
Simulations were performed where the solvation term (fa_sol) was removed from
the score function since solvation effects from TMAO introduction could not be
accounted for directly. Moreover, fragment insertions was employed alongside φ/ψ
angle sampling in an effort to incorporate the possible formation of significant
secondary structure. Fragment libraries were prepared from the primary sequence
of wild-type αS using Robetta, a protein prediction server which uses Rosetta
software and was developed and supported by the Rosetta Commons and the
Baker Lab

225.

Modifications to the base method for each simulation for the 2 M

TMAO data set are detailed with the reported results.
In order to produce a simulation which accurately represented the FRET
data, each distance constraint was implemented with a "knowledge" weighting
factor, γ. This knowledge weighting factor, γ, is inversely proportional to the
standard deviation in the calculated distance, based on a given version of the
polymer-scaled Förster equation.
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𝑁

𝛾(𝐸𝐹𝑅𝐸𝑇 ) = 𝑆

(Eq. 5.20, S16)
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𝑑(𝐸𝐹𝑅𝐸𝑇 ))

(Eq. 5.21, S17)

Constraints were applied using one of two functions based on the probability
distribution functions used to interpret the FRET data. The Gaussian chain (Eq.
5.13) and normal distribution (Eq. 5.14) functions were transformed into Eq. 5.22
and 5.23 respectively to generate potential energy functions termed the Gaussian
chain constraint and the harmonic constraint functions respectively.

3
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𝜎2

(Eq. 5.22, S18)

2

))

(Eq. 5.23, S19)

The additional term, a, in both equations represents the “thermodynamic”
weighting factor of the constraints with respect to the Rosetta score function. The
optimal thermodynamic weighting factor was determined empirically by running
trial simulations with a set to values from 0.25-5. The breadth, σ for the harmonic
restraints (Eq. 5.23) was determined from a relationship between the average
distance and the normal distribution breadth derived from the simulated structures
used to generate the semi-empirical constraints. The optimal weight (a) was
determined to be 1, since at that value constraints were satisfied but the resulting
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ensembles were not overconstrained so as to yield physically unreasonable
conformations. For each interpretation of the data, both constraint functions were
applied to determine the efficacy of the constraining method and the data
interpretation. Simulations assessing the constraint weight and the method of
constraining generated 120 outputs, where the lowest 100 structures were used in
analysis due to the lack of differences in energy in the outputs. Final simulations
of the Gaussian chain interpreted and Gaussian chain constrained data produced
1020 structures where the lowest 1000 were used for interpretation.

Simulation Output Analysis:
HydroPro was used to calculate the diffusion coefficients and radii of
gyration.226 For analysis of 2 M simulated structures in HydroPro, the input
viscosity was multiplied by the ratio of the 0 M:2 M diffusion times of
AlexaFluor488. This effectively accounted for the increase in viscosity in 2 M
versus 0 M TMAO. Following determination in HydroPro, the diffusion coefficient
was converted for comparison with the diffusion coefficient determined from FCS
using a previously published conversion equation detailed in Eq. 5.24, while the
diffusion coefficient was determined from the measured diffusion time via Eq. 5.25
227.

𝐷𝐶𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑒𝑑 =

𝐷𝐻𝑦𝑑𝑟𝑜𝑃𝑟𝑜 +0.582

𝐷𝑃 = 𝐷𝐴𝐹488

1.08
𝜏𝐴𝐹488
𝜏𝑃
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(Eq. 5.24)
(Eq. 5.25)

In these equations, DP, DAF488, DHydroPro and DCalibrated are the diffusion
coefficients of the protein of interest, AlexaFluor488, as determined from literature,
from HydroPro and the experimentally calibrated diffusion coefficient for
comparison to DP respectively. Additionally, τAF488 and τP are the experimentally
derived diffusion times of AlexaFluor488 and the protein of interest respectively.
All distances required for Flory scaling plots, heat maps and comparisons
to experimental FRET data were extracted from C-alpha to C-alpha distances for
each residue using Python or BioPython and all calculations were performed using
NumPy. For EFRET determination, distance values from each member of a given
ensemble were transformed into EFRET values using the classical Förster equation
prior to averaging to capture the explicit distance probability distribution of the
ensemble. The same method was used to calculate comparisons to paramagnetic
relaxation enhancement data, where distances were extracted from C-alpha to
amide proton distance. Distances converted into intensity ratios as described by
Piana et. al. and the intensity ratios were averaged to calculate the final values

97.

Impact of the Thermodynamic Constraint Weight:
Assessment of the thermodynamic constraint weight effects were assessed
prior to application of the knowledge constraint weight. This was done in order to
assess the maximum impact of the constraint set. Knowledge constraints applied
to the full simulation were scaled to a maximum value determined by the
thermodynamic constraint as shown in Eq. 5.22 and Eq. 5.23, which is why
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determination of the maximum impact of the constraint set was crucial.
Experimentally constrained simulations were run as described below with the
omission of side chain rotamer packing using constraints where the distances were
determined by using the Gaussian chain version of the polymer scaled Förster
equation and were applied using the Gaussian chain derived constraining function.

Figure 5.2: Determination of Optimal Thermodynamic Constraint Value. Radius of
gyration (left) and average Flory scaling behavior (right) of simulated structures
with varying values of the thermodynamic constraint weight, a.
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Figure 5.3a: Effect of Constraints on Interresidue Distance Heat Maps. Heat maps
depicting the average interresidue distance for each thermodynamic constraint
weight, a, (left) and average difference in interresidue distance between
constrained and unconstrained simulations (right). Heat maps depict averages
from an unconstrained simulation (top row) and simulations with thermodynamic
constraint weights set to 0.25 (middle row) and 0.5 (bottom row).
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Figure 5.3b: Effect of Constraints on Interresidue Distance Heat Maps. Heat maps
depicting the average interresidue distance for each thermodynamic constraint
weight, a, (left) and average difference in interresidue distance between
constrained and unconstrained simulations (right). Heat maps depict averages
from simulations with thermodynamic constraint weights set to 1.0 (top row), 2.5
(middle row) and 5.0 (bottom row).
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Assessment of the Constraint Functional Form and Sampling Method:
Simulations were performed utilizing distances from the Gaussian chain
(Eq. 5.13) and semi-empirical (Eq. 5.14) FRET distribution analyses in conjunction
with either the Gaussian chain (Eq. 5.22) or harmonic (Eq. 5.23) constraints. This
was done to assure that no bias was introduced by selecting a particular
constraining method. No significant differences in the resulting ensembles were
observed between simulations run with different constraint data or constraining
functions when comparing the results in Flory-scaling plots (Fig. 5.4), or plots of
computed EFRET values (Fig. 5.5-5.6), diffusion coefficients (Fig. 5.7), or “heat
maps” of global structural analyses (Fig. 5.14a-5.14b).

Figure 5.4: Flory Scaling Plots. Plots of Flory scaling determined from simulated
ensembles constrained with distance constraints from measurements in 0 M (top
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left) and 2 M (top right/bottom left) TMAO. Names in the legends represent the
probability distribution used in the polymer-scaled Förster equation for obtaining
distances (Gaussian-chain = GC or semi-empirical = Pr) followed by the
constraining function employed (Gaussian-chain = GC or harmonic potential =
HR). Simulations marked with † indicate that the weight of the solvation term
(fa_sol) was set to 0 while simulations marked with ‡ indicated that fragment
insertion was incorporated within the search.
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Figure 5.5: 0 M TMAO EFRET Plots. (Previous Page) Plots show the average and
standard deviation of the EFRET values determined from simulated ensembles
constrained with distance constraints from measurements in 0 M (top/middle) and
2 M (bottom) TMAO. Names in the legends represent the probability distribution
used in the polymer-scaled Förster equation for obtaining distances (Gaussianchain = GC or semi-empirical = Pr) followed by the constraining function employed
(Gaussian-chain = GC or harmonic potential = HR). Simulations marked with †
indicate that the weight of the solvation term (fa_sol) was set to 0 while simulations
marked with ‡ indicated that fragment insertion was incorporated within the search.

Figure 5.6: 2 M TMAO EFRET Plots. (Next Page) Plots show the average and
standard deviation of the EFRET values determined from simulated ensembles
constrained with distance constraints from measurements in 2 M TMAO. Names
in the legends represent the probability distribution used in the polymer-scaled
Förster equation for obtaining distances (Gaussian-chain = GC or semi-empirical
= Pr) followed by the constraining function employed (Gaussian-chain = GC or
harmonic potential = HR). Simulations marked with † indicate that the weight of
the solvation term (fa_sol) was set to 0 while simulations marked with ‡ indicated
that fragment insertion was incorporated within the search.
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Figure 5.7: Diffusion Coefficients. Plots show the average diffusion coefficient
determined from FCS data (black line) and from various simulations (red points).
Simulation names represent the concentration of TMAO in which measurements
were taken, the probability distribution used in the polymer-scaled Förster equation
for obtaining distances (Gaussian-chain = GC or semi-empirical = Pr) and the
constraining function employed (Gaussian-chain = GC or harmonic potential =
HR), respectively. Simulations marked with † indicate that the weight of the
solvation term (fa_sol) was set to 0 while simulations marked with ‡ indicated that
fragment insertion was incorporated within the search.

§ 5.6 Results
We began by generating two libraries of proteins, labelled with either CnfTrp or Fam-Raz pairs, and making FRET measurements in varying concentrations
of TMAO.

For both FRET pairs, we observed changes in photophysical

parameters impacting the extraction of distance information from FRET data that
necessitated performing control fluorescence measurements using singly-labelled
proteins. When calculating R0 (Eq. 5.9) for these experiments, there were four
parameters of interest, D, J,  2 and n, which represent the quantum yield of the
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FRET donor, the overlap integral between donor emission and acceptor
absorbance, the orientation factor between the two fluorophores, and the refractive
index of the solution, respectively. Of these parameters, we determined that
changes in D as a function of environment contributed most significantly to
changes in R0 for both Cnf and Fam.

Additionally, Zheng et al. previously

demonstrated that for disordered proteins the orientations of the fluorophores are
sufficiently isotropic to warrant the approximation of 2 = 2/3, which is the value for
an isotropic distribution of orientations

64.

Fluorescence measurements made on

donor-only and acceptor-only proteins enabled us to not only account for changes
in D to enhance our accuracy in calculating R0, but also allowed us to easily
overcome the difficulties of interpreting highly overlapped spectra and extract
distances from EFRET measurements for use in modeling.

Cnf-Trp library
The Cnf-Trp construct library consisted of a total of 27 proteins, 17 doublelabeled and 10 single-labeled αS mutants, spanning 16 unique intramolecular
distances. Acquiring concentration-matched emission spectra for each singlelabeled construct in varying TMAO conditions allowed for tracking of changes in
the quantum yield and spectral shape of Cnf and Trp emission. The sensitivity of
these photophysical properties to increasing concentrations of TMAO was initially
assessed for the free amino acids (Fig. 5.8).
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Figure 5.8: Steady-state Fluorescence Spectra of Free Fluorophores. Plots show
background subtracted spectra of Cnf (top left), Trp (top right), Fam (bottom left)
and Raz (bottom right) for 0 (blue), 2 (red) and 4 M TMAO (black).

Although a decrease in the quantum yield was observed for both Cnf and
Trp, no major change in emission maximum was observed in the Trp spectrum. In
contrast to the free amino acid measurements, Trp-containing αS mutants
successively blue-shifted in increasing concentrations of TMAO, as a result of
changes in local environment upon compaction. Thus, measuring single-labeled
spectra was not only crucial for tracking spectral changes due to environmental
effects, but was also essential for deconvoluting the highly overlapped Cnf and Trp
emission spectra in constructs containing both fluorophores. EFRET values were
obtained for each probe pair in buffer containing 0, 2, and 4 M TMAO. Figure 5.9
shows the deconvolution of a 0 M measurement as well as a 2 M measurement
for the Cnf125-Trp94 pair. As expected, EFRET increases, correlating with the
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expected decrease in inter-residue distance resulting from compaction in TMAO.
Without TMAO present, in most cases this probe pair is not able to accurately
capture the apparent intraresidue distance as seen in low EFRET values outside of
the most reliable FRET range (EFRET = 0.3-0.7). This is most clearly observed in
Figure 5.10, where the distances extracted from these data are largely invariant
above sequence separations of 50 residues. However, in cases where the probes
are relatively close in primary sequence, the utility of this short-range pair is clearly
demonstrated. In the presence of 2 M, and especially 4 M TMAO, a significant
number of the probed regions display EFRET values within the optimal range for
accurate distance determination.

Figure 5.9: Determination of EFRET. Left: Background subtracted fluorescence
emission spectra of constructs labeled with Cnf, Trp, or both Cnf and Trp in 0 M
(top) and 2 M TMAO (bottom). Right: Double-labeled Cnf-Trp spectrum compared
to weighted sum of Cnf-only and Trp-only spectra, along with the contributions from
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each single-labeled spectrum shown for 0 M (top) and 2 M TMAO (bottom)
spectra.

Figure 5.10: Comparison of experimental and simulated data. Left: Distances
extracted from EFRET measurements of the Cnf-Trp and Fam-Raz libraries shown
with interresidue distances for a given primary sequence separation in
unconstrained or constrained MC simulations. The average (solid line) and
standard deviation (dashed line) of interresidue distances are shown for the
simulated ensembles. Right: Experimental and simulated EFRET values. Dashes
represent average EFRET values for each pair of labeled residues, with
interconnecting lines to guide the eye. The average (point) and standard deviation
(line) of EFRET values obtained based on interresidue separations in the
unconstrained or constrained simulated ensembles.

Fam-Raz library
To complement our Cnf-Trp data, we also performed FRET measurements
with a probe pair with a longer working range. A set of 21 constructs, consisting of
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10 dual-labeled and 11 single-labeled analogs containing Fam and/or Raz, was
produced to accurately monitor long range distance changes during the
compaction of αS by TMAO. In cases where exceedingly low EFRET was observed
with the short-range probe pair, we observed efficiencies much closer to the
optimal efficiency range for the Fam-Raz pair. This was most significant in the
absence of TMAO. However, our measurements approached the short end of the
working range for the Fam-Raz pair in some instances in 2 M TMAO and
exhausted its utility in 4 M TMAO.
In 4 M TMAO, the long working range of this probe pair was effective for
assessing the formation of oligomers, which were reported by Uversky et al. When
mixing Fam and Raz single-labeled species in 4 M TMAO, there was a significant
reduction in the lifetime of the Fam labeled construct, consistent with
intermolecular FRET (Figs. 5.11a-5.11c).
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Figure 5.11a: Intermolecular FRET Lifetime Decays and Fits. Plots show lifetime
decays and fits of (Left) αS-Fam9 + αS-Raz94, (Middle) αS-Fam9 + αS-Raz136
and (Right) αS-Fam24 + αS-Raz94 in (Top-Bottom) 0, 2 and 4 M TMAO. Decay of
single-labeled Fam constuct decays are shown before (red) and after (blue) the
addition of the Raz containing construct with fits shown as dashed lines.
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Figure 5.11b: Intermolecular FRET Lifetime Decays and Fits. Plots show lifetime
decays and fits of (Left) αS-Fam87 + αS-Raz94, (Middle) αS-Fam114 + αSRaz136 and (Right) αS-Fam123 + αS-Raz94 in (Top-Bottom) 0, 2 and 4 M TMAO.
Decay of single-labeled Fam constuct decays are shown before (red) and after
(blue) the addition of the Raz containing construct with fits shown as dashed lines.
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Figure 5.11c: Intermolecular FRET Lifetime Decays and Fits. Plots show lifetime
decays and fits of αS-Fam136 + αS-Raz94 in (Left-Right) 0, 2 and 4 M TMAO.
Decay of single-labeled Fam constuct decays are shown before (red) and after
(blue) the addition of the Raz containing construct with fits shown as dashed lines.

In buffer or 2 M TMAO, there was no observed change in the lifetime of the
Fam labeled protein due to the presence of the protein containing Raz. FCS and
AFM measurements also demonstrate the formation of oligomers in 4 M TMAO
(Figs. 5.12–5.13). As a result of these observations, we decided to forego modeling
the 4 M structure due to the complexity of deconvoluting intra- and intermolecular
FRET in oligomers.
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Figure 5.12: Autocorrelation plots from FCS Data. Plots show the average
autocorrelation decays from 10 measurements (red) with fits (black-dashed) for
αS-AF4889 (Top), αS-AF488114 (Middle) and αS-AF488130 (Left) in 0 M (Left)
and 2 M (Right) TMAO.
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Table 5.6: FCS Data
Position (TMAO)

9 (0 M)

114 (0 M)

130 (0 M)

N

8.9006

17.809

6.8298

Delay Time

0.401

0.42034

0.40662

Intensity

59007

193000

51376

0.43 ± 0.027

0.418 ± 0.010

0.411 ± 0.010

Position (TMAO)

9 (2 M)

114 (2 M)

130 (2 M)

N

12.889

38.693

17.384

Delay Time

0.79827

0.94794

0.68422

44824

163510

54824

0.822 ± 0.007

0.946 ± 0.035

0.779 ± 0.037

αS

Intensity
αS
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Figure 5.13: The effect of TMAO on the aggregation of wild type αS. Top: AFM
images of the dried samples. Bottom: corresponding volume histograms of the αS
aggregates. The αS concentration used for these samples are (left) 10 μM,
(middle) 0.1 μM, and (right) 0.5 μM. Each volume histogram was obtained with
accumulated data from more than five AFM images screened at various area on
the sample. No αS fibrillization is observed, which is consistent with the fact that
αS fibrillization in solution can’t occur in low concentrations and under static
conditions, and no agitation or shacking of the solution were performed here.

Interpretation of FRET data
Because αS is disordered, the interresidue distance separating any given
label pair is widely distributed. To accurately obtain an average distance value, this
distribution needs to be taken into account. Therefore, the corresponding
interresidue distances were calculated using a polymer-scaled Förster equation,
Eq. 5.12, taking into account changes in R0 resulting from changes in quantum
yield for each labeling position. Distances were calculated using both the Gaussian
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chain (Eq. 5.13) and semiempirical (Eq. 5.14) models, which produced significantly
different sets of results. Conceptually, two positions labeled with two FRET pairs
with different R0 values should have distinct FRET efficiencies, but comparable
extracted distances. Since the Cnf-Trp and Fam-Raz libraries contained a limited
number of labeled positions in common, for comparison the distances were plotted
in Fig. 5.11 as a function of probe pair primary sequence separation.

Figure 5.14: Distance from Polymer-Scaled Förster Equation. Plot show distances
obtained from steady-state derived EFRET values through the Gaussian chain
(GC) or semi-epirical (Pr) forms of the polymer-scaled Förster equation. Plots are
shown for data obtained in 0 M (left) and 2 M (right) TMAO.

We reasoned that the consistency between data from the Cnf-Trp and FamRaz libraries on a Flory scaling plot should help us to identify the more accurate
probability distribution. In Fig. 5.14, it is clear that there is substantially better
agreement between the Cnf-Trp and Fam-Raz data sets when applying the
Gaussian chain distribution to extract distance data from the EFRET values.
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Simulations
After data collection, simulations were performed in PyRosetta to generate
structural ensembles that represent the changes observed by FRET. Before
introducing FRET-based constraints, we optimized a PyRosetta script to effectively
produce ensembles of structures in general agreement with previously published
radius of gyration (Rg) and radius of hydration (Rh) values 205, 228. Simulations were
performed where the weighting of the FRET constraints relative to other Rosetta
energy terms (a, Eqs. 5.22 and 5.23) was varied, and different shapes for the FRET
constraint function were assessed. These constraint function shapes were based
on the Gaussian chain (Eq. 5.13) or semiempirical (Eq. 5.14) distance distributions
used in the FRET analyses. Given the greater consistency between Cnf-Trp and
Fam-Raz data when using the Gaussian chain probability distribution (above), we
favored using this function for implementing constraints as well. However, we
tested all combinations to ensure that no bias was introduced based on the pairing
of distribution functions used in FRET data analysis and in constraint
implementation. The results of these tests are detailed in Figs. 5.2-5.7, 5.14a-5.15c
and are discussed further below. We found that setting the weight of the
constraints relative to the other score function components to unity allowed the
FRET constraints to influence the structure without overconstraining, and that
reasonable variations of the shape of the constraint function did not dramatically
influence the simulation results. Thus, in the main text, we exclusively report
simulations performed using the Gaussian chain distribution, with all other
simulations reported in the Supporting Material. The 2 M TMAO simulations were
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performed with the solvation term removed in an effort to account for the significant
change in solvation. Unconstrained simulations performed with this altered score
function provided a more compact starting point for introducing FRET constraints,
whereas constrained ensembles were noticeably more compact (Figs. 5.4-5.7).
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Figure 5.14a: Global structural summary for 0 M TMAO ensembles. Plots are
derived from unconstrained (top set), 0M_GC-GC (middle set) and 0M_GC-HR
(bottom set) simulations. Simulation names represent the concentration of TMAO
in which measurements were taken, the probability distribution used in the
polymer-scaled Förster equation for obtaining distances (Gaussian-chain = GC or
semi-empirical = Pr) and the constraining function employed (Gaussian-chain =
GC or harmonic potential = HR), respectively. Structures (left) show the 10 lowest
energy structures faded with the single lowest energy structure darkened (blue red, N-term - C-term). Heat map (middle) shows the average inter-residue
distances from all output structures (above diagonal) and the inter-residue
distances from the single lowest energy structure (below diagonal) as a function of
residue pair. Histogram (right) of the percent of output structures for a given radius
of gyration with bin widths of 2 Å.
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Figure 5.14b: Global structural summary for 0 M TMAO ensembles. Plots are
derived from 0M_Pr-GC (top set), 0M_Pr-HR (middle set) and unconstrained†
(bottom set) simulations. Simulation names represent the concentration of TMAO
in which measurements were taken, the probability distribution used in the
polymer-scaled Förster equation for obtaining distances (Gaussian-chain = GC or
semi-empirical = Pr) and the constraining function employed (Gaussian-chain =
GC or harmonic potential = HR), respectively. Structures (left) show the 10 lowest
energy structures faded with the single lowest energy structure darkened (blue red, N-term - C-term). Heat map (middle) shows the average inter-residue
distances from all output structures (above diagonal) and the inter-residue
distances from the single lowest energy structure (below diagonal) as a function of
residue pair. Histogram (right) of the percent of output structures for a given radius
of gyration with bin widths of 2 Å. Simulations marked with † indicate that the
weight of the solvation term (fa_sol) was set to 0.
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Figure 5.15a: Global structural summary for 2 M TMAO ensembles. Plots are
derived from 2M_GC-GC† (top set), 2M_GC-HR† (middle set) and 2M_Pr-GC†
(bottom set) simulations. Simulation names represent the concentration of TMAO
in which measurements were taken, the probability distribution used in the
polymer-scaled Förster equation for obtaining distances (Gaussian-chain = GC or
semi-empirical = Pr) and the constraining function employed (Gaussian-chain =
GC or harmonic potential = HR), respectively. Structures (left) show the 10 lowest
energy structures faded with the single lowest energy structure darkened (blue red, N-term - C-term). Heat map (middle) shows the average inter-residue
distances from all output structures (above diagonal) and the inter-residue
distances from the single lowest energy structure (below diagonal) as a function of
residue pair. Histogram (right) of the percent of output structures for a given radius
of gyration with bin widths of 2 Å. Simulations marked with † indicate that the
weight of the solvation term (fa_sol) was set to 0.
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Figure 5.15b: Global structural summary for 2 M TMAO ensembles. Plots are
derived from 2M_Pr-HR† (top set), 2M_GC-GC (middle set) and 2M_GC-GC‡
(bottom set) simulations. Simulation names represent the concentration of TMAO
in which measurements were taken, the probability distribution used in the
polymer-scaled Förster equation for obtaining distances (Gaussian-chain = GC or
semi-empirical = Pr) and the constraining function employed (Gaussian-chain =
GC or harmonic potential = HR), respectively. Structures (left) show the 10 lowest
energy structures faded with the single lowest energy structure darkened (blue red, N-term - C-term). Heat map (middle) shows the average inter-residue
distances from all output structures (above diagonal) and the inter-residue
distances from the single lowest energy structure (below diagonal) as a function of
residue pair. Histogram (right) of the percent of output structures for a given radius
of gyration with bin widths of 2 Å. Simulations marked with † indicate that the
weight of the solvation term (fa_sol) was set to 0 while simulations marked with ‡
indicated that fragment insertion was incorporated within the search.
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Figure 5.15c: Global structural summary for 2 M TMAO ensembles. Plots are
derived from unconstrained†‡ (top set) and 2M_GC-GC†‡ (bottom set)
simulations. Simulation names represent the concentration of TMAO in which
measurements were taken, the probability distribution used in the polymer-scaled
Förster equation for obtaining distances (Gaussian-chain = GC or semi-empirical
= Pr) and the constraining function employed (Gaussian-chain = GC or harmonic
potential = HR), respectively. Structures (left) show the 10 lowest energy structures
faded with the single lowest energy structure darkened (blue - red, N-term - Cterm). Heat map (middle) shows the average inter-residue distances from all output
structures (above diagonal) and the inter-residue distances from the single lowest
energy structure (below diagonal) as a function of residue pair. Histogram (right)
of the percent of output structures for a given radius of gyration with bin widths of
2 Å. Simulations marked with † indicate that the weight of the solvation term
(fa_sol) was set to 0 while simulations marked with ‡ indicated that fragment
insertion was incorporated within the search.

Moreover, for simulations of the 2 M ensemble, fragment insertion was
incorporated within the MC search to increase the amount of resultant secondary
structure which has been observed by circular dichroism studies of the TMAOinduced conformation

133.

Although this significantly increased the number of
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helices, there was no marked improvement in the match of simulated structures
with experimental FRET data (Fig. 5.4-5.7).
Initially, we compared the constrained simulations to the FRET data using
Flory scaling plots, where the average interresidue distance (between α-carbons)
as a function of sequence separation was plotted for the ensemble of 1000 lowest
energy structures with experimental FRET data overlaid as discrete points (Fig.
5.10, left). All experimental data were close to the average simulation distance or
within the standard deviation for both 0 and 2 M ensembles, with the notable
exception of the Fam9-Raz136 FRET data. It is notable that the distance determined
for this FRET pair using the harmonic potential (Fig. 5.14) does not show such
dramatic discord with the other distances, potentially suggesting a limitation of the
Gaussian chain model for very long distance ranges. We also predicted FRET
values for all of the pairs of label sites for comparison to the experimental FRET
data (Fig. 5.10, right). Distances between the α-carbons of the amino acids at the
label sites were extracted from each structure in a simulated structural ensemble
and converted to EFRET values using the classical Förster equation (Eq. 5.12,
where P(r,x) = 1). Since the variations in conformation in the ensemble explicitly
capture the distribution of interresidue distances, the average EFRET was computed
as a simple average of the values extracted from each structure with no further
correction for polymer scaling of the distance distribution. We found good
agreement, with an average absolute EFRET difference of 0.09 and all experimental
values falling within the standard deviation of the simulated values. As discussed
below, the close match between these values helps to validate our choice of a
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polymer-scaled distance distribution function in interpreting EFRET values to input
constraints in the simulations.

Figure 5.16: Analysis of αS structural ensembles. Left: Representative structures
from 0 and 2 M simulations. The darkened structure in the foreground is the lowest
energy structure and the faded ensemble in the background includes the 10 lowest
energy structures. Middle: Heat maps showing the average interresidue distances
in the simulated ensembles. Each heat map shows the average distance for the
full simulated ensemble of structures above the diagonal and distances from the
single lowest energy structure below the diagonal. Top right: Histograms of radii of
gyration of structures from simulations, plotted with literature values of Rg
determined from SAXS data and the hydrodynamic radius from NMR studies.
Bottom right: Diffusion coefficients from FCS and simulated structures.

Fig. 5.16 shows the 10 lowest energy structures from the 0 and 2 M
simulations, aligned and with a single structure darkened for clarity. One can see
significant compaction of the 2 M ensemble, which can be quantified using
histograms of the Rg for each structure in the ensemble. The average radius of
gyration in 0 M TMAO is 29.3 ± 4.6 Å, which shrinks to 23.5 ± 3.4 Å in 2 M TMAO.
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Interestingly, despite this compaction, αS remains disordered in 2 M TMAO. The
disorder can be visualized using a plot of the distribution of interresidue distances
as a two-dimensional “heat map,” with interresidue distances for the entire
ensemble plotted above the diagonal and interresidue distances for the single
darkened structure below the diagonal. As seen in the middle plots in Fig. 5.16, in
both 0 and 2 M TMAO, the average interresidue distance scales with primary
sequence separation, despite the fact that long-range contacts occur in individual
structures within the ensembles (Fig. 5.17).
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Figure 5.17: Contact maps from experimentally constrained ensembles. Contact
maps from the 0M_GC-GC (top) and 2M_GC-GC† (bottom) ensembles. A cutoff
distance of 10 Å was set as a contact. Each half of each heat map are analyses of
the same ensemble and show all residue pairs which make contact in one or more
structures from the ensemble as white while residue pairs which do not make
contact are shown in blue (top left). The fraction of structures of the ensemble
which make contact are shown over the full fractional scale with a red/white
gradient (bottom right).
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Figure 5.18: Average interresidue distance heat map. Heat map showing the
average difference in interresidue distance between the 0M_GC-GC and 2M_GCGC† ensembles.

Figure 5.19: Experimentally constrained ensemble Flory scaling plot. Flory scaling
plots of 0M_GC-GC (red) and 2M_GC-GC† (blue) simulated ensembles along with
the random coil simulation (black) used for the construction of P2(r,x) and a curve
representing the scaling of a globule protein(green) 68.
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Figure 5.20: Experimentally constrained ensemble DSSP analysis. DSSP
analysis of 0M_GC-GC (red) and 2M_GC-GC† (blue) ensembles for comparison.
(Top Left) Histogram showing the percent of structures binned based on the total
solvent accessible surface area of a given structure (Å2). (Top Right) Histogram
showing the percent of structures binned based on the total number of
intramolecular hydrogen bonds present in a given structure. (Bottom Left) Plot of
the average value of the cosine of the angle between the backbone carbonyl of the
current residue and the carbonyl of the previous residue (TCO) for each residue
for each structure within a given ensemble. (Bottom Right) Plot of the average
value relative solvent accessibility for each residue for each structure within a given
ensemble.
This combined information indicated that, in the presence of 2 M TMAO, αS
populates a compacted disordered ensemble that still maintains a high degree of
structural heterogeneity. To confirm that the structure ensembles were consistent
with other experimental observables, we calculated the diffusion coefficient for
each structure of the 0 and 2 M ensembles using HydroPro
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226.

As seen in

Fig. 5.16, the calculated diffusion coefficients are slightly (16%) smaller, but in
reasonable agreement with those measured in our FCS experiments.

Comparison of structure ensembles to data from literature
We compared our structural models in the absence of TMAO to data from
the literature as well as other published models. The average Rg of our 0 M
ensemble matched well with reported values of Rg from SAXS experiments and Rh
(typically 30% larger than Rg) from NMR experiments

205, 228.

Furthermore, our

models agreed remarkably well with both the primary NMR PRE data (Fig. 5.21)
and Flory scaling plots of the resulting models (Fig. 5.22) reported by Allison et al.
126.
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Figure 5.21: Intensity ratios from PRE measurements. Each plot shows the
measured intensity ratio from PRE data obtained by Allison et. al. (grey bars) and
the calculated average intensity ratio from the constrained simulation (red lines)
were derived from data acquired in 0 M TMAO and interpreted using the
Gaussian-chain polymer scaled Förster equation 126. Plots show data for spinlabel placement at residues 24 (top left), 42 (top right), 62 (middle left), 87
(middle right) and 103 (bottom right).
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Figure 5.22: Flory scaling plot comparison to previously published ensemble. Plot
shows the average distance as a function of sequence separation for simulated
ensembles (PED9AAC) and unconstrained and constrained simulations reported
herein 125-126. Distance constraints were derived from data acquired in 0 M TMAO
and interpreted using the Gaussian-chain polymer scaled Förster equation.
Constraints were implemented using the Gaussian-chain constraint function.
We do observe rare contacts between regions of the protein that are distant
in primary sequence (Fig. 5.17), consistent with reports of transient C-terminal
contacts with the NAC and N-terminus 200.
Although there is limited information on the structure of αS in 2 M TMAO,
we find that our models agree with the available information. Similar to previous
studies, our circular dichroism measurements made in 0 or 2 M TMAO show little
change in αS helicity (Fig. 5.23), consistent with our models which show that the
2 M ensembles are still highly disordered.
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Figure 5.23: CD spectra of αS in varying concentrations of TMAO. Full plot and
insert show the same data set, where the insert is adjusted to show difference in
spectra above 220 nm. Measurements were taken on an Aviv model 410 circular
dichorism spectrometer in 1 mm path length quartz cuvettes and were performed
with 20 μM wild-type αS in 20 mM Tris 100 mM NaCl pH 7.5. TMAO was added to
each buffer and the pH was readjusted at 25 °C. Scans from 190-260 nm were
performed with a 1 nm bandwidth, 1 nm step size and an averaging time of 10
seconds.
Previously, Uversky and coworkers monitored fibrillization of αS in TMAO
using thioflavin T (ThT) fluorescence, and found that aggregation was accelerated,
but that the final level of ThT fluorescence was lower. Our own studies with Congo
Red (Fig. 5.24) corroborated this observation, although, intriguingly, changes in
fluorescence polarization (Fig. 5.25) were slower in 2 M TMAO, possibly indicating
that the ThT and Congo Red spectroscopic properties are changed in TMAO.
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Figure 5.24: Aggregation kinetics of αS monitored by Congo Red. Aggregation
was performed with 100 μM wild-type αS in 20 mM Tris 100 mM NaCl pH 7.5.
TMAO was added to each buffer and the pH was readjusted. Samples were
agitated in an orbital shaker at 1500 rpm at 37 °C. At each timepoint, 10 μL of
sample was removed and added to 140 μL of 20 μM Congo Red in water and
incubated for 20 minutes at room temperature prior to measurement. Absorption
spectra (230-700 nm) were measured in a 96-well black CoStar clear bottom plate
on a Tecan M1000 plate reader. Kinetics were fit to Eq. 5.26 in Prism with the
detailed values in Table 5.7.
𝑌 = A + (B-A)⁄(1 + (C/x)^D)
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(Eq. 5.26)

Table 5.7: Values from fits of Congo Red aggregation kinetics.
0 M TMAO

2 M TMAO

4 M TMAO

A

0.5977

0.6289

0.7003

B

1.123

1.03

0.7656

C

9.989

6.397

19.72

D

4.357

1.708

1.104

R2

0.9855

0.9526

0.9062

Figure 5.25: Aggregation kinetics of αS monitored by fluorescence polarization.
Aggregation was performed with 100 μM αS-Fam136 in 20 mM Tris 100 mM NaCl
pH 7.5. TMAO was added to each buffer and the pH was readjusted. Samples
were agitated in an orbital shaker at 1500 rpm at 37 °C. At each timepoint, 10 μL
of sample was removed and added to 90 μL of 20 mM Tris 100 mM NaCl pH 7.5.
Fluorescence polarization measurements were taken in a 96-well black CoStar
clear bottom plate on a Tecan F200 plate reader. Kinetics were fit to Eq. 5.26 in
Prism with the detailed values in Table 5.8.
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Table 5.8: Values from fits of fluorescence polarization aggregation kinetics.
0 M TMAO

2 M TMAO

4 M TMAO

A

48.65

58.28

76.27

B

278.1

240.9

86.22

C

8.495

13.74

23.99

D

3.82

2.248

80.41

R2

0.9806

0.9734

0.2733

Thus, although compacted, αS remains disordered and able to sample
conformations that lead to fibril formation. This can be seen in Figs. 5.19 and 5.20
where, despite compaction observed by changes in solvent-accessible surface
area, metrics such as numbers of intramolecular hydrogen bonds and backbone
dihedral angles do not indicate the presence of persistent structure.

§ 5.7 Discussion
Our previous study of αS structures using MC simulations with only a
repulsive Lennard-Jones potential and harmonic constraints based on singlemolecule FRET data gave structural ensembles with global properties that
matched well to experimental measurements such as Rg. This modeling protocol,
with constrained simulations utilizing exclusively a repulsive van der Waals
potential, was extremely efficient in its simplicity, but the resulting models lacked
atomic-scale details that could be used in generating hypotheses or interpreting
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mechanisms of conformational change. We and others have also performed
unconstrained simulations which included the amino acids using single-sphere
“centroid” representations of the side chains, as well as all-atom molecular
dynamics simulations of αS, which do provide such detailed information, but are
much more computationally intensive and generally limited in the conformational
space explored. We wished to find an intermediate level of simulation wherein we
could include side chains in MC simulations and maintain efficient sampling.
However, we reasoned that the previous long-range constraints (>30 Å) derived
from single-molecule FRET data would not provide sufficient information on shortrange interactions to properly direct these simulations. Thus, we here included
data from the short-range Cnf-Trp pair along with data from the Fam-Raz pair,
which has a comparable FRET range to the previous single-molecule FRET
probes. These short-range probe pairs may be crucial for identifying contacts or
collapsed regions that can exist under varied solution conditions or in the presence
of allosteric molecules.

Assessing the validity of P(r)
We reasoned at the outset that the Gaussian chain P(r) was more accurate
because it led to greater consistency between the distances obtained from the CnfTrp and Fam-Raz libraries. However, this method of analysis was complicated by
the limited numbers of intramolecular distances in a range that could be accurately
captured by both pairs, as these probes were selected specifically for their efficacy
across different distance ranges. Furthermore, one can observe that the Cnf-Trp
207

distances are largely invariant after reaching a sequences separation of ∼50
residues due to a working range that extends to only ∼35 Å. Therefore, our
assignment of the Gaussian chain P(r) as the more accurate distribution function
arises from visual inspection of the Flory scaling plots in Fig. 5.14 in the 25–45 Å
range, which encompass the upper and lower bounds of the Cnf-Trp and Fam-Raz
probe pairs, respectively. It is important to note that at very short (<15 residues)
and very long (>115 residues) sequence separations, the calculated distances are
likely unable to be accommodated by any conformation of the protein.
Furthermore, the functional form of the distribution may also be dependent on the
number of residues between two probes (e.g., short sequence separations cannot
have truly polymer-like behavior and may need to be treated with classical FRET
equations) or heterogeneity not accounted for by polymer-scaling behaviors 229.

Differences between constraint methods
Since IDPs have relatively flat energetic landscapes, improper introduction
of constraints can easily result in ensembles where the resultant conformations
are not sufficiently diverse, especially proximal to constrained sites. This arises
primarily from constraining potentials that are too deep or too narrow, but can also
occur when conformational space is not effectively sampled. The latter problem
could be caused by poor parameterization of the Metropolis criterion (such as
selection of a kT value that is too low) or by not having an appropriate score
function to produce the multiple local minima present within a single pair-wise
constraint potential. By expanding our score function from a single repulsive van
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der Waals term to the current optimal score function utilized by Rosetta, we assure
that output states populate local minima that allow us to extract high-resolution
information and provide an effective buffer for constraint introduction. Achieving
unconstrained simulations of this quality required significant adjustment of
PyRosetta scripts, which normally are used to model folded proteins rather than
IDPs. These optimization efforts will be reported in detail elsewhere. In addition to
improved modeling scripts, we hypothesized that issues related to the constraint
functional form could be circumvented by directly employing appropriate distance
distributions for disordered ensembles to analyze the FRET data.
Nonetheless, we performed simulations with all four combinations of the two
P(r) functions used to obtain distances and the two corresponding constraining
functions. This allowed us to consider how the ensembles were influenced by the
method of constraining in addition to the sets of distances used as constraints.
Figs. 5.4-5.7, 5.14a-5.15c demonstrate that neither the method of constraint nor
the P(r) utilized for the distance determination through Eq. 5.12 had a dramatic
impact on the resulting structures. This likely arises from the fact that distances
from the unconstrained simulation are already very close to the distances obtained
from the experiments. Despite the relative agreement between the ensembles
produced across all constraining methods for a given concentration of TMAO,
there are several noteworthy observations. Figs. 5.14a-5.15c show that in all cases
in which a harmonic potential was employed, the structural diversity, most clearly
observable in the dispersion of Rg values, is visibly decreased. Moreover,
harmonic constraints consistently produced deviations in the scaling behavior,
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where the heat maps (Figs. 5,14a-5,15c) reveal distances between the N-terminal
region and the NAC domain that are, on average, longer than those between the
C-terminal region and the NAC. This observation is independent of the input data,
as these nuances are observed for both data sets, with constraints from data
obtained utilizing P2(r,x) further enhancing these trends. These observations
demonstrate that there are significant differences between these ensembles which
result exclusively from the functional form of the constraining potential.
The relative impacts of changes in the score function or in the constraints
are evident in comparisons between 2 M simulations performed using Gaussian
chain derived data with or without constraints or solvation term modification (Figs.
5.4, 5.14a-5.15c). FRET constraints alone compacted the 2 M ensemble (2 M GCGC) relative to the 0 M ensemble (0 M GC-GC), but were not sufficient to generate
ensembles that were consistent with the 2 M experimental data. However, it is
important to note the marked differences between the 0 and 2 M ensembles, as
these demonstrate that simulations in PyRosetta can be significantly influenced by
constraints, which was not evident from the 0 M simulations alone. The fact that
these constraints alone were unable to produce ensembles in full agreement with
the 2 M data suggests that αS in the presence of molar quantities of TMAO
populates a subset of conformations that are not accessible with the standard
score function. With the solvation term removed, comparison of the 2 M
constrained (2M GC-GC†, see Fig. 5.15a) and unconstrained (Unconstrained†, see
Fig. 5.14b) simulations demonstrate that the constraints serve to exclude extended
structures. This further suggests that the application of constraints does not
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produce new conformations not present in the unconstrained population, but can
effectively remove unfavorable structures from an ensemble based on
experimental data. Overall, we see this as a favorable compromise as the
necessity to modulate the unconstrained population through changes to the
PyRosetta scoring is likely driven by the dramatic change in buffer conditions,
which would not be present in many other applications. Systems where dramatic
changes in solvent conditions occur (as in this study) can be effectively
represented by adjusting the score function, whereas intramolecular (or
intermolecular) contacts can be accounted for by changing the constraint
functional form to accurately represent experimental data.

Comparison of experimental and simulated data
Initial comparisons between the experimental and simulated distances in
Figs. 5.10 and 5.4 demonstrate that most of the obtained distances fall within 1 SD
of the average interresidue distance for the given sequence separation. The
observed disagreements at high and low sequence separation are likely due to
inaccuracies in the determination of the experimental distance arising from either
the working range of the probe or the polymer-scaling function, as previously
discussed. Moreover, agreement in simulated and experimental FRET efficiencies
in Figs. 5.10, 5.5, and 5.6 demonstrate that the underlying conformation dispersion
is accurately captured, since appropriate efficiencies are obtained for both probe
pairs. The FCS measurements herein also demonstrate that the simulated
ensembles are of approximately the correct overall size and that the degree of
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compaction is qualitatively accurate. The quantitative disagreement between the
simulated diffusion coefficients observed in Fig. 5.16, where the simulated
diffusion coefficients are systematically lower than the experimental values, could
arise from several different factors. Given that the overall size agrees with
previously published NMR and SAXS data, it is possible that we encountered
small, systematic inaccuracies in determining diffusion coefficients resulting from
a combination of the treatment of the disordered ensemble in HydroPro, the need
for an empirical conversion factor, or accounting for the change in viscosity
induced by TMAO. Importantly, we have demonstrated in Figs. 5.21 and 5.22,
respectively, that our 0 M ensembles agree with previously published PRE data
and the structural ensembles generated from those data

104, 126

.

It is worth noting that in our effort to establish an efficient, intermediate level
of simulation, we chose not to pursue some elements that could have further
improved the accuracy or tested the boundaries of our simulations. For example,
we elected not to incorporate probe/linker spatial exploration. Although we
acknowledge that simulations would be made more accurate by including
representations of the probes, with FRET based on distances between fluorophore
transition dipoles instead of α-carbons, this would have significantly increased the
computational time, undermining our intention of creating an efficient approach.
Additionally, we envision that coupling our method with the strategy previously
employed by Dobson and Vendruscolo, where constraining functions were
iteratively updated, could produce a more refined, but computationally intensive,
version of our modeling protocol

104.

Moreover, this method circumvents the need
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to assume a probability distribution function when interpreting the FRET data, as
the constraints would be applied directly as FRET efficiencies. Finally, since
introduction of a new constraint functional form is as simple as writing a new
function in Python, we hypothesize that our method of constraint introduction,
where assumptions regarding underlying distributions are directly converted into a
potential, is not only useful for applying FRET data from disordered systems, but
would also allow for efficient incorporation of other types of experimental data such
as PRE data 107-108, 126 .

§ 5.8 Conclusions
We have developed a Rosetta modeling protocol using explicit protein side
chains and sophisticated score functions in combination with appropriately
weighted distance constraints to generate models of IDPs. By performing
simulations that were constrained with experimental FRET data from two libraries
containing different FRET pairs, we were able to model the ensemble of αS in
buffer and in the presence of 2 M TMAO. Our models agreed well with independent
measurements of αS structure from FCS, NMR, PRE, and SAXS data, and were
computationally less taxing than traditional molecular dynamics simulations. In
future work, we intend to explore the degree to which ensembles generated in
PyRosetta capture residual secondary structure and the accuracy of values
computed from these ensembles, such as chemical shifts or J-couplings in
comparison with NMR experiments. The modifications made to our Rosetta
modeling protocol allowed us to produce reasonable αS starting models in the
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absence of constraints. The quality of these unconstrained models gives us greater
confidence in interpreting the interactions observed in the constrained structural
ensembles, and makes the simulations more robust to the inclusion of an
inconsistent constraint. After careful consideration of constraint function shape and
weight, we have found a form that allows them to influence the structural ensemble
without overconstraining. Future investigations could employ different weights for
different FRET pairs, or different functional forms for different distance ranges.
Our modeling protocol for IDPs incorporates atomic detail relevant to the
study of chemical-, ligand-, or environment-induced conformational changes, and
yet is sufficiently rapid both in data collection and simulation time to be applied in
a moderate throughput fashion. Once libraries of labeled proteins have been
generated, FRET measurements of the type reported here could easily be
acquired under a variety of conditions, potentially even in a multiwell format. The
collection of FRET constraints could then be used to generate structural
ensembles to explore hypotheses for mechanisms of conformational change or to
rationalize trends among molecules and modifications that modulate IDP
conformation. For example, Kakish et al.
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have recently shown that bis-

heterocycles linked by a flexible tether are able to bind to αS and induce
conformational changes in the monomer that inhibit its propensity to aggregate.
The procedures used here to study the effects of TMAO on αS structure could be
applied to study such molecules with therapeutic potential. Furthermore, recent
work has shown that modifications such as serine glycosylation and tyrosine
phosphorylation affect aggregation and membrane binding respectively
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231-232.

Subsequent modification of the current labeled library, or production of a new
library, would allow one to utilize the method reported herein to visualize the effect
of these and other posttranslational modifications on the disordered ensemble.
Although certain classes of molecules or solution conditions may spectroscopically
interfere with our FRET probes, it is important to note that we can easily vary these
probes using essentially the same labeling strategies. For example, we have
recently reported a methoxycoumarin-acridonylalanine FRET pair that can be
introduced by a combination of cysteine modification and unnatural amino acid
mutagenesis

51.

Finally, it is important to note that our methods are not restricted

to pure IDPs like monomeric αS, but can be applied to disordered regions of folded
proteins or ordered aggregates such as the N- and C-terminal regions of fibrillar
αS 47, 233.
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CHAPTER 6: A UNIFIED DE NOVO APPROACH FOR PREDICTING THE
STRUCTURES OF ORDERED AND DISORDERED PROTEINS.
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§ 6.1 Introduction
Intrinsically disordered proteins (IDPs) and intrinsically disordered regions
(IDRs) of proteins have garnered increasing attention due to growing recognition
of their roles in cellular health and disease.2, 234 These highly dynamic systems
play crucial roles in signaling pathways, the function of the nuclear pore, lipid
transport, membraneless organelles, and several pathologies. 2,

20, 234

These

functions are often related to structural transitions, where protein-protein
interactions or ligand binding events facilitate conversion from a broad
conformational ensemble to a much smaller number of states. 2 The ability to model
both the conformationally diverse states as well as the induced ordered structures
of IDPs is essential for mechanistic understanding of their activity and for potential
therapeutic development for IDP-related proteinopathies.
As interest in IDPs and IDRs has continued to grow, experimental and
theoretical techniques originally developed for structured proteins have been
adapted to accommodate these dynamic systems. Although NMR, fluorescence
and scattering-based methods have all been effectively utilized to characterize
unstructured systems, the production of representative structural ensembles for
IDPs using computational methods has proven far more challenging.53, 60-61, 68, 104,
107-108, 200-202, 219

Many approaches have constructed ensembles by using

experimental data to filter sets of potential structures generated from random-coil
or Protein Data Bank (PDB) fragment libraries.107-108, 199 Molecular dynamics (MD)
based methods have been developed and optimized to predict IDP ensembles. 97100, 105

Monte Carlo (MC) methods, such as those employed in CAMPARI, have
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demonstrated efficacy in modeling structural ensembles with and without data
restraints, but protocols developed to date cannot generally accommodate both
folded proteins and IDPs.53, 68, 235-236
Our goal was to develop an architecture which effectively handles both
ordered and disordered proteins and can generate accurate structural
representations of both, de novo. Furthermore, we want to develop algorithms that
do not suffer the hardware and computational time burdens associated with MD
simulations. We posit that MC sampling, which allows for broad sampling of
conformational space, is more efficient than the relatively local sampling
associated with MD. However, one major hurdle with MC methods is that the
identification of true minima is often challenging. With these ideas in mind, we have
turned our attention towards the Rosetta Modeling Suite. This platform has
demonstrated extensive success in predicting structures for ordered systems
through the use of a simulated annealing MC approach with limited gradient-based
minimization.237 Simulated annealing methods effectively reduce simulation time
by utilizing coarse grained representations during early stages of sampling and
can greatly favor the identification of minima. In addition, Rosetta has been utilized
successfully to model IDRs and IDPs with the application of experimental
constraints.53, 68, 236
Here, we focus on adapting two algorithms: AbInitio, which can predict
folded protein structure from sequence, and FloppyTail, which can produce
structural ensembles of IDRs.236, 238-240 For the first time, to our knowledge, we
tested these method’s ability to produce an accurate structural ensemble of an
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IDP, α-synuclein (αS), for which there exists a battery of experimental data. αS is
fully disordered in solution and is a key player in the pathogenesis of Parkinson's
Disease and other proteinopathies and is one of the most well-studied IDPs.19-20
After demonstrating the limitations of both algorithms, we developed a generalized
simulation format in PyRosetta that allowed us to test the efficacy of the underlying
energy term and sampling methods that exist in Rosetta.114 After identifying issues
with Rosetta’s knowledge-based terms and fragment sampling approach, we
demonstrate methods for improving the energy term accuracy and fragment
selection process. Although the solutions posited here are applied exclusively to
Rosetta, both the issues themselves and the solutions are finding that are likely
generalizable for other Monte-Carlo based methods.110 Lastly, we demonstrate
that the incorporation of these improvements, along with additional improvements
to sampling schemes, affords two improved algorithms, AbInitioVO and
FastFloppyTail, which in concert allow for the accurate prediction of structural
representations of proteins across all degrees of foldedness.
When considering a unified architecture, we noted that Rosetta-based
algorithms such as AbInitio, designed for folded structures, and FloppyTail,
designed for disordered structures, vary dramatically in their approaches.236, 238, 240
AbInitio utilized simulated annealing, coarse-graining and knowledge-based
scoring terms to sample nine-residue (9-mer) and three-residue (3-mer) fragments
culled from the PDB.238-240 With each simulation stage more score terms are added
to the MC score function and the number of fragment insertions tested between
score events is reduced. Lastly, the simulated structures are processed via the
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Relax algorithm, which performs a series of gradient based minimizations with
varied weightings of the repulsive van der Waals term.190 This allows the protein
to pulse and wiggle towards an energetically minimized conformation. By
comparison, FloppyTail also utilized knowledge-based scoring and coarsegraining to perform initial 3-mer sampling.236 Following initial simulation under a
coarse-grained representation, the structure is converted into an all atom
representation and 3-mer sampling proceed under the “score12” all-atom score
function used by Rosetta. Throughout, fragment insertion steps are coupled to
gradient based minimization and, after the algorithm switches to an all-atom
representation, sidechain rotamer sampling is also added.

§ 6.2 Methods
Computational Resources
All simulations were performed on the University of Pennsylvania School of
Arts and Sciences General Purpose Cluster (GPC). Each of the four GPC compute
nodes contains 24 cores at 2.6 Ghz, 256 GB RAM, 1 GbE Networking, 56 Gb
Infiniband and 3.6 TB OS/Scratch storage. All times reported herein were from
140-residue αS. On average, Full-atom Generalized Simulations required ~3 hours
per structure while simulations using exclusively Centroid course-graining required
~30 minutes per structure. Simulations using both course-grained and all-atom
molecular representations (SimAnn) took ~ 1.5 hours per structure and the
previously reported FloppyTail simulation method took ~30 minutes per structure
whereas FastFloppyTail simulation method took ~ 3 minutes per structure. The
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AbInitio and AbInitioVO algorithms both required ~ 45 minutes per structure and
Relaxes took ~ 3 minutes a structure.

Generalized Simulation Format:
We chose to sample the effects of full-atom and centroid AtomTypes on the
simulation, in an effort to assess the possibility of using the course-grained method
to speed up the simulation during initial sampling steps as is frequently done in
Rosetta. Additionally, we assessed the utility of different score terms and focused
on six different score weights (VDW: exclusively repulsive van der Waals term
"fa_rep", CenStd: "cen_std" score term weights, CenStdExt: "cen_std" score term
weights adding "rama", "cenpack", "hbond_lr_bb" and "hbond_sr_bb" all at weights
of 1.0, Beta: "beta_nov15" score term weights, SimAnn: simulated annealing
where additional score terms were included as sampling progressed utilizing
"score0", "score1", "score2", "score3" and "beta_nov15", CenNath: "vdw", "rama",
"pair", "env", "hbond_lr_bb" and "hbond_sr_bb" all at weights of 1.0, and CenOpt:
identical to the SimAnn centroid score functions with “rg” at a weight of 0 and
“hbond_lr_bb” and “hbond_sr_bb” at weights of 1.0).68 Finally, we utilized three
different types of Movers within each of the different AtomType/ScoreFunction
combinations (PP: φ/ψ torsion angle changes using Small/Shear Movers, FI:
fragment insertion, and SC: side-chain rotamer optimization using the
PackRotamersMover).

The

simulation

nomenclature

is

in

the

form

AtomType_Scoring_Sampling. For example, FA_Beta_PPFI utilizes the full-atom
AtomType, the "beta_nov15" scoring term weights for the ScoreFunction and
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application of both phi/psi sampling and fragment insertion. To assess the impact
of each of these parameters on the resultant ensemble, a base script was devised
which could be easily altered to analyze variable effects while keeping the number
of Movers applied to the protein backbone over the course of the simulation
constant. In brief, the method consisted primarily of RandomMovers, which select
and apply a single move from a detailed set of movers comprised of SmallMovers
and ShearMovers (apply φ/ψ torsion angle changes), as well as MinMovers
(perform gradient-descent minimization to locate local minima). Fragment insertion
in the form of the ClassicFragmentMover was added directly to RandomMovers
for both 9-mer and 3-mer fragments. Side-chain sampling was not added directly
to the RandomMover, but was applied after a move from the RandomMover. The
number of moves applied by the RandomMover prior to application of the
Metropolis-Hastings acceptance criteria were decreased over the course of the
simulation. The temperature (specified kT) value was also decreased. Lastly, the
structure was set to the lowest energy structure found after each sampling stage
and at the end of the simulation. For each simulation the resultant ensembles
consisted of ~1000 structures.

Construction of Fragment Libraries:
The Robetta server was used to generate the initial fragment library for
testing all variants of the “Generalized Simulation” along with “FloppyTail” and
“FloppyTail_ref2015”.225 Production of the custom fragment libraries used were
prepared

using

the

FragmentPicker
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application

in

Rosetta. 241

The

"FloppyTail_Quota" library was prepared using secondary structure probability
predictions from the primary sequence of α-synuclein (αS) using the Jufo, PsiPred
and RaptorX servers.242-244 The "FloppyTail_Loop" library was prepared by
exchanging the secondary structure predictions with a single manually crafted
prediction input that contains 1.0 loop probabilities at every residue of the
sequence.
All “FloppyTail” simulations not previously addressed, including all
FastFloppyTail simulations of non-αS disordered proteins, utilized a quota-style
fragment library using the same inputs as detailed above, where the disordered
probability prediction was used to re-weight loop contributions as described in the
main text. Additionally, AbInitio and AbInitioVO simulations were generated using
the FragmentPicker following the best protocol, using only PsiPred predictions as
inputs. AbInitioVO PsiPred predictions were loop reweighted as described in the
main text. All fragment libraries contained 200 fragments.

§ 6.3 Calculation of Data from Ensembles
FRET Data:
FRET efficiencies (EFRETs) for each residue pair were computed for each
individual structure and averaged across all structures in a given ensemble to
determine the average EFRET of the ensemble. This was performed through
application of the Förster Equation:
1

𝐸𝐹𝑅𝐸𝑇 = 1+(𝑟⁄𝑅

0)
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6

(Eqn. 6.1)57

which is dependent on the interfluorophore distance, r, and the Förster distance
(R0). For expedience, we approximated the interfluorophore distance as the
distance between the Cα atoms of the labeled residues.

Distance Data
Distances for each residue pair were determined from the distances
between the Cα atoms of each residue for each structure in a given ensemble and
were averaged over all members of the ensemble.

PRE Data:
Paramagnetic relaxation enhancement (PRE) values (Γ2) were computed
and converted to the experimentally observed value (Iox/Ired) from each structure in
the ensemble using the formulas:
𝐾

3𝜏

𝛤2 = [𝑟 6 (4𝜏𝑐 + 1+𝜔2𝑐𝜏 2)]
𝑐

𝐼𝑜𝑥
𝐼𝑟𝑒𝑑

=

𝑅2𝑟𝑒𝑑 𝑒𝑥𝑝(−𝛤2 𝑡)
𝑅2𝑟𝑒𝑑 +𝛤2

(Eqn. 6.2)
(Eqn. 6.3)

previously detailed by Sung et al.201 Here, K is a constant that describes the
spin properties for the nitroxide radical (1.23 x 10-32 cm6 s-2), c is the correlation
time for the electron-nuclear interaction vector (4 ns) and ω/2π is the Larmour
frequency of an amide proton (computed in all cases for a 700 MHz field), R2red is
the transverse relaxation rate in the diamagnetic state (set to 4 s-1) and t is the total
INEPT evolution time of the HSQC experiment, which was 10 ms for comparisons
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to data from Dedmon et al.104 (as previously done by Piana et al.97) and 4 ms for
comparisons to data from Sung et al.201

Chemical Shift Data:
The amide proton (H), amide nitrogen (N), carbonyl carbon (C), α-carbon
(Cα) and β-carbon (Cβ) chemical shifts were all computed using the SPARTA+
package developed by Shen and Bax.245 The chemical shift values were computed
for each structure and averages were computed uniformly across a given
ensemble.

Residual Dipolar Couplings:
All residual dipolar couplings (RDCs) were computed using PALES. 246 For
each structure in a given ensemble, the RDC for a given residue was computed
considering only a 15 residue segment where the residue of interest occupied the
central position, as previously done by Piana et al.97 For the first and last seven
residues in a given protein, the N- and C-terminal 15 residue segments were used.
The averages were computed for the 1000 lowest energy structures in each
ensemble.

J-Couplings:
The NMR J-couplings were calculated using fitted Karplus equations
previously utilized by Shen and Bax from backbone φ/ψ dihedral angles.247 For
each structure, φ and ψ were computed in DSSP.248 As with other values, the J225

coupling was computed for each residue in each structure and averaged across
all members of the ensemble. The Karplus equations used to compute each Jcoupling are detailed below:

3

𝐽𝐻𝑁−𝐻𝐴 = 7.97 cos2 (𝜑 − 60°) − 1.26 cos(𝜑 − 60°) + 0.63

(Eqn 6.4)249

1

𝐽𝐶𝛼−𝐻𝛼 = 𝐴𝑅𝐶 + 1.4 sin(𝜓 + 138°) − 4.1 cos(2[𝜓 + 138°]) + 1.7 cos(2[𝜑 + 60°])
(Eqn 6.5)250
1

𝐽𝐶𝛼−𝑁 = 9.5098 − 0.9799 cos(𝜓) + 1.7040 cos 2 (𝜓)
2

(Eqn 6.6) 251

𝐽𝐶𝛼−𝑁 = 𝐶 − 1.5176 cos(𝜓) − 0.2047 cos 2 (𝜓)

(Eqn 6.7)247

3

(Eqn 6.7)252

𝐽𝐶 ′ −𝐶 ′ = 0.46 − 0.95 cos(𝜓) + 1.78 cos 2 (𝜓)

For both the 1JCα-Hα and the 2JCα-N couplings, the value of the constants ARC
and C are amino acid dependent. For Val, Thr, Ile, and Ser C = 7.65 while for all
other amino acids, C = 8.15.247 The constant ARC values are listed in Table S1
below and originate from the random coil 1JCα-Hα values.250
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Table 6.1: Values for Computing J-Couplings.
Residue

ARC

Residue

ARC

Residue

ARC

Residue

ARC

Ala

143.7

Glu

141.9

Met

142.2

Trp

143.0

Arg

141.5

His

143.8

Phe

142.9

Tyr

143.0

Asn

141.5

Ile

141.3

Pro

148.4

Val

141.3

Asp

142.5

Leu

141.1

Ser

142.1

Other

140.3

Gln

141.1

Lys

141.5

Thr

141.4

§ 6.3 Results
To determine the effective capacity of each method, structural predictions
were preformed using the AbInitio and FloppyTail methods, and were compared
to 1) Förster resonance energy transfer (FRET) data from four different probe
pairs, 2) inter-residue distances, determined from FRET, 3) electron transfer
experiments, and 4) paramagnetic relaxation enhancement (PRE) measurements,
to assess global ensemble accuracy.51,

53, 68, 104, 201, 253-254

Furthermore, the

accuracy of residue level information for αS ensembles was analyzed through
comparison to 5) chemical shift (δ) data, 6) residual dipolar couplings (RDCs) and
7) NMR J-couplings.201, 247
Of the two methods, FloppyTail significantly outperformed the AbInitio in
generating accurate disordered ensembles of αS, as might be expected (referred
to as FlopppyTail_score12 and AbInitio, respectively, Tables 6.2-4). The
FloppyTail ensemble demonstrated an impressive degree of agreement with
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global descriptors of the proteins overall topology including radius of gyration (Rg),
EFRET, distance and PRE data (Figs. 6.3b, 6.4b, 6.5b and 6.22) However, upon
comparison to residue-level information, we noted that the predicted C and Cβ
chemical shifts (Fig. 6.52) as well as 2JNCα J-couplings (Fig. 6.84) deviate from the
experimental data (Tables 6.3-4). These deviations are likely attributable to
overpopulations of helical structure and is clearly observed when plotting per
residue helical propensity across all members of the resultant ensemble (Fig.
6.2b). Indeed, overpopulations of helical architectures was not isolated to the
FloppyTail simulation and was more pronounced in the AbIntio simulated
ensemble (Fig. 6.2b). In contrast with the FloppyTail output, the AbInitio algorithm
also presented severe discrepancies in the overall Rg and other global parameters
compared to experimental values (Figs 6.3b, 6.4b, 6.5b and 6.33). Overall, both
methods overpopulate helical architecture, while the AbInitio method additionally
produces overcompacted structures. In comparison to other simulation
approaches

previously

explored

in

the

literature,

overcompaction

and

overpopulation of helices are common problems in both MD and MC-based
methods which have been optimized for ordered proteins. 97, 99-100, 109-110

Employment of a Generalized Simulation Format
To overcome these barriers, a new method was drafted in PyRosetta
allowing for a comparison of 17 different combinations of score functions, sampling
schemes and atomic representations.114 PyRosetta is a python-wrapped version
of Rosetta, that allows for new algorithm development in a relatively easy coding
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language without the need to compile. The nomenclature and specifics of each
simulation are detailed in the Supporting Information. In short, the format consists
of six sampling stages where the temperature used for assessing the Metropolis
criteria is decreased at each stage. Sampling consists of φ/ψ backbone torsion
angle sampling, fragment insertion and/or sidechain rotamer sampling (indicated
by PP, FI and SC suffixes in the generalized simulation names respectively).
Additionally, simulations were tested under different score function and atomic
representations utilizing the standard centroid scoring procedure in Rosetta, the
standard full-atom score function in Rosetta, or the scoring procedure utilized by
AbInitio (CenStd, Beta, and SimAnn prefixes respectively).194, 238-240 Additionally,
polymer-like self-avoid walk simulations were also performed where the score
function was exclusively comprised of a repulsive van der Waals energy term.
(VDW prefix).194
We observed that over-compaction was most severe when using the
centroid

coarse-grained

representation

(CenStd_PP

and

CenStd_PPFI

simulations, Table 6.2, Figs. 6.3a, 6.4a, 6.5a, 6.10 and 6.11). The “centroid”
coarse-graining approach represents the backbone atoms explicitly, while
reducing sidechain atoms to a single pseudo-atom located on the gamma-carbon,
with appropriate parameters to approximate the side-chain.240 This representation
utilizes several knowledge-based score terms in place of the physics-based energy
terms which are utilized in the explicit, all-atom representations in Rosetta.194
Although we observed overcompaction when employing centroid coarse graining,
we observe that either subsequent all-atom sampling (all SimAnn simulations,
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Figs. 6.15-18) or sampling utilizing the specific centroid score function utilized by
the FloppyTail algorithm (all CenStd_Ext simulations, Figs. 6.12-13) alleviated
compaction (Table 6.2 and Figs. 6.3a, 6.4a and 6.5a).236 Therefore, we were able
to determine that the “rg” score term, which is excluded from the score terms
utilized in the centroid phase of the FloppyTail algorithm, was the likely source of
overcompation.
Unlike overcompaction, overpopulation of helical structures appeared to
occur independent of the atomic representation or score function and was solely
an artifact of sampling. Indeed, overpopulation occurred in all cases where
fragments were sampled (all PPFI and PPFISC simulations, chemical shifts: Figs.
6.37, 6.38, 6.41, 6.43, 6.46 and 6.47 J-couplings: Figs. 6.68, 6.69, 6.72, 6.74 and
6.78) except when the protein was reduced to self-avoiding polymer (VDW_PPFI
and VDW_PPFISC simulations, chemical shifts: Figs. 6.50 and 6.51 and Jcouplings: Figs. 6.81 and 6.82) as observed in Figure 6.2. Therefore, we
hypothesized that fragment selection, as opposed to the fragment sampling
condition, was the likely source of error.
Lastly, we observed that sidechain sampling had a relatively minimal impact
in the absence of fragment sampling. Inspecting the all-atom simulations and
simulated annealing simulations (Beta, SimAnn and VDW simulations) we observe
that the impact of sidechain sampling is relatively small compared to the impact of
sampling fragments (Tables 6.2-4). Since sidechain packing in Rosetta accounts
for a significant portion of the simulation time, we rationalize that simulation speed
might be enhance by reducing the frequency of sidechain sampling events.
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Increased Accuracy through Improved Fragment Selection
Fragment libraries in Rosetta are typically generated from 3-state
secondary structure predictions based on protein primary sequences. 241 For the
initial assessment of the performance of FloppyTail, a fragment library generated
from the Robetta server was employed.225 We further corroborated our hypothesis
that the observed overpopulation of helical structures originated from sampling,
and not scoring, by confirming that the FloppyTail algorithm yielded a similar output
when using an up-to-date all-atom score function, “ref2015”.194 This was indeed
the case with no apparent differences in comparisons to all experimental data
(FloppyTail_ref2015 simulation, Figs. 6.2b, 6.3b, 6.4b, 6.5b, 6.23, 6.53, 6.66d and
6.84) Therefore, we wanted to assess the impact of sampling a broader array of
input fragments through manual construction of a new fragment library. To do this
we employed the FragmentPicker protocol.241 This method utilizes secondary
structure inputs from servers such as PsiPred, Jufo and RaptorX, which predict the
probability of each residue existing in a helix, sheet or loop for a supplied
sequence.242-244 Traditionally, structural predictions in Rosetta utilize a fragment
selection scheme where only fragments that match the highest probability
architecture for each residue are chosen.241 This is referred to as a “best” protocol,
which can be exchanged for a “quota” fragment selection protocol, which
probabilistically collects fragments such that the frequency with which each
secondary structural element is sampled for a given residues matches the
probabilities in the input prediction. This library, though sampling a broader array
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of secondary structural elements, provided a very minor improvement (Tables 6.24) and still presented regions with a significant helical content (FloppyTail_Quota
simulation, Figs. 6.2b, 6.3b, 6.4b, 6.5b, 6.24, 6.54, 6.66d and 6.85). This was
unsurprising as all three predictions used contained a significant helical probability
corresponding to the region of αS that organizes into a helices when bound to
membranes.23-24 Therefore, we attempted to remove all fragment sampling from
the protocol (FloppyTail_NoFrags simulation), exclusively employing pseudorandom φ/ψ torsional sampling. The resulting simulation provided very good
agreement with all data (Tables 6.2-4, Figs. 6.2b, 6.3b, 6.4b, 6.5b, 6.25, 6.55,
6.66d and 6.86), however we suspected that this approach would be insufficient
for IDPs which transit more frequently between folded and unfolded architectures.
Recent studies by Bax and coworkers demonstrated that loops from PDB
structures populated a similar Ramanchandran backbone dihedral space to that of
IDPs.255 Therefore, we hypothesized that a fragment library composed exclusively
of loops might allow us to re-introduce fragment insertion. Replacement of the
initial fragment library with an all-loop library in the FloppyTail algorithm resulted in
an

ensemble

which

was

devoid

of

extended

secondary

structure

(FloppyTail_Loops simulation, Tables 6.2-4, Figs. 6.2b, 6.3b, 6.4b, 6.5b, 6.26,
6.56, 6.66e and 6.87). Although this fragment library was sufficient to demonstrate
that fragment sampling can be employed in an efficacious manner, this strategy
for fragment library construction would require prior knowledge of a protein’s
degree of order. Therefore, we sought to identify a surrogate for this knowledge,
identifying disordered probability predictions from primary sequence as a
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potentially useful candidate. Along with secondary structure predictions, many
servers provide disordered probability predictions.243-244 Although many servers
incorrectly characterized αS as being probabilistically ordered in at least a single
stretch of residues, the RaptorX sever provided a correct prediction that the protein
was entirely disordered. 243-244 Therefore, we envisioned that disordered probability
predictions from RaptorX could be used to reweight the secondary structure
predictions by adjusting the loop probability as follows:

′ (𝑙𝑜𝑜𝑝)
𝑃𝑟𝑒𝑠
= 𝑃𝑟𝑒𝑠 (𝑑𝑖𝑠𝑜𝑟𝑑𝑒𝑟)

(Eq. 6.9)

′ (𝑠ℎ𝑒𝑒𝑡)
𝑃𝑟𝑒𝑠
= (1 − 𝑃𝑟𝑒𝑠 (𝑑𝑖𝑠𝑜𝑟𝑑𝑒𝑟)) × 𝑃𝑟𝑒𝑠 (𝑠ℎ𝑒𝑒𝑡)

(Eq. 6.10)

′ (ℎ𝑒𝑙𝑖𝑥)
𝑃𝑟𝑒𝑠
= (1 − 𝑃𝑟𝑒𝑠 (𝑑𝑖𝑠𝑜𝑟𝑑𝑒𝑟)) × 𝑃𝑟𝑒𝑠 (ℎ𝑒𝑙𝑖𝑥)

(Eq. 6.11)

Here, Pres(disorder) represents the predicted probability of a given residue
to be disordered, while Pres(loop), Pres(helix), Pres(sheet) represent the probability
of the residue being a loop, helix or sheet. Additionally, primed and non-primed
variables represent the reweighted and original predictions respectively.
Gratifyingly, the resultant fragment library constructed using these reweighted loop
predictions as inputs for the previously described “quota” fragment library
construction approach resulted in a highly accurate FloppyTail output ensemble
(FloppyTail simulation, Tables 6.2-4, Figs. 6.2b, 6.3b, 6.4b, 6.5b, 6.27, 6.57, 6.66e
and 6.88) comprised of very few helices.
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Acceleration and Improved Accuracy via Adjustment to Sampling
As previously stated, results from the generalized simulation suggest that a
reduction of sidechain sampling could afford an accelerated simulation with
comparable accuracy. Therefore, we removed sidechain sampling from one of the
interior loops of the FloppyTail protocol, reducing the sampling frequency 15-fold.
This resulted in a substantial ~10-fold reduction in compute time and produced an
ensemble (FloppyTail_Rot simulation, Tables 6.2-4, Figs. 6.2b, 6.3b, 6.4b, 6.5b,
6.29, 6.61, 6.66f and 6.92) that was nearly identical across all experimental
comparisons. Additionally, unlike a traditional MC approach, at several stages of
the FloppyTail simulation, the structure is returned to the lowest energy structure
encountered in the search up until that point. 236 This helps to restrict sampling to
states near minima, while allowing limited sampling following Metropolis criteria
acceptance to avoid trapping in local minima. Serendipitously, we discovered that
reducing the amount of sampling between instances where the structure is
returned to the lowest energy conformer further improved agreement with the
experimental data, resulting in the algorithm now called FastFloppyTail (Tables
6.2-4, Figs. 6.2b, 6.3b, 6.4b, 6.5b, 6.31, 6.59, 6.66e and 6.90). Finally, we
employed the Relax algorithm, commonly used after the AbIntio algorithm, to
further minimize outputs from the FastFloppyTail simulation, and again were met
with an additional improvement in the overall agreement with experimental data
(Tables 6.2-4, Figs. 6.2b, 6.3b, 6.4b and 6.5b, FloppyTail_Relax: 6.28, 6.58, 6.66e
and

6.89,

FloppyTail_Rot_Relax:

6.30,

6.62,

FastFloppyTail_Relax: 6.32, 6.60, 6.66f, 6.91.194,
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6.66f,

238-239

6.93,

and

This final coupled

algorithm, FastFloppyTail-Relax, produces αS ensembles with comparable
agreement with ensembles generated from state-of-the-art MD (Tables 6.2-4).

Re-defining Knowledge Based Terms
Although improved fragment selection was sufficient for delivering the
improved FastFloppyTail method for generating disordered protein structural
ensembles, the reliance of knowledge-based terms for the prediction of folded
proteins required additional attention. The final stages of the AbInitio simulation is
reliant on the “rg” score term, whose energetic penalty is equal to the R g of the
structure.240 Although this facilitates the compaction necessary for the adoption of
well packed folded proteins, this produces severe over competition in IDPs and
IDRs. Therefore, we propose replacement of this term with a score term that
compares the Rg of the current simulated protein structure to that expected from
polymer-scaling laws. Employing the following equations from Schuler and coworkers, we can predict an expected Rg from the hydrophobic or charge content
of a protein from a given sequence:

∗

2𝑙𝑝 𝑏
̅𝑅̅̅𝑔̅ = √
𝑁𝑣
(2𝑣+1)(2𝑣+2)

(Eq. 6.12) 256

Here, ̅𝑅̅̅𝑔̅ is the predicted mean Rg value determined from the persistence
length (lp* = 0.53 nm) and the average distance between two Cα atoms (b = 0.38
nm), which have been previously determined, along with the number of residues
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in the sequence, N, and the scaling factor, v. The polymer scaling term, v, can be
computed using Eqs. 6.13 or 6.14 depending on whether net charge or
hydrophobicity serves as the dominating characteristic.

1

𝜈(𝑄) = 3 + 𝑎 [1 +
1

𝜈(𝐻) = 3 + 𝑎 [1 +

exp (𝑥0 −𝑄) −1
𝑧

]

exp (𝑥0 +𝑐𝐻−𝑑) −1
𝑧

]

(Eq. 6.13)256
(Eq. 6.14) 256

In Eqs. 6.13 and 6.14, constants have been previously determined through
fitting to experimental data (a = 0.394, z = 0.09, x 0 = 0.114, c = 1.72 and d = 0.9)
while variable Q and H represent the net charge and the mean hydrophobicity
respectively.256 To select between the scaling factors computed by the net charge
and hydrophobicity when computing an expected radius of gyration, the
polyampholyte theory was applied to determine the effect of the net charge on the
excluded volume of the system by computing the excess volume:

𝑣∗ =

4𝜋𝑙𝐵 (𝑓−𝑔)2
𝜅2

−

𝜋𝑙𝐵 2 (𝑓+𝑔)2
𝜅

(Eq. 6.15)256

Here, f and g are the fraction of positively (Arg/Lys) and negatively (Glu/Asp)
charged residues, respectively, κ is the Debye length defined by 𝜅 −1 = 0.304⁄√𝐼 ,
where I is the ionic strength and lB is the Bjerrum length defined by:
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2

𝑙𝐵 = 𝑒 ⁄(4𝜋𝜀 𝜀 𝑘 𝑇)
0 𝑟 𝐵

(Eq. 6.16)256

In the above equation, e is the elementary charge (1.602 × 10-19), ε0 is the
dielectric constant (8.854 × 10-12), εr is the permittivity of water (78.7) and kB is
the Boltzmann constant. In the general case for the calculation of v*, the ionic
strength and the temperature are set to 0.15 M and 298 K respectively. Since
values of v* greater than zero correspond to net electrostatic repulsion, when v* is
greater than zero, the scaling term computed using the net charge is applied when
predicting the radius of gyration. Conversely, when v* is less than zero, there is a
net electrostatic attraction, forcing the scaling based on the hydrophobicity to
dominate. In cases where both the fractions of positively and negatively charged
residues are zero, the scaling is determined using the net hydrophobicity. Lastly,
in the cases where either the fraction of positively or negatively charged residues
equals zero, the scaling due to the net charge is selected.
Upon further inspection of the above method proposed by Hofmann et al.,
we noted that when testing this function for lysozyme (PDB: 2LZM) the predicted
scaling value (ν = 0.519) is significantly higher than the expected value for a folded
protein.256 Since the fitting was performed on denatured proteins, the work by
Hofmann et al. shows that when determining the radius of gyration for a suite of
proteins from the Protein Data Bank, the minimum observed scaling factor is not
equal to 0.33, which is the value for well-folded proteins, but instead is ~ 0.4.256
Therefore, we utilized the per residue disordered probability of the protein to
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determine if a given segment of the protein of interest was folded or unfolded. For
predictions by the RaptorX server we used the suggested cutoff, where residues
with a disordered probability >0.5 were determined to be disordered.244 Segments
were defined as any stretch of residues greater than 10 in which all residues were
of the same classification, ordered or disordered. Segments deemed ordered were
assigned a scaling value of v = 0.33 while the scaling value for disordered regions
was computed using the above equations. Therefore, we intend to predict R g
values for each ordered/disordered segment and compute the associated score
on a per segment bases, with the overall score simply representing the sum of the
scores across all segments.
To incorporate the predicted Rg within an energy term we elected to craft a
potential from a general version of a self-avoiding walk (SAW) probability
distribution, previously employed by Zheng, Best, Schuler and coworkers, that
accommodates changes in the scaling exponent.65

4𝜋

2+𝑔

𝑟

( 𝑔)
𝑃(𝑟) = 𝐴 ̅̅̅̅
𝑅
𝑅

𝑟𝑔

𝛿

) ]
exp [−𝛼 (̅̅̅̅
𝑅

(Eq. 6.17) 65

𝑔 = (𝛾 − 1)⁄𝑣 𝑎𝑛𝑑 𝛿 = 1⁄(1 − 𝑣)

(Eq. 6.18 and 6.19) 65

𝑔

𝑔

𝑔

Above, rg represents the Rg of the structure being assess by the scoring
function and again ̅𝑅̅̅𝑔̅ represents the predicted mean Rg. The constants g and δ in
Eq. 6.17 are defined in the subsequent equations Eq. 6.18 and 6.19. The constant
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γ (1.1615) has been previously estimated for proteins, while the constants A and
α are determined for a given ̅𝑅̅̅𝑔̅ and v pair based on the normalization conditions:

∞

∞

2

∫0 𝑃(𝑟𝑔 )𝑑𝑟𝑔 = 1 𝑎𝑛𝑑 ∫0 𝑃(𝑟𝑔 )𝑟𝑔 2 𝑑𝑟𝑔 = ̅𝑅̅̅𝑔̅

(Eq. 6.20 and 6.21) 65

This distribution provides a broad distribution of radii of gyration while at the same
time preventing structures from becoming overly compact. The per segment
energy potential is defined as:

𝐸̅̅̅̅
𝑅𝑔 (𝑟𝑔 ) = 1 − 𝑃(𝑟𝑔 )⁄𝑚𝑎𝑥[𝑃(𝑟𝑔 )]

(Eq. 6.22) 65

Through this form, the energy value scales from zero to one for any average Rg
allowing the weight of this score term within our overall score function to determine
the depth of the potential. To determine the optimal weight of the new Rg score
term, αS simulations were performed under the AbInitio protocol using a range of
weighting values. We identified the optimal weighting value as that which
maximized the impact of the score term on the average radius of gyration while
minimizing the restriction on the conformational diversity (Fig. 6.1). Combination
of this novel scoring approach with the previously described fragment selection
strategy results in the new simulation termed AbInitioVO, or AbInitio Variable
Order.
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Figure 6.1: Determination of optimal new Rg score term weight. Plot shows the
average (filled blue circles) and standard deviation (filled red circles) radius of
gyration resultant from simulations with various relative weights of the new Rg
score term compared to the simulation lacking the traditional rg term (open red and
blue circles) and experimental data from SAXS 228 (pink dashed line) and NMR205
(cyan dashed line). The vertical black dashed line illustrates the chosen optimal
score term weight, as this pushes the average Rg closest to the experimental value
without over-constraining the sampling. Therefore, the weights of all terms in the
new score3 term is equivalent to the traditional score3 term, with the canonical rg
term set to weight a zero and the weight of this new term set to 84.

Accurate De Novo Prediction of Disordered and Ordered Proteins
To determine whether this modified AbInitioVO protocol outperforms the
original AbItitio method, a set of 25 proteins were selected containing a variety of
different secondary structural elements and spanning varying levels of
order/disorder. For each AbInitioVO simulation, disordered probability predictions
were performed based on the input sequence using RaptorX and fragment libraries
were assembled using a best fragment selection protocol based on a loopreweighted secondary structure prediction from PsiPred, using Eqs. 6.9-6.11. The
resultant structural predictions from AbIntioVO were compared to structures
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generated using the standard AbInitio protocol (Table 6.5). For ordered and
partially-ordered proteins, prediction accuracy was assessed by comparing the
resultant structures to x-ray crystal structures and NMR structures deposited in the
PDB by computing Cα-RMSDs. Disordered proteins were inspected for agreement
with the experimentally determined Rg of each protein (Table 6.5). Overall, we
observed that across all ordered and partially-ordered proteins tested, that
AbInitioVO performs comparably to AbInito for the prediction of folded regions
across all secondary structures (Table 6.5, Folding Funnels: Figs. 6.100-117,
Structural Overlays: Figs. 6.124-141). Although there are some cases where
AbInitioVO appears to be outperformed by AbInitio (ex: 1b3a, 1bq9, 1ejf, 1lwm)
there are at leas as many cases where AbIntioVO outperforms AbInitio (ex: 1shf,
1bk2, 1ghc, 1ubi). For partially-ordered proteins, as expected, the average Rg is
from the AbInitioVO simulations is larger than the for AbInitio simulations (Fig
6.98). Curiously, we observed that ordered proteins were on average slightly more
compact in AbInitioVO compared to AbInitio (Fig. 6.97). Lastly, we find that the
resultant average Rg values for disordered protein from AbInitioVO are more inline with the experimental Rgs than those from AbInitio (Table 6.5, Fig 6.99). These
results support the notion that AbInitioVO is able to correctly predict the folded
portions of ordered and partially-ordered proteins, while identifying disordered
regions with the correct secondary structure and overall size. These disordered
regions can then be simulated using the FastFloppyTail approach to create
accurate structural ensemble of disordered and partially-ordered proteins.
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Table 6.2: Comparison of Simulated αS Ensembles to Global Experimental Data.

Name

Rg (Å)

EFRET

IO/IR

Dist.

RMSD

RMSD

RMSD

Generalized Simulation
VDW_PP

43.7 + 8.0

0.18

0.23

17.5

VDW_PPFI

39.7 + 6.8

0.15

0.21

13.17

VDW_PPFISC

40.0 + 7.0

0.15

0.21

14.0

CenStd_PP

19.6 + 2.5

0.28

0.20

11.9

CenStd_PPFI

19.2 + 2.5

0.28

0.22

12.5

CenNath

33.4 + 7.9

0.11

0.18

8.09

CenStd_Ext_PP

32.7 + 8.7

0.11

0.17

7.02

CenStd_Ext_PPFI

25.6 + 5.6

0.17

0.16

6.69

Beta_PP

30.6 + 5.5

0.13

0.17

8.23

Beta_PPFI

36.4 + 6.9

0.12

0.19

11.7

Beta_PPFISC

40.5 + 6.7

0.18

0.20

15.2

Beta_PPSC

30.3 + 5.3

0.13

0.17

7.74

SimAnn_PP

33.9 + 7.0

0.10

0.18

8.54

SimAnn_PPFI

33.4 + 6.8

0.11

0.18

9.02

SimAnn_PPFISC

25.5 + 4.0

0.18

0.17

8.14

SimAnn_PPSC

31.7 + 6.3

0.12

0.17

7.38

FloppyTail
FloppyTail_score12

32.8 + 6.0

0.12

0.18

8.36

FloppyTail_ref2015

33.9 + 6.4

0.12

0.18

9.39

FloppyTail_Quota

34.2 + 6.1

0.12

0.18

9.02

FloppyTail_Loops

35.3 + 6.7

0.12

0.18

9.75

FloppyTail_NoFrags

34.8 + 6.3

0.12

0.18

9.00

FloppyTail-Relax

27.7 + 8.1

0.15

0.15

7.03

FloppyTail

34.0 + 7.7

0.11

0.18

7.94

FastFloppyTail-Relax

31.0 + 9.0

0.11

0.17

5.37

FastFloppyTail

38.0 + 9.4

0.12

0.20

10.1

FloppyTail_Rot

37.2 + 8.6

0.12

0.19

10.4

FloppyTail_Rot-Relax

29.2 + 8.7

0.13

0.15

6.25

AbInitio
DeNovoIDP

28.4 + 5.1

0.15

0.17

9.63

AbInitio

17.3 + 1.0

0.32

0.31

12.2

AbInitioVO

22.7 + 2.6

0.24

0.22

12.9

0.17

-

Robustelli et. al.
a99SB-disp

36.73

242

99

-

*Atom type abbreviations: CEN = centroid, FA = full-atom.
** Rg values can be compared to experimentally determined values of 33.0 ± 3.0
Å and 26.6 ± 0.5 Å from SAXS228 and NMR205 data, respectively. EFRET RMSD
values were computed from data from Ferrie et. al., Ferrie et. al. and Nath et.
al.51, 53, 68 Distance RMSD values were computed from Grupi et. al. and Lee et
al.253-254 PRE RMSD values were computed from data from Sung et. al. and
Dedmon et. al.104, 201
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Table 6.3: Comparison of Simulated αS Ensembles to Chemical Shift and RDC
Data.
Simulation Name

N

H

C

Cα

Cβ

Generalized Simulation
0.88 0.84 0.76 1.05

All
CS

RDC
D.E

RDC
M.Z.

0.87

0.65

0.55

VDW_PP

1.19

VDW_PPFI

1.52

0.17

0.55

0.65

1.06

0.91

0.63

0.55

VDW_PPFISC

1.83

0.19

0.49

0.50

1.08

1.01

0.61

0.52

CenStd_PP

3.42

0.25

0.70

0.65

1.28

1.69

0.64

0.55

CenStd_PPFI

3.66

0.20

0.66

1.07

1.31

1.83

0.60

0.44

CenNath

2.10

0.22

0.40

0.50

1.37

1.16

0.64

0.51

CenStd_Ext_PP

2.07

0.22

0.40

0.49

1.35

1.15

0.64

0.51

CenStd_Ext_PPFI

3.60

0.28

1.28

1.52

1.42

1.95

0.61

0.36

Beta_PP

0.95

1.06

0.57

2.67

0.14

1.38

0.64

0.54

Beta_PPFI

3.37

0.31

1.18

1.58

1.18

1.83

0.62

0.39

Beta_PPFISC

2.93

0.26

1.68

2.60

1.23

1.99

0.61

0.32

Beta_PPSC

1.59

0.13

1.00

0.41

1.11

0.99

0.66

0.57

SimAnn_PP

2.74

0.14

0.65

0.49

1.06

1.37

0.63

0.52

SimAnn_PPFI

3.63

0.31

0.83

1.10

1.14

1.81

0.60

0.43

SimAnn_PPFISC

3.10

0.27

1.20

1.81

1.08

1.77

0.59

0.37

SimAnn_PPSC

2.17

0.12

0.64

0.43

1.03

1.13

0.63

0.51

FloppyTail
FloppyTail_score12

2.03

0.18

0.39

0.58

1.02

1.07

0.63

0.48

FloppyTail_ref2015

1.93

0.17

0.39

0.58

1.02

1.02

0.63

0.48

FloppyTail_Quota

1.75

0.18

0.38

0.46

1.03

0.95

0.64

0.49

FloppyTail_Loops

1.52

0.13

0.40

0.39

1.02

0.86

0.65

0.55

FloppyTail_NoFrags

1.52

0.13

0.41

0.38

1.01

0.86

0.64

0.55

FloppyTail-Relax

1.79

0.13

0.38

0.34

0.98

0.94

0.63

0.44

FloppyTail

1.69

0.13

0.36

0.35

0.98

0.90

0.62

0.44

FastFloppyTail-Relax

1.62

0.11

0.47

0.36

1.02

0.90

0.63

0.42

FastFloppyTail

1.55

0.12

0.42

0.33

1.01

0.86

0.62

0.41

FloppyTail_Rot

1.66

0.13

0.36

0.33

0.98

0.89

0.62

0.44

FloppyTail_Rot-Relax

1.77

0.12

0.38

0.34

0.97

0.93

0.63

0.44

AbInitio
DeNovoIDP

1.67

0.22

0.39

0.48

1.04

0.93

0.67

0.52

AbInitio

2.68

0.25

1.37

2.08

1.23

1.73

0.60

0.38

AbInitioVO

2.24

0.24

0.61

0.72

1.03

1.19

0.63

0.47

1.04

0.85

-

0.41

Robustelli et. al.
a99SB-disp

1.46

0.14

0.31

244

0.51

*All chemical shift data are reported as RMSD values from computed from data
from Sung et al.201 RDC values are computed as Q-values, as described in
Zweckstetter et. al.246, based on data from Sung et. al. (RDC D.E.)201 and
Bertoncini et. al. (RDC M.Z.).200
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Table 6.4: Comparison of Simulated αS Ensembles to J-Coupling Data
3

JC’C’

All J

VDW_PP

Generalized Simulation
2.38
1.31
0.63
0.42

0.69

1.30

VDW_PPFI

2.63

1.10

0.72

0.74

0.57

1.38

VDW_PPFISC

2.39

1.51

0.94

0.93

0.52

1.42

CenStd_PP

1.41

1.37

0.66

0.46

0.61

0.99

CenStd_PPFI

1.21

1.68

0.98

1.25

0.14

1.17

CenNath

1.67

1.46

0.25

0.45

0.41

1.03

CenStd_Ext_PP

1.61

1.43

0.25

0.45

0.39

1.00

CenStd_Ext_PPFI

1.85

3.15

0.89

1.55

0.42

1.83

Beta_PP

0.89

1.39

0.43

0.40

0.73

0.85

Beta_PPFI

1.22

2.81

0.91

1.29

0.38

1.55

Beta_PPFISC

2.41

4.31

1.15

1.48

0.40

2.37

Beta_PPSC

0.82

1.28

0.38

0.40

0.74

0.79

SimAnn_PP

0.67

1.68

0.55

0.45

0.58

0.91

SimAnn_PPFI

0.84

2.08

0.91

1.37

0.24

1.25

SimAnn_PPFISC

1.50

3.21

0.99

1.39

0.34

1.77

SimAnn_PPSC

0.43

1.39

0.60

0.49

0.50

0.76

Simulation Name

3

JHNHα

1

JCαHα

1

JNCα

2

JNCα

FloppyTail
FloppyTail_score12

0.48

1.64

0.54

0.70

0.16

0.88

FloppyTail_ref2015

0.52

1.68

0.52

0.79

0.17

0.88

FloppyTail_Quota

0.62

1.55

0.49

0.74

0.19

0.85

FloppyTail_Loops

0.51

1.10

0.35

0.43

0.10

0.60

FloppyTail_NoFrags

0.53

1.11

0.35

0.43

0.10

0.60

FloppyTail-Relax

0.59

1.25

0.41

0.54

0.16

0.69

FloppyTail
FastFloppyTailRelax
FastFloppyTail

0.64

1.45

0.40

0.53

0.16

0.77

0.65

1.14

0.36

0.39

0.26

0.64

0.56

1.22

0.35

0.39

0.24

0.65

FloppyTail_Rot
FloppyTail_RotRelax

0.61

1.41

0.40

0.51

0.16

0.75

0.60

1.23

0.40

0.52

0.17

0.68

DeNovoIDP

0.74

1.55

0.72

0.98

0.28

0.95

AbInitio

2.15

3.49

0.99

1.32

0.37

1.98

AbInitioVO

1.16

1.82

0.71

1.12

0.25

1.13

-

0.18

-

AbInitio

Robustelli et. al
a99SB-disp

1.11

-

-

*All data are reported as RMSD values computed from data from Mantsyzov et
al. and Lee et. al.247, 252
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Analysis of Per Residue Percent Helicity for α-Synuclein Simulations

Figure 6.2a: Plots of Percent Helicity. Plots of the percentage of structures
containing helices on a per residue basis from Beta_PP (Row 1 Left), Beta_PPFI
(Row 1 Middle), Beta_PPFISC (Row 1 Right), Beta_PPSC (Row 2 Left),
CenStd_PP (Row 2 Middle), CenStd_PPFI (Row 2 Right), CenStd_Ext_PP (Row
3 Left), CenStd_Ext_PPFI (Row 3 Middle), CenNath (Row 3 Right), SimAnn_PP
(Row 4 Left), SimAnn_PPFI (Row 4 Middle), SimAnn_PPFISC (Row 4 Right),
SimAnn_PPSC (Row 5 Left), VDW_PP (Row 5 Middle) and VDW_PPFI (Row 5
Right) ensembles compared to percentages computed from Sung et. al. chemical
shift data using the D2D method from Camilloni et. al.201, 257
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Figure 6.2b: Plots of Percent Helicity. Plots of the percentage of structures
containing helices on a per residue basis from VDW_PPFISC (Row 1 Left),
FloppyTail_score12 (Row 1 Middle), FloppyTail_ref2015 (Row 1 Right),
FloppyTail_Quota (Row 2 Left), FloppyTail_NoFrags (Row 2 Middle),
FloppyTail_Loops (Row 2 Right), FloppyTail (Row 3 Left), FloppyTail_Relax (Row
3 Middle), FastFloppyTail (Row 3 Right), FastFloppyTail_Relax (Row 4 Left),
FloppyTail_Rot (Row 4 Middle), FloppyTail_Rot_Relax (Row 4 Right), AbInitio
(Row 5 Left), AbInitioVO (Row 5 Middle) and DeNovoIDP (Row 5 Right) ensembles
compared to percentages computed from Sung et. al. chemical shift data using the
D2D method from Camilloni et. al.201, 257
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Radii of Gyration for α-Synuclein Simulations

Figure 6.3a: Histograms of Radii of Gyration. Histograms of the radius of gyration
from Beta_PP (Row 1 Left), Beta_PPFI (Row 1 Middle), Beta_PPFISC (Row 1
Right), Beta_PPSC (Row 2 Left), CenStd_PP (Row 2 Middle), CenStd_PPFI (Row
2 Right), CenStd_Ext_PP (Row 3 Left), CenStd_Ext_PPFI (Row 3 Middle),
CenNath (Row 3 Right), SimAnn_PP (Row 4 Left), SimAnn_PPFI (Row 4 Middle),
SimAnn_PPFISC (Row 4 Right), SimAnn_PPSC (Row 5 Left), VDW_PP (Row 5
Middle) and VDW_PPFI (Row 5 Right) ensembles compared to experimental
values from SAXS228 (grey) and NMR205 (black).
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Figure 6.3b: Histograms of Radii of Gyration. Histograms of the radius of gyration
from VDW_PPFISC (Row 1 Left), FloppyTail_score12 (Row 1 Middle),
FloppyTail_ref2015 (Row 1 Right), FloppyTail_Quota (Row 2 Left),
FloppyTail_NoFrags (Row 2 Middle), FloppyTail_Loops (Row 2 Right), FloppyTail
(Row 3 Left), FloppyTail_Relax (Row 3 Middle), FastFloppyTail (Row 3 Right),
FastFloppyTail_Relax (Row 4 Left), FloppyTail_Rot (Row 4 Middle),
FloppyTail_Rot_Relax (Row 4 Right), AbInitio (Row 5 Left), AbInitioVO (Row 5
Middle) and DeNovoIDP (Row 5 Right) ensembles compared to experimental
values from SAXS228 (grey) and NMR205 (black).
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Comparison of EFRET Data from α-Synuclein Simulations

Figure 6.4a: Comparison of Simulated EFRET with Experimental EFRET.
Simulated EFRETs for Beta_PP (Row 1 Left), Beta_PPFI (Row 1 Center),
Beta_PPFISC (Row 1 Right), Beta_PPSC (Row 2 Left), CenStd_PP (Row 2
Center), CenStd_PPFI (Row 2 Right), CenStd_Ext_PP (Row 3 Left),
CenStd_Ext_PPFI (Row 3 Center), CenNath (Row 3 Right), SimAnn_PP (Row 4
Left), SimAnn_PPFI (Row 4 Center), SimAnn_PPFISC (Row 4 Right),
SimAnn_PPSC (Row 5 Left) , VDW_PP (Row 5 Middle) , VDW_PPFISC (Row 5
Right) with data from Ferrie et al. Cnf-Trp53 (Purple) and Fam-Raz53 (Red) Pairs,
Ferrie et al. Mcm-Acd pair51 (Blue), and Nath et al.68 (Green).
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Figure 6.4b: Comparison of Simulated EFRET with Experimental EFRET.
Simulated EFRETs for VDW_PPFISC (Row 1 Left), FloppyTail_score12 (Row 1
Center), FloppyTail_ref2015 (Row 1 Right), FloppyTail_Loops (Row 2 Left),
FloppyTail_Quota (Row 2 Center), FloppyTail_NoFrags (Row 2 Right), FloppyTail
(Row 3 Left), FloppyTail_Relax (Row 3 Center), FastFloppyTail (Row 3 Right),
FastFloppyTail_Relax (Row 4
Left), FloppyTail_Rot (Row 4 Center),
FloppyTail_Rot_Relax (Row 4 Right), AbInitio (Row 5 Left) , AbInitioVO (Row 5
Middle) , DeNovoIDP (Row 5 Right) with data from Ferrie et al. Cnf-Trp53 (Purple)
and Fam-Raz53 (Red) Pairs, Ferrie et al. Mcm-Acd pair51 (Blue), and Nath et al.68
(Green).
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Comparison of Distance from α-Synuclein Simulations

Figure 6.5a: Comparison of Simulated Distance with Experimental Distances.
Simulated EFRETs for Beta_PP (Row 1 Left), Beta_PPFI (Row 1 Center),
Beta_PPFISC (Row 1 Right), Beta_PPSC (Row 2 Left), CenStd_PP (Row 2
Center), CenStd_PPFI (Row 2 Right), CenStd_Ext_PP (Row 3 Left),
CenStd_Ext_PPFI (Row 3 Center), CenNath (Row 3 Right), SimAnn_PP (Row 4
Left), SimAnn_PPFI (Row 4 Center), SimAnn_PPFISC (Row 4 Right),
SimAnn_PPSC (Row 5 Left) , VDW_PP (Row 5 Middle) , VDW_PPFISC (Row 5
Right) with data from Lee et al.253 (Red) and Grupi et al.254 (Blue).
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Figure 6.5b: Comparison of Simulated Distance with Experimental Distances.
Simulated EFRETs for VDW_PPFISC (Row 1 Left), FloppyTail_score12 (Row 1
Center), FloppyTail_ref2015 (Row 1 Right), FloppyTail_Loops (Row 2 Left),
FloppyTail_Quota (Row 2 Center), FloppyTail_NoFrags (Row 2 Right), FloppyTail
(Row 3 Left), FloppyTail_Relax (Row 3 Center), FastFloppyTail (Row 3 Right),
FastFloppyTail_Relax (Row 4
Left), FloppyTail_Rot (Row 4 Center),
FloppyTail_Rot_Relax (Row 4 Right), AbInitio (Row 5 Left) , AbInitioVO (Row 5
Middle) , DeNovoIDP (Row 5 Right) with data from Lee et al.253 (Red) and Grupi
et al.254 (Blue).
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Comparison with α-Synuclein PRE Data

Figure 6.6: Comparison of Simulated Beta_PP PRE Values and Experimental
PRE Values. Simulated PRE values from Beta_PP (red line) overlayed on top of
experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.7: Comparison of Simulated Beta_PPFI PRE Values and Experimental
PRE Values. Simulated PRE values from Beta_PPFI (red line) overlayed on top of
experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.8: Comparison of Simulated Beta_PPFISC PRE Values and
Experimental PRE Values. Simulated PRE values from Beta_PPFISC (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.9: Comparison of Simulated Beta_PPSC PRE Values and Experimental
PRE Values. Simulated PRE values from Beta_PPSC (red line) overlayed on top
of experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.10: Comparison of Simulated CenStd_PP PRE Values and Experimental
PRE Values. Simulated PRE values from CenStd_PP (red line) overlayed on top
of experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.11: Comparison of Simulated CenStd_PPFI PRE Values and
Experimental PRE Values. Simulated PRE values from CenStd_PPFI (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.12: Comparison of Simulated CenStd_Ext_PP PRE Values and
Experimental PRE Values. Simulated PRE values from CenStd_Ext_PP (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.13: Comparison of Simulated CenStd_Ext_PPFI PRE Values and
Experimental PRE Values. Simulated PRE values from CenStd_Ext_PPFI (red
line) overlayed on top of experimental data (grey bars) from positions 20 (Top Left),
24 (Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.14: Comparison of Simulated CenNath PRE Values and Experimental
PRE Values. Simulated PRE values from CenNath (red line) overlayed on top of
experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.15: Comparison of Simulated SimAnn_PP PRE Values and Experimental
PRE Values. Simulated PRE values from SimAnn_PP (red line) overlayed on top
of experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.16: Comparison of Simulated SimAnn_PPFI PRE Values and
Experimental PRE Values. Simulated PRE values from SimAnn_PPFI (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.17: Comparison of Simulated SimAnn_PPFISC PRE Values and
Experimental PRE Values. Simulated PRE values from SimAnn_PPFISC (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.18: Comparison of Simulated SimAnn_PPSC PRE Values and
Experimental PRE Values. Simulated PRE values from SimAnn_PPSC (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.19: Comparison of Simulated VDW_PP PRE Values and Experimental
PRE Values. Simulated PRE values from VDW_PP (red line) overlayed on top of
experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.20: Comparison of Simulated VDW_PPFI PRE Values and Experimental
PRE Values. Simulated PRE values from VDW_PPFI (red line) overlayed on top
of experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.21: Comparison of Simulated VDW_PPFISC PRE Values and
Experimental PRE Values. Simulated PRE values from VDW_PPFISC (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.22: Comparison of Simulated FloppyTail_score12 PRE Values and
Experimental PRE Values. Simulated PRE values from FloppyTail_score12 (red
line) overlayed on top of experimental data (grey bars) from positions 20 (Top Left),
24 (Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.23: Comparison of Simulated FloppyTail_ref2015 PRE Values and
Experimental PRE Values. Simulated PRE values from FloppyTail_ref2015 (red
line) overlayed on top of experimental data (grey bars) from positions 20 (Top Left),
24 (Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.24: Comparison of Simulated FloppyTail_Quota PRE Values and
Experimental PRE Values. Simulated PRE values from FloppyTail_Quota (red
line) overlayed on top of experimental data (grey bars) from positions 20 (Top Left),
24 (Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.25: Comparison of Simulated FloppyTail_NoFrags PRE Values and
Experimental PRE Values. Simulated PRE values from FloppyTail_NoFrags (red
line) overlayed on top of experimental data (grey bars) from positions 20 (Top Left),
24 (Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.26: Comparison of Simulated FloppyTail_Loops PRE Values and
Experimental PRE Values. Simulated PRE values from FloppyTail_Loops (red
line) overlayed on top of experimental data (grey bars) from positions 20 (Top Left),
24 (Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.27: Comparison of Simulated FloppyTail PRE Values and Experimental
PRE Values. Simulated PRE values from FloppyTail (red line) overlayed on top of
experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104

276

Figure 6.28: Comparison of Simulated FloppyTail_Relax PRE Values and
Experimental PRE Values. Simulated PRE values from FloppyTail_Relax (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.29: Comparison of Simulated FloppyTail_Rot PRE Values and
Experimental PRE Values. Simulated PRE values from FloppyTail_Rot (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.30: Comparison of Simulated FloppyTail_Rot_Relax PRE Values and
Experimental PRE Values. Simulated PRE values from FloppyTail_Rot_Relax (red
line) overlayed on top of experimental data (grey bars) from positions 20 (Top Left),
24 (Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.31: Comparison of Simulated FastFloppyTail PRE Values and
Experimental PRE Values. Simulated PRE values from FastFloppyTail (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.32: Comparison of Simulated FastFloppyTail PRE Values and
Experimental PRE Values. Simulated PRE values from FastFloppyTail (red line)
overlayed on top of experimental data (grey bars) from positions 20 (Top Left), 24
(Top Right), 42 (Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle
Left), 87 (Lower Middle Right), 103 (Bottom Left), 120 (Bottom Right).
Experimental data for positions 20, 85, and 120 are from Sung et al.201 and data
for positions 24, 42, 62, 87, and 103 are from Dedmon et al.104
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Figure 6.33: Comparison of Simulated AbInitio PRE Values and Experimental
PRE Values. Simulated PRE values from AbInitio (red line) overlayed on top of
experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.34: Comparison of Simulated AbInitioVO PRE Values and Experimental
PRE Values. Simulated PRE values from AbInitioVO (red line) overlayed on top of
experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Figure 6.35: Comparison of Simulated DeNovoIDP PRE Values and Experimental
PRE Values. Simulated PRE values from DeNovoIDP (red line) overlayed on top
of experimental data (grey bars) from positions 20 (Top Left), 24 (Top Right), 42
(Upper Middle Left), 62 (Upper Middle Right), 85 (Lower Middle Left), 87 (Lower
Middle Right), 103 (Bottom Left), 120 (Bottom Right). Experimental data for
positions 20, 85, and 120 are from Sung et al.201 and data for positions 24, 42, 62,
87, and 103 are from Dedmon et al.104
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Comparison with α-Synuclein Chemical Shift Data

Figure 6.36: Comparison of Simulated Beta_PP and Experimental NMR Chemical
Shift Data. Simulated Chemical Shift values from the Beta_PP ensemble (red)
overlayed on experimental data (black bars) of N (Top), H (Upper Middle), C
(Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung et al.201
Neighbor corrected random coil chemical shift values have been subtracted from
both simulated and experimental data.245
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Figure 6.37: Comparison of Simulated Beta_PPFI and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the Beta_PPFI
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.38: Comparison of Simulated Beta_PPFISC and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the Beta_PPFISC
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.39: Comparison of Simulated Beta_PPSC and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the Beta_PPSC
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.40: Comparison of Simulated CenStd_PP and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the CenStd_PP
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.41: Comparison of Simulated CenStd_PPFI and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the CenStd_PPFI
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.42: Comparison of Simulated CenStd_Ext_PP and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the CenStd_Ext_PP
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.43: Comparison of Simulated CenStd_Ext_PPFI and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the CenStd_Ext_PPFI
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.44: Comparison of Simulated CenNath and Experimental NMR Chemical
Shift Data. Simulated Chemical Shift values from the CenNath ensemble (red)
overlayed on experimental data (black bars) of N (Top), H (Upper Middle), C
(Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung et al.201
Neighbor corrected random coil chemical shift values have been subtracted from
both simulated and experimental data.245
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Figure 6.45: Comparison of Simulated SimAnn_PP and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the SimAnn_PP
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data.245
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Figure 6.46: Comparison of Simulated SimAnn_PPFI and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the SimAnn_PPFI
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.47: Comparison of Simulated SimAnn_PPFISC and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the SimAnn_PPFISC
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245

296

Figure 6.48: Comparison of Simulated SimAnn_PPSC and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the SimAnn_PPSC
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.49: Comparison of Simulated VDW_PP and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the VDW_PP
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data.245
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Figure 6.50: Comparison of Simulated VDW_PPFI and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the VDW_PPFI
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.51: Comparison of Simulated VDW_PPFISC and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the VDW_PPFISC
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.52: Comparison of Simulated FloppyTail_score12 and Experimental
NMR Chemical Shift Data. Simulated Chemical Shift values from the
FloppyTail_score12 ensemble (red) overlayed on experimental data (black bars)
of N (Top), H (Upper Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom)
chemical shifts from Sung et al.201 Neighbor corrected random coil chemical shift
values have been subtracted from both simulated and experimental data. 245
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Figure 6.53: Comparison of Simulated FloppyTail_ref2015 and Experimental
NMR Chemical Shift Data. Simulated Chemical Shift values from the
FloppyTail_ref2015 ensemble (red) overlayed on experimental data (black bars)
of N (Top), H (Upper Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom)
chemical shifts from Sung et al.201 Neighbor corrected random coil chemical shift
values have been subtracted from both simulated and experimental data.245
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Figure 6.54: Comparison of Simulated FloppyTail_Quota and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the FloppyTail_Quota
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.55: Comparison of Simulated FloppyTail_NoFrags and Experimental
NMR Chemical Shift Data. Simulated Chemical Shift values from the
FloppyTail_NoFrags ensemble (red) overlayed on experimental data (black bars)
of N (Top), H (Upper Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom)
chemical shifts from Sung et al.201 Neighbor corrected random coil chemical shift
values have been subtracted from both simulated and experimental data.245
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Figure 6.56: Comparison of Simulated FloppyTail_Loops and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from FloppyTail_Loops
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.57: Comparison of Simulated FloppyTail and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the FloppyTail
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.58: Comparison of Simulated FloppyTail_Relax and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the FloppyTail_Relax
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.59: Comparison of Simulated FastFloppyTail and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the FastFloppyTail
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data.245
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Figure 6.60: Comparison of Simulated FastFloppyTail_Relax and Experimental
NMR Chemical Shift Data. Simulated Chemical Shift values from the
FastFloppyTail_Relax ensemble (red) overlayed on experimental data (black bars)
of N (Top), H (Upper Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom)
chemical shifts from Sung et al.201 Neighbor corrected random coil chemical shift
values have been subtracted from both simulated and experimental data. 245
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Figure 6.61: Comparison of Simulated FloppyTail_Rot and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the FloppyTail_Rot
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data.245
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Figure 6.62: Comparison of Simulated FloppyTail_Rot_Relax and Experimental
NMR Chemical Shift Data. Simulated Chemical Shift values from the
FloppyTail_Rot_Relax ensemble (red) overlayed on experimental data (black
bars) of N (Top), H (Upper Middle), C (Middle), Cα (Lower Middle), and Cβ
(Bottom) chemical shifts from Sung et al.201 Neighbor corrected random coil
chemical shift values have been subtracted from both simulated and experimental
data.245
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Figure 6.63: Comparison of Simulated AbInitio and Experimental NMR Chemical
Shift Data. Simulated Chemical Shift values from the AbInitio ensemble (red)
overlayed on experimental data (black bars) of N (Top), H (Upper Middle), C
(Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung et al.201
Neighbor corrected random coil chemical shift values have been subtracted from
both simulated and experimental data.245
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Figure 6.64: Comparison of Simulated AbInitioVO and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the AbInitioVO
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Figure 6.65: Comparison of Simulated DeNovoIDP and Experimental NMR
Chemical Shift Data. Simulated Chemical Shift values from the DeNovoIDP
ensemble (red) overlayed on experimental data (black bars) of N (Top), H (Upper
Middle), C (Middle), Cα (Lower Middle), and Cβ (Bottom) chemical shifts from Sung
et al.201 Neighbor corrected random coil chemical shift values have been
subtracted from both simulated and experimental data. 245
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Comparison with α-Synuclein Residual Dipolar Coupling Data

Figure 6.66a: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. Simulated RDC values (red line) from Beta_PP (Top), Beta_PPFI
(Upper Middle), Beta_PPFISC (Lower Middle), and Beta_PPSC (Bottom)
overlayed on experimental data (black bars) from Bertoncini et. al.200
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Figure 6.66b: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. Simulated RDC values (red line) from CenStd_PP (Top),
CenStd_PPFI (Upper Middle), CenStd_Ext_PP (Lower Middle), and
CenStd_Ext_PPFI (Bottom) overlayed on experimental data (black bars) from
Bertoncini et. al.200
316

Figure 6.66c: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. Simulated RDC values (red line) from SimAnn_PP (Top),
SimAnn_PPFI (Upper Middle), SimAnn_PPFISC (Lower Middle), and
SimAnn_PPSC (Bottom) overlayed on experimental data (black bars) from
Bertoncini et. al.200
317

Figure 6.66d: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. Simulated RDC values (red line) from CenNath (Top), VDW_PP
(Upper Middle), VDW_PPFI (Lower Middle), and VDW_PPFISC (Bottom)
overlayed on experimental data (black bars) from Bertoncini et. al.200
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Figure 6.66d: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. Simulated RDC values (red line) from FloppyTail_score12 (Top),
FloppyTail_ref2015 (Upper Middle), FloppyTail_Quota (Lower Middle), and
FloppyTail_NoFrags (Bottom) overlayed on experimental data (black bars) from
Bertoncini et. al.200
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Figure 6.66e: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. Simulated RDC values (red line) from FloppyTail_Loops (Top),
FloppyTail (Upper Middle), FloppyTail_Relax (Lower Middle), and FastFloppyTail
(Bottom) overlayed on experimental data (black bars) from Bertoncini et. al.200
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Figure 6.66f: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. Simulated RDC values (red line) from FastFloppyTail_Relax (Top),
FloppyTail_Rot (Upper Middle), FloppyTail_Rot_Relax (Lower Middle), and
AbInitio (Bottom) overlayed on experimental data (black bars) from Bertoncini et.
al.200
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Figure 6.66g: Comparison of Simulated and Experimental Residual Dipolar
Coupling Data. Simulated RDC values (red line) from AbInitioVO (Top) and
DeNovoIDP (Bottom) overlayed on experimental data (black bars) from Bertoncini
et. al.200
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Comparison with α-Synuclein J-Coupling Data

Figure 6.67: Comparison of Simulated Beta_PP and Experimental J-Coupling
Data. Simulated Chemical Shift values from the Beta_PP ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.68: Comparison of Simulated Beta_PPFI and Experimental J-Coupling
Data. Simulated Chemical Shift values from the Beta_PPFI ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.69: Comparison of Simulated Beta_PPFISC and Experimental JCoupling Data. Simulated Chemical Shift values from the Beta_PPFISC ensemble
(red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.70: Comparison of Simulated Beta_PPSC and Experimental J-Coupling
Data. Simulated Chemical Shift values from the Beta_PPSC ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.71: Comparison of Simulated CenStd_PP and Experimental J-Coupling
Data. Simulated Chemical Shift values from the CenStd_PP ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.72: Comparison of Simulated CenStd_PPFI and Experimental JCoupling Data. Simulated Chemical Shift values from the CenStd_PPFI ensemble
(red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper
Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from Mantsyzov
et al. and Lee et. al.247, 252
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Figure 6.73: Comparison of Simulated CenStd_Ext_PP and Experimental JCoupling Data. Simulated Chemical Shift values from the CenStd_Ext_PP
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.74: Comparison with α-Synuclein PRE Data Comparison of Simulated
CenStd_Ext_PPFI and Experimental J-Coupling Data. Simulated Chemical Shift
values from the CenStd_Ext_PPFI ensemble (red) overlayed on experimental data
(black) of 3JHNHα (Top), 3JHNHα (Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle)
and 2JNCα (Bottom) from Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.75: Comparison of Simulated CenNath and Experimental J-Coupling
Data. Simulated Chemical Shift values from the CenNath ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.76: Comparison of Simulated SimAnn_PP and Experimental J-Coupling
Data. Simulated Chemical Shift values from the SimAnn_PP ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.

332

Figure 6.77: Comparison of Simulated SimAnn_PPFI and Experimental JCoupling Data. Simulated Chemical Shift values from the SimAnn_PPFI ensemble
(red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper
Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from Mantsyzov
et al. and Lee et. al.247, 252
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Figure 6.78: Comparison of Simulated SimAnn_PPFISC and Experimental JCoupling Data. Simulated Chemical Shift values from the SimAnn_PPFISC
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.79: Comparison of Simulated SimAnn_PPSC and Experimental JCoupling Data. Simulated Chemical Shift values from the SimAnn_PPSC
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.80: Comparison of Simulated VDW_PP and Experimental J-Coupling
Data. Simulated Chemical Shift values from the VDW_PP ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.81: Comparison of Simulated VDW_PPFI and Experimental J-Coupling
Data. Simulated Chemical Shift values from the VDW_PPFI ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.82: Comparison of Simulated VDW_PPFISC and Experimental JCoupling Data. Simulated Chemical Shift values from the VDW_PPFISC ensemble
(red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.83: Comparison of Simulated FloppyTail_score12 and Experimental JCoupling Data. Simulated Chemical Shift values from the FloppyTail_score12
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.84: Comparison of Simulated FloppyTail_ref2015 and Experimental JCoupling Data. Simulated Chemical Shift values from the FloppyTail_ref2015
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.85: Comparison of Simulated FloppyTail_Quota and Experimental JCoupling Data. Simulated Chemical Shift values from the FloppyTail_Quota
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.86: Comparison of Simulated FloppyTail_NoFrags
Coupling Data. Simulated Chemical Shift values from the
ensemble (red) overlayed on experimental data (black) of
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and
Mantsyzov et al. and Lee et. al.247, 252
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and Experimental JFloppyTail_NoFrags
3J
3
HNHα (Top), JHNHα
2J
NCα (Bottom) from

Figure 6.87: Comparison of Simulated FloppyTail_Loops and Experimental JCoupling Data. Simulated Chemical Shift values from the FloppyTail_Loops
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.88: Comparison of Simulated FloppyTail and Experimental J-Coupling
Data. Simulated Chemical Shift values from the FloppyTail ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.89: Comparison of Simulated FloppyTail_Relax and Experimental JCoupling Data. Simulated Chemical Shift values from the FloppyTail_Relax
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.90: Comparison of Simulated FastFloppyTail and Experimental JCoupling Data. Simulated Chemical Shift values from the FastFloppyTail
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.91: Comparison of Simulated FastFloppyTail_Relax and Experimental JCoupling Data. Simulated Chemical Shift values from the FastFloppyTail_Relax
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.92: Comparison of Simulated FloppyTail_Rot and Experimental JCoupling Data. Simulated Chemical Shift values from the FloppyTail_Rot
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.93: Comparison of Simulated FloppyTail_Rot_Relax and Experimental
J-Coupling Data. Simulated Chemical Shift values from the FloppyTail_Rot_Relax
ensemble (red) overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα
(Upper Middle), 1JHαCα (Middle), 1JNCα (Lower Middle) and 2JNCα (Bottom) from
Mantsyzov et al. and Lee et. al.247, 252
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Figure 6.94: Comparison of Simulated AbInitio and Experimental J-Coupling Data.
Simulated Chemical Shift values from the AbInitio ensemble (red) overlayed on
experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle), 1JHαCα (Middle),
1J
2
247,
NCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and Lee et. al.
252
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Figure 6.95: Comparison of Simulated AbInitioVO and Experimental J-Coupling
Data. Simulated Chemical Shift values from the AbInitioVO ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Figure 6.96: Comparison of Simulated DeNovoIDP and Experimental J-Coupling
Data. Simulated Chemical Shift values from the DeNovoIDP ensemble (red)
overlayed on experimental data (black) of 3JHNHα (Top), 3JHNHα (Upper Middle),
1J
1
2
HαCα (Middle), JNCα (Lower Middle) and JNCα (Bottom) from Mantsyzov et al. and
247,
252
Lee et. al.
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Comparison of AbInitio and AbInitioVO Simulations to Experimental Data
Table 6.5: Comparison of AbInitio and AbInitioVO Outputs to PDB Structures
PDB
ID

# of
Res.

Ordered
Region

1B3A
1BK2

67
57
54
54
64
70
63
59
76
61

-

2LSU

144
160
76
225
93
76
100
110

27-115
1-110
1-76
41-114
26-93
1-49
14-90
1-89

ASYN
DSH3
NTAL
PAAA
SIC1
TAUK

140
59
125
142
92
130

-

1BQ9
1ENH
1HZ6
1PGX
1R69
1SHF
1UBI
5CRO
1D7Q
1EJF
1FOX
1GHC
1LWM
1VZS
2L42

Fold
Type

Min RMSD
AbInitio
AbInitio
VO
Ordered
3.31
2.68
2.16
2.33

<Rg>
AbInitio
AbInitio
VO

α/β
β
3.91
β
2.64
1.18
α
0.77
1.99
α/β
2.16
3.54
α
3.71
1.14
α
0.99
1.52
β
3.30
2.59
α/β
2.72
4.56
α/β
4.35
Partially-Ordered
6.41
α/β
6.38
7.73
β
6.97
1.22
α/β
1.10

12.0
11.4

α/β
α
α
α/β
α

3.04
1.43
2.02
6.70
1.06
Disordered

2.33
3.61
1.98
5.32

21.6
15.2
13.3
14.3

1.64

-

-

-

Exp Rg

11.8
11.1
10.7
10.5
12.1
13.0
10.5
11.2
12.3
11.0

-

-

14.9

21.8
26.5
12.1
47.6
17.5
12.8
14.0
13.9

17.4
12.3
15.9
18.4
14.0
16.0

28.4
11.5
27.0
19.6
30.6
15.9

33.0 / 26.6
10.3 / 18.3
27.5
22.4
32.1
-

11.0
10.7
12.4
13.0
10.7
11.8
12.5
11.3
17.4
18.4
12.7

-

-

* Experimental values for the radius of gyration were determined for ASYN from
SAXS228 and NMR205 experiments, for DSH3 from NMR experiments capturing
the Rg of the folded258 and unfolded259 states, for NTAL from NMR
experiments260, for PAAA from a simulated ensemble generated from SAXS and
NMR experiments261, for SIC1 from simulated ensembles from SAXS and NMR
experiments262 and was not reported for TAUK.124
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Comparison of Radii of Gyration:

Figure 6.97: Radii of Gyration of Ordered Proteins.
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Figure 6.98: Radii of Gyration of Partially-Ordered Proteins.

355

Figure 6.99: Radii of Gyration of Disordered Proteins.
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Comparison of Folding Funnels

Figure 6.100: Folding Funnel Comparison for 1bka. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the PDB structure.
For each folding funnel, histograms of the computed RMSD (top) and REU (right)
are shown. KDE plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue)
folding funnels.

Figure 6.101: Folding Funnel Comparison for 1bq9. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the PDB structure.
For each folding funnel, histograms of the computed RMSD (top) and REU (right)
are shown. KDE plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue)
folding funnels.
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Figure 6.102: Folding Funnel Comparison for 1enh. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the PDB structure.
For each folding funnel, histograms of the computed RMSD (top) and REU (right)
are shown. KDE plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue)
folding funnels.

Figure 6.103: Folding Funnel Comparison for 1hz6. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the PDB structure.
For each folding funnel, histograms of the computed RMSD (top) and REU (right)
are shown. KDE plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue)
folding funnels.
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Figure 6.104: Folding Funnel Comparison for 1pgx. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the PDB structure.
For each folding funnel, histograms of the computed RMSD (top) and REU (right)
are shown. KDE plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue)
folding funnels.

Figure 6.105: Folding Funnel Comparison for 1r69. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the PDB structure. For each folding
funnel, histograms of the computed RMSD (top) and REU (right) are shown. KDE
plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue) folding funnels.
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Figure 6.106: Folding Funnel Comparison for 1shf. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the PDB structure. For each folding
funnel, histograms of the computed RMSD (top) and REU (right) are shown. KDE
plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue) folding funnels.

Figure 6.107: Folding Funnel Comparison for 1ubi. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the PDB structure. For each folding
funnel, histograms of the computed RMSD (top) and REU (right) are shown. KDE
plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue) folding funnels.
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Figure 6.108: Folding Funnel Comparison for 5cro. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the PDB structure. For each folding
funnel, histograms of the computed RMSD (top) and REU (right) are shown. KDE
plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue) folding funnels.

Figure 6.109: Folding Funnel Comparison for 1b3a. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the folded domain
of the PDB structure. For each folding funnel, histograms of the computed RMSD
(top) and REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo
(red) and AbInitio (blue) folding funnels.
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Figure 6.110: Folding Funnel Comparison for 1d7q. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the folded domain
of the PDB structure. For each folding funnel, histograms of the computed RMSD
(top) and REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo
(red) and AbInitio (blue) folding funnels.

Figure 6.111: Folding Funnel Comparison for 1ejf. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the folded domain of the PDB
structure. For each folding funnel, histograms of the computed RMSD (top) and
REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo (red) and
AbInitio (blue) folding funnels.
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Figure 6.112: Folding Funnel Comparison for 1fox. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the folded domain of the PDB
structure. For each folding funnel, histograms of the computed RMSD (top) and
REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo (red) and
AbInitio (blue) folding funnels.

Figure 6.113: Folding Funnel Comparison for 1ghc. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the folded domain
of the PDB structure. For each folding funnel, histograms of the computed RMSD
(top) and REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo
(red) and AbInitio (blue) folding funnels.
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Figure 6.114: Folding Funnel Comparison for 1lwm. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the folded domain
of the PDB structure. For each folding funnel, histograms of the computed RMSD
(top) and REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo
(red) and AbInitio (blue) folding funnels.

Figure 6.115: Folding Funnel Comparison for 1vzs. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the folded domain of the PDB
structure. For each folding funnel, histograms of the computed RMSD (top) and
REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo (red) and
AbInitio (blue) folding funnels.
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Figure 6.116: Folding Funnel Comparison for 2l42. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the folded domain of the PDB
structure. For each folding funnel, histograms of the computed RMSD (top) and
REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo (red) and
AbInitio (blue) folding funnels.

Figure 6.117: Folding Funnel Comparison for 2lsu. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the folded domain of the PDB
structure. For each folding funnel, histograms of the computed RMSD (top) and
REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo (red) and
AbInitio (blue) folding funnels.

365

Figure 6.118: Folding Funnel Comparison for asyn. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the lowest energy
structure. For each folding funnel, histograms of the computed RMSD (top) and
REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo (red) and
AbInitio (blue) folding funnels.

Figure 6.119: Folding Funnel Comparison for dsh3. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the lowest energy
structure. For each folding funnel, histograms of the computed RMSD (top) and
REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo (red) and
AbInitio (blue) folding funnels.
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Figure 6.120: Folding Funnel Comparison for ntal. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the lowest energy structure. For
each folding funnel, histograms of the computed RMSD (top) and REU (right) are
shown. KDE plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue)
folding funnels.

Figure 6.121: Folding Funnel Comparison for paaa. Folding funnel from
AbInitioVO (left) and AbInitio (middle) simulations plotting Cα RMSD versus
Rosetta Energy Units (REU) from each structure compared to the lowest energy
structure. For each folding funnel, histograms of the computed RMSD (top) and
REU (right) are shown. KDE plot (right) showing overlay of AbInitiovo (red) and
AbInitio (blue) folding funnels.
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Figure 6.122: Folding Funnel Comparison for sic1. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the lowest energy structure. For
each folding funnel, histograms of the computed RMSD (top) and REU (right) are
shown. KDE plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue)
folding funnels.

Figure 6.123: Folding Funnel Comparison for tauk. Folding funnel from AbInitioVO
(left) and AbInitio (middle) simulations plotting Cα RMSD versus Rosetta Energy
Units (REU) from each structure compared to the lowest energy structure. For
each folding funnel, histograms of the computed RMSD (top) and REU (right) are
shown. KDE plot (right) showing overlay of AbInitiovo (red) and AbInitio (blue)
folding funnels.
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Comparisons of Folded Domain Structures of Ordered and Partially-Ordered
Proteins

Figure 6.124: 1bk2 Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1bk2
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.125: 1bq9 Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1bq9
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.126: 1enh Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1enh
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(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.127: 1hz6 Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1hz6
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.128: 1pgx Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1pgx
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)
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Figure 6.129: 1r69 Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1r69
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.130: 1shf Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1shf
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.131: 1ubi Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1ubi
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)
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Figure 6.132: 5cro Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 5cro
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.133: 1b3a Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1b3a
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.134: 1d7q Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1d7q
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)
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Figure 6.135: 1ejf Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1ejf
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.136: 1fox Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1fox
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.137: 1ghc Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1ghc
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(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.138: 1lwm Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1lwm
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.139: 1vzs Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 1vzs
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)
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Figure 6.140: 2l42 Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 2l42
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)

Figure 6.141: 2lsu Lowest RMSD Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right) along with the overlay (center) of PDB 2lsu
(white) and the single lowest RMSD structure from AbInitioVO (red) and AbInitio
(blue)
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Structural Comparisons of Disordered Domains of Partially-Ordered and
Disordered Proteins

Figure 6.142: 1b3a Lowest RMSD Full Structures. 10 lowest RMSD structures
from AbInitioVO (left) and AbInitio (right)

Figure 6.143: 1d7q Lowest RMSD Full Structures. 10 lowest RMSD structures
from AbInitioVO (left) and AbInitio (right)

Figure 6.144: 1ejf Lowest RMSD Full Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right)
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Figure 6.145: 1fox Lowest RMSD Full Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right)

Figure 6.146: 1ghc Lowest RMSD Full Structures. 10 lowest RMSD structures
from AbInitioVO (left) and AbInitio (right)

Figure 6.147: 1lwm Lowest RMSD Full Structures. 10 lowest RMSD structures
from AbInitioVO (left) and AbInitio (right)
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Figure 6.148: 1vzs Lowest RMSD Full Structures. 10 lowest RMSD structures
from AbInitioVO (left) and AbInitio (right)

Figure 6.149: 2l42 Lowest RMSD Full Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right)

Figure 6.150: 2lsu Lowest RMSD Full Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right)
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Figure 6.151: Asyn Lowest RMSD Full Structures. 10 lowest RMSD structures
from AbInitioVO (left) and AbInitio (right)

Figure 6.152: Dsh3 Lowest RMSD Full Structures. 10 lowest RMSD structures
from AbInitioVO (left) and AbInitio (right)

Figure 6.153: Ntal Lowest RMSD Full Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right)
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Figure 6.154: Paaa Lowest RMSD Full Structures. 10 lowest RMSD structures
from AbInitioVO (left) and AbInitio (right)

Figure 6.155: Sic1 Lowest RMSD Full Structures. 10 lowest RMSD structures from
AbInitioVO (left) and AbInitio (right)

Figure 6.156: Tauk Lowest RMSD Full Structures. 10 lowest RMSD structures
from AbInitioVO (left) and AbInitio (right)
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CHAPTER 7: HIGH-THROUGHPUT IN SILICO AND IN VITRO SCREENING
FOR COMPOUNDS THAT SELECTIVELY BIND TO ALPHA-SYNUCLEIN
FIBRILS.
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§ 7.1 Introduction
α-Synuclein (αS) is a 140 amino acid, intrinsically disordered protein which
is abundantly expressed at the presynaptic termini of central nervous systems
neurons.19, 263 When bound to membranes, αS takes on a partially helical structure
and is involved is various physiological activities.23, 264 Although the function of αS
is poorly understood, its localization, along with knockout and overexpression
studies, suggests that alongside synapsin, VAMP2 and others, αS plays a
significant role in maintaining synaptic vesicle reserve pools, neurotransmitter
release and synapse function and plasticity.19,

27-28

Conversely, the potential

pathological role of αS is well documented, where neuronal inclusions comprised
principally of fibrillar αS termed Lewy bodies (LBs) and Lewy neurites (LNs) have
long served as post-mortem hallmarks of Parkinson’s Disease (PD).19,

22

Furthermore, similar aggregates can be observed in dementia with Lewy bodies
(DLB), while a second form of aggregate has been identified in multiple system
atrophy (MSA).34 Compared to LBs and LNs which often appear in the substantia
nigra, glia cell inclusions (GCIs) associated with MSA are found in
oligodendrocytes of white matter tracts.34 However, the inability to track fibril
formation and localization in living patients has hindered the development of robust
correlations between PD progression and fibril burden and prevents αS fibrils from
serving as useful clinical markers.
To date, diagnosis of PD has primarily relied on the presentation of clinical
symptoms, chiefly motor deficits. Although these symptoms are effective in
tracking progression at later stages of disease, they are not observed until a
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substantial degree of neuronal loss has occurred. 30 Moreover, these symptoms
are not exclusive to PD, but are observed for other Parkinsonian syndromes. 33
Therefore, since differences in the presence and localization of fibrillar αS have
already been established, methods for tracking deposits in patients could clarify
diagnosis. Over the past decade, a breakthrough in the clinical evaluation of
Alzheimer’s disease (AD) was enabled in vivo imaging of amyloid β (a) plaques
with positron emission tomography (PET), a molecular imaging technique. 265-271
The development of a and tau specific PET probes has allowed researchers to
determine that the formation of a aggregates precedes disease onset while taubased neurofibrillary tangles (NFTs) occur later in disease progression.272 These
promising results from the imaging studies of AD patients have generated interest
in the development of PET radiotracers to image S and improve the diagnosis of
PD.
Despite these advancements, the development of imaging probes with the
requisite specificity for use in PD research and diagnosis has been challenging. In
addition to LBs and LNs, PD patients also present neuronal aggregates comprised
of a and tau.273 Although the Petersson and Mach laboratories as well as others
have successfully identified compounds with moderate binding affinity for
employment as PET imaging agents, no compound to date has displayed high
enough affinity and specificity for use as a radioligand. 274-275 Previously, following
publication of the first solid-state NMR structure of αS fibrils by Rienstra and
colleagues, we demonstrated that through the combined use of computational
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docking, competition radioligand binding assays and photocrosslinking mass
spectrometry we were able to posit binding sites for several previously developed
compounds.47, 276
Here, we explore the utility of another computational approach, exemplarbased in silico screening, in an effort to develop a molecule that potently and
specifically binds to αS fibrils.277 Through the application of this method we have
identified a molecular scaffold and confirmed through structure-activity relationship
(SAR) studies that members of this isoxazole containing compound series have
nanomolar affinity for αS fibrils. Moreover, several of these compounds have
moderate specificity for αS over a fibrils. Lastly, we demonstrate the potential of
this molecule as a PET probe by imaging fibrillar αS deposits in mouse brain tissue
using a radiolabeled analog of the identified molecule.

§ 7.2 Methods
In-Silico Exemplar-based Screening in Align-It.
The Rosetta Modeling Suite was used to map exemplars at each residue of
the 2N0A PDB by running47:
ROSETTA/make_exemplar.linuxgccrelease -database
ROSETTA/database -in:file:s 2N0A.pdb -pocket_grid_size 12 -pocket_static_grid
-pocket_filter_by_exemplar -pocket_surface_dist 1 -central_relax_pdb_num XX
Where residues for the previously identified sites 2, 3/13 and 9
corresponded to residues 156, 163 and 198.276 In order to allow Align-It to
recognize the exemplar outputs from Rosetta, the hydrogen bond donating and
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accepting parameters in Align-It were altered. Prior to compiling Align-It, the
following lines were added at line 42 to the file hDonFuncCalc.cpp in the src
directory:
if (a->GetAtomicNum() == 4)
{
PharmacophorePoint p;
p.func = HDON;
p.point.x = a->x();
p.point.y = a->y();
p.point.z = a->z();
p.hasNormal = false;
p.alpha = funcSigma[HDON];
pharmacophore->push_back(p);
}

Additionally, the following lines were added to line 42 to the file
hAccFuncCalc.app in src directory:

if (atom->GetAtomicNum() == 10)
{
if(_hAccCalcAccSurf(atom) < 0.02)
{
continue;
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}
PharmacophorePoint p;
p.func = HACC;
p.point.x = atom->x();
p.point.y = atom->y();
p.point.z = atom->z();
p.hasNormal = false;
p.alpha = funcSigma[HACC];
pharmacophore->push_back(p);
}

The ZINC15, lead-like, commercially available compound database,
consisting of ~ 10 million molecules was used for the initial screen against the three
sites.278 Molecular alignments of target molecules to each selected exemplar were
performed using Align-It which reduces each molecule/exemplar to a set of
pharmacophores and reports a Tanimoto Coefficient for each alignment which
captures both agreements in molecular features and their alignment in threedimensional space.279 The top 30 compounds as quantified by the Tanimoto
Coefficient from each search were retained and a subset of compounds from each
search was selected by hand for experimentation. Since the compounds identified
for site 3/13 were either too small or too similar to compounds previously
explored,276 select compounds from the site 2 and site 9 screens were used in
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subsequent experimental screens and the full set of compounds can be found in
Figures 7.5 and 7.7.
Preparation of αS Monomer Fibrils.
Recombinant expression and purification of wild-type αS protein was
performed as previously described.78, 276 Fibrils were prepared in a manner similar
to previously described, where 100 μM αS monomer was incubated in 20 mM tris
100 mM NaCl, pH 7.4 at 37 C and shaken at 1300 rpm for 3 days.78, 276

Preparation of a fibrils.
a fibrils were prepared as described previously.280 Briefly, monomer a (1
mg, Bachem) was dissolved in hexafluoroisopropanol (HFIP) at a concentration of
2 mg/mL and incubated for 1 hour at 37 °C until the peptide completely dissolved.
Then HFIP was evaporated under air. The peptide powder was dissolved again in
HFIP (2 mg/mL), aliquoted and left to dry overnight under vacuum. Aliquots were
stored in a freezer at -20 °C.
To prepare fibrils, the HFIP-treated peptide aliquot was dissolved in 10 mM
NaOH (10 µL) solution, then the sample was diluted with 90 µL 10 mM phosphate
buffer, pH 7.4. Concentration of the peptide solution was confirmed by measuring
the absorbance at 214 nm with NanoDrop 2000c spectrophotometer. Extinction
coefficient (76848 M-1cm-1) was calculated using literature values.281 Next, the
solution was agitated by a continuous slow rotation at room temperature for 3 days
and fibril formation was confirmed by TEM.
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Aggregation and Disaggregation Fluorescence Polarization Assays.
Wild-type and fluorescently labeled α-synuclein was produced as previously
described.119 Aggregations were performed at a total monomer concentration of
100 μM with 1 % labeled αS in 20 mM tris 100 NaCl pH 7.4 in the presence of 10
and 100 μM compound and with equivalent volume of DMSO as a control. At each
timepoint an aliquot of the fibrilization reaction was removed and diluted 10-fold in
buffer. Fluorescence polarization was measured in a half-area well plate at a total
volume of 50 μL on a Tecan F200 plate reader. Aggregations were performed in
triplicate.
Disaggregation experiments were performed on labeled fibril samples
prepared as described above in the absence of compound. A final concentration
of 10 μM fibrils was added to each well for each disaggregation experiment and
each compound was added just prior to measurement to the final concentrations
detailed in Figure 7.9 and total volumes of 50 μL. Samples were shaken at 149
rpm at room temperature with polarization measurements taken every 150 second.

Photocrosslinking Assay.
Aggregations prepared as described above were dosed with equimolar
photocrosslinking compound in DMSO and shaken overnight at 37 °C shaking at
250 rpm. A control was also prepared where the same volume of DMSO used to
add compound was added and incubated as previously described. Following
incubation samples were irradiated under a TLC lamp (365 nm) for 1 hour. Fibrillar
samples were disaggregated by adding 20 mM SDS and boiled for 20 mins. SDS
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and

excess

compound

were

removed

through

chloroform

methanol

precipitation.282 Samples were digested with trypsin at 37 °C and were the resultant
peptides were analyzed by MALDI mass spectrometry to identify crosslinking site.

Screening compound library.
Compounds 1-17 were purchased from vendors that were listed on the
ZINC15 compound library. Compounds were screened for αS binding and after
identifying the lead compound, 6, the core structure of compound 6 and its
pyrazole or oxadiazole derivatives were used for similarity search on the websites
of Mcule, Inc., ChemDiv, Inc., MolPort, and Enamine, Ltd. The similarity threshold
was set to higher than 0.8, then compound 18-56 were chosen and ordered from
the four companies mentioned above.
In order to screen the purchased compounds for αS binding, 100 nM of each
compounds were incubated for 1 hour at 37 °C with 100 nM ASyn fibrils and [3H]Tg-190b (6 nM) or [3H]-BF2846 (3 nM) in 50 mM Tris-HCl, pH 7.4. Total binding
was measured in the absence of competitor and nonspecific binding was
determined in reactions containing cold Tg-190b (1 µM) or BF2846 (0.5 µM). After
incubation, bound and free radioligand were separated by vacuum filtration
through Whatman GF/C filters (Brandel) in a 24-sample harvester system
(Brandel), followed by washing with buffer containing 10 mM Tris-HCl (pH 7.4) and
150 mM NaCl. Filters containing the bound ligand were mixed with 3 mL of
scintillation cocktail (MicroScint-20, PerkinElmer Informatics, Inc.) and counted
after 12 hours of incubation on a MicroBeta System (PerkinElmer Informatics, Inc.).
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All data points were performed in triplicates. Percentage of bound radioligand
relative to total binding was plotted and data was analyzed by One-Way ANOVA,
comparing the mean of each data set to the mean of total binding.

Competition binding assay.
αS fibrils (100 nM for site 2 and 50 nM for site 9) or aβ fibrils (100 nM) were
mixed with site 2 ligand [3H]-Tg-190b (6 nM) or site 9 ligand [3H]-BF2846 (3 nM)
and varying concentration of cold compounds. Compounds were diluted in 50 mM
Tris-HCl (pH 7.4) and mixed with fibrils and radioligand in a total volume of 150 µL.
Total binding was measured in the absence of competitor and nonspecific binding
was determined in reactions containing cold Tg-190b (1 µM) or BF2846 (0.5 µM).
In a duplicate set of binding reaction, fibrils were replaced with equal volume of
buffer to measure the amount of radioligand binding to the filter paper. Reactions
were incubated at 37 °C for 1 hour. After incubation bound and free radioligand
were separated by vacuum filtration through Whatman GF/C filters (Brandel) in a
24-sample harvester system (Brandel), followed by washing with buffer containing
10 mM Tris-HCl (pH 7.4) and 150 mM NaCl. Filters containing the bound ligand
were mixed with 3 mL of scintillation cocktail (MicroScint-20, PerkinElmer
Informatics, Inc.) and counted after 12 hours of incubation on a MicroBeta System
(PerkinElmer Informatics, Inc.). All data points were performed in triplicates. Ki
values were calculated by fitting the data to the equation below by nonlinear
regression, using GraphPad Prism software:
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logEC50 = log(10𝑙𝑜𝑔𝐾𝑖 ∗ (1 + [𝑟𝑎𝑑𝑖𝑜𝑙𝑖𝑔𝑎𝑛𝑑]/𝐾𝑑 ))

(Eq. 7.1)

Y = Bottom + (Top-Bottom) / (1+ 10(𝑋−𝑙𝑜𝑔𝐸𝐶50 ) )

(Eq. 7.2)

Where logEC50 is the log of the concentration of competitor that results in
binding half-way between Bottom and Top; logKi is the log of the molar equilibrium
dissociation constant of unlabeled ligand; [radioligand] is the concentration of hot
ligand in nM; Kd is the equilibrium dissociation constant of the hot ligand in nM;
Top and Bottom are plateaus in the units of Y axis.

Saturation binding assay.
αS (50 nM) or aβ (100 nM) fibrils were incubated for 1 hour at 37 °C with
increasing concentrations of [125I]61 in 50 mM Tris-HCl, pH 7.4, in a total volume
of 150 µL. Nonspecific binding was determined in a duplicate set of binding
reactions containing 2 µM cold 52. To measure the amount of radioligand binding
to the filter paper, fibrils were replaced with equal volume of buffer in a duplicate
set of binding reaction. After incubation, bound and free radioligand were
separated by vacuum filtration through Whatman GF/C filters (Brandel) in a 24sample harvester system (Brandel), followed by washing with buffer containing 10
mM Tris-HCl (pH 7.4) and 150 mM NaCl. Filters containing the bound ligand were
counted immediately on 2470 WIZARD Automatic Gamma Counter (Perkin Elmer).
All data points were performed in triplicate. The equilibrium dissociation constant
(Kd) and the maximal number of binding sites (Bmax) were determined by fitting
the data to the equation Y = Bmax*X/(Kd+X), using GraphPad Prism software.
391

Animals.
A53T (B6C3-Tg(Prnp-SNCA*A53T)83Vle/J) and B6C3F1/J mice were
obtained from The Jackson Laboratory. All animal studies were performed under
protocols approved by the University of Pennsylvania Institutional Animal Care and
Use Committee. Animals were euthanized by cervical dislocation under isoflurane
anesthesia at 17 months of age and the brain was extracted for autoradiography
and microscopy.

In vitro autoradiography.
Blocks of mouse brain tissue were frozen in optimal cutting temperature
compound (OCT, Tissue-Tek, Sakura Finetek, USA). The frozen tissue was sliced
into 10 µM thick sections in a Leica CM1950 cryostat and mounted onto Apex
Superior Adhesive slides (Leica). Frozen sections of both A53T and B6C3F1/J
mouse brain tissue were thawed at RT for 20 min, then washed with 40% ethanol
in PBS for 5 min. Next, sections were incubated (1 hour at RT) with 40% ethanol
in PBS containing either [125I]61 (6 nM) alone or [125I]61 (6 nM) with 20 µM cold Tg190b. After incubation, sections were washed in ice-cold 40% ethanol in PBS
(2x30 sec), followed by a wash in ice-cold DI water (1 min). Sections were dried in
a stream of air and then exposed to a phosphor screen (Fujifilm) and the screen
was imaged on a Typhoon FLA 7000 phosphor imager (GE Healthcare Europe).
Raw autoradiography images were imported to MATLAB R2017b (MathWorks
Inc., Natick, MA) to extract individual image. Each autoradiography image was
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manually registered to corresponding staining image by using PMOD image
analysis software (version 3.7; PMOD Technologies Ltd, Zurich, Switzerland).

Immunofluorescence.
Frozen brain tissue sections, adjacent to the ones used for autoradiography,
were thawed at room temperature for 20 min. Sections were fixed with 4%
paraformaldehyde in PBS, washed with PBS three-times, then permeabilized with
0.1% Triton X-100 in PBS. Sections were blocked with 10% normal goat serum
(Fisher Scientific) at room temperature for 1 hour, then with goat F(ab) anti-mouse
IgG H&L (1:1000 in 1% normal goat serum in PBS with 0.2% Tween-20; ab6668)
for 1 hour at RT. After blocking, sections were incubated with primary Anti-αS
(phosphor S129) antibody (81A; 1:1000 in 1% normal goat serum in PBST)
overnight at 4 °C. After three washes with PBST, the tissue was incubated with a
secondary antibody labeled with Alexa Fluor 488 (1:500 in 1% normal goat serum
in PBST) for 1 hour at room temperature. Tissue was washed with PBST twice,
then with PBS once and coverslipped. The fluorescent images were acquired by a
Zeiss Axio Imager M2 microscope.

§ 7.3 Results
Exemplar-Based In-Silico Screen
Through methods developed by Karanicolas and colleagues, using the
Rosetta Modeling Suite, exemplars can be facilely generated for any protein of
interest given an input structure.283 An exemplar is a pseudoligand designed to be
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a perfect molecular complement to a surface exposed pocket on a protein of
interest (Fig 7.1b).277, 283 Following selection of an anchor residue, the protein is
cast onto a three-dimensional grid, and grid points that correspond to the protein
pocket are “chemotyped” by the adjacent functional features on the protein. Based
on whether the protein surface presents hydrogen bond donating or accepting
moieties or a hydrophobic patch, grid points are assigned characteristics that are
complementary to the protein surface. Subsequently, molecular alignment of
compounds from a database allows for rapid in silico screening to identify
molecular architectures that satisfy the chemical features (i.e. hydrogen
bonding/accepting) captured by the exemplar (Fig 7.1b).277
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Figure 7.1: Exemplar-based in-silico screening. (a) PDB 2N0A with exemplars of
previously described sites 2 (Y39-S42-T44) and 9 (G86-F94-K96) shown as
spheres representing hydrophobic (cyan), hydrogen bond donating (yellow) and
accepting (light blue) pharmacophores. Compounds used in site-specific
competition binding experiments are listed with for each site in gray. (b) Workflow
for identifying small molecules.276 A zoom in on the site 2 exemplar is shown on
the left with compound 6 docked in the conformation identified from the ZINC
database by Align-It .278-279

In order to assess the potential efficacy of using an exemplar-based
approach, we targeted sites that had been identified through our prior efforts as
the binding sites for a myriad of previously described αS fibril radioligands (Fig
7.1a).276 Our previous work highlights two compounds, [3H]Tg-190b and
[3H]BF2846 (Fig 7.2), which selectively bind to site 2 and 9 respectively and can
be utilized for in vitro competition binding assays to screen compounds identified
in silico.
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Figure 7.2: Radioligand Structure and Initial Binding Assay. (Top Left) Molecular
structure of radioligands used in the screening and competition binding assays.
(Top Left ) Radioligand displacement assay testing binding affinity of each
compounds against a site 9 radioligand, [3H]BF2846. (Bottom Left) Molecular
structures of the two top hits (2 and 6) from the initial screen. (Bottom Right)
Competition binding curves in αS fibrils (100 nM) for compounds 2 and 6. αS fibrils
were incubated with [3H]Tg-190b (6 nM) and increasing concentrations of
competitors (2 and 6). Compounds 2 and 6 have Ki values of 85.6 nM and 1.18
nM, respectively. Data points represent mean ± s.d. (n=3).
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Figure 7.3. Molecular structures of 17 compounds from the Exemplar screening.
Compound 6 showed high affinity for Asyn fibrils in vitro and its core structure was
used for similarity search.

Therefore, we selected these two sites as our initial targets. Using the 2N0A
PDB structure deposited by Rienstra and colleagues, pocket templates were
generated using residues 44 and 86 of the central strand of the fibril as anchor
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points for sites 2 and 9 respectively. The exemplar for each site was screened
using Align-It against ~ 10 million commercially available, lead-like molecules from
the ZINC15 database. The top 50 molecules which displayed the best overlap with
each exemplar pseudoligand were retained. From the top 50 molecules identified
in the initial screen at sites 2 and 9 (Figs 7.4-5 and 7.6-7), 17 compounds were
purchased and were employed in high throughput screening to determine their
relative affinities for αS fibrils. Of the set of molecules selected, 2 molecules were
able to displace the site 2 specific radioligand [3H]Tg-190b (Fig 7.2a). Competitive
binding experiments revealed that compounds 2 and 6 displayed inhibitor
constants (Ki) of 85.6 nM and 1.18 nM, respectively, against a site 2 specific
radioligand (Fig 7.2b).284

Figure 7.4: Site 2 Exemplar from PDB 2N0A fibril.
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Figure 7.5: Top Hits from ZINC15 database for Site 2 Exemplar.
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Figure 7.6: Site 9 Exemplar from PDB 2N0A fibril.
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Figure 7.7: Top Hits from ZINC15 database for Site 9 Exemplar.

Lead Compound Binds to Site 2 and Does Not Affect αS Aggregation
Following the identification of two potential lead compounds, we decided to
further investigate the more potent binder to confirm that the compound 1) binds
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to the target site on αS fibrils and that 2) the compound is non-perturbing and does
not affect the aggregation of αS. We posit that a suitable imaging compound should
not perturb the aggregation process, nor should it remodel or disaggregate fibrils.
Therefore, a derivative of compound 6 was synthesized by Marshall Lougee with
a photocrosslinking group to confirm the binding location (Fig. 7.8). Following
incubation of compound 62 with αS fibrils and irradiation with 365 nm light, the
sample was analyzed by full-protein and trypsin digest MALDI mass spectrometry
(Fig. 7.8). Analysis of the resultant data revealed a clear single mass shift,
suggesting that most of the compound binds at a single site. Furthermore, analysis
of the digested sample confirmed that crosslinking could be observed at the target
site, site 2, initially used in the in silico screen (Fig. 7.8).
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Figure 7.8: Photocrosslinking of radioligand analog to αS fibrils. Top: Experimental
scheme illustrating that following incubation of 62, a photocrosslinkable analog of
6 synthesized by Marshall Lougee, with αS fibrils that irradiation with UV light and
fibril digest results in identification of the compound binding site. Bottom: MALDI
mass spectrometry data before (left) and after (right) digestion of αS with trypsin
following photocrosslinking with a BJ-1-094 analog.

To confirm that the probe does not affect the aggregation state or propensity
of αS, we generated fluorescently labeled αS for use in fluorescence polarization
(FP) assays performed by Marshall Lougee. By attaching fluorescein-maleimide to
a Y136C mutant αS construct FP can be used to monitor fibril aggregation and
stability as well as the compound’s effect on these processes, as previously
described.78, 119 The compound did not show any significant effect on the rate of
aggregation or on the stability of αS fibrils (Fig 7.9).
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Figure 7.9: Impact of identified molecule on αS fibril aggregation and stability. Top:
Experimental scheme illustrating that incorporation of fluorescently labeled
monomer into fibrils results in a significant increase in fluorescent polarization
allowing aggregation to disaggregation to be tracked. Middle: Aggregation of αS in
the presence of 1% labeled monomer along with 10 and 100 μM 6 compound.
Bottom: Assessment of potential remodeling of 1% labeled αS fibrils by 6
compared to EGCG and NDGA as a positive control and DMSO as a negative
control.

SAR Screen to Improve Affinity/Specificity
In order to improve the affinity and selectivity of compound 6, Zsofia
Lengyel-Zhand conducted an SAR screen by culling structurally similar
compounds from the Mcule library via similarity search. 285 In total 39 molecules,
summarized in Figure 7.10 and Figure 7.11, assayed the impact of various
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substituents on the two terminal aryl rings as well as the importance of the central
isoxazole by replacement with a pyrazole or oxadiazole. High throughput
screening of the selected compounds revealed that the majority of them effectively
displace the site 2 radioligand (Fig. 7.10b), however only 3 of the compounds
showed binding to site 9 (Fig. 7.10c). One of these compounds features the
replacement of the central isoxazole with a pyrazole (compound 55) and
interestingly was the only non-isoxazole compound to show any affinity for either
site of αS fibrils. Moreover, all binding competent compounds with a bromine
substitution at the para position of the leftmost ring (as drawn in Fig 3a) display a
high affinity for both site 2 and site 9 (compounds 28 and 31). Furthermore, we find
that ortho substitutions on the rightmost ring (compounds 18, 22, 27, 30, 38, 47,
49 and 54) hinder binding while meta substitutions (compounds 20, 28, 40, 41 and
52) are tolerated. That same rightmost aryl system is also largely intolerant to the
addition of halogens (compounds 23, 25, 32, 35, 37, 44, 50) but accommodates
more electron donating groups such as methyl (compounds 28, 36 and 40) and
methoxy (19, 21, 24, 31, 34 and 39) groups. Lastly, we find that branching points
such as the insertion of a methyl group at the methyl ether adjacent to the central
amide eliminates binding (compound 23 and 35).
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Figure 7.10: SAR screen based on exemplar compound (6). (a) Example set of
compounds identified through similarity search. The core structure of 6 and its
pyrazole and oxadiazole derivatives were used for similarity search, with similarity
threshold set to 0.8 or higher. (b,c) Radioligand displacement assay testing binding
affinity of each compounds against a site 2 (b) or site 9 (c) radioligand. Data points
represent mean ± s.d. (n=3).
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Figure 7.11. Molecular structure of the 39 compounds from the similarity search.
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αS Fibrils Ki (nM)

aβ Fibrils

Ligand

[3H]Tg-190b

[3H]BF2846

[3H]BF2846

6

1.18 (0.90-1.56)

32.7 (20.7-51.5)

7.59 (3.14-18.7)

24

47.9 (22.3-101)

139 (87.1-268)

352 (206-609)

28

1.97 (1.51-2.58)

8.57 (3.77-19.5)

4.13 (2.10-8.54)

31

34.4 (13.6-84.6)

7.53 (5.21-10.9)

16.8 (11.0-25.5)

39

2.83 (1.55-5.14)

>1000

19.3 (7.07-53.9)

40

5.63 (2.05-15.5)

>1000

15.7 (4.97-48.3)

52

8.39 (4.94-14.2)

>1000

11.2 (3.69-34.2)

Table 7.1: Comparison of Ki values in αS and aβ (using aβ42) fibrils. Values
were determined by competition binding assay with [3H]Tg-190b or [3H]BF2846.
95% confidence intervals for Ki values are shown in parentheses (n=3).

High throughput screening of the SAR library was analyzed with One-Way
ANOVA and compounds showing the highest affinity for S fibrils (P<0.0001) were
selected for in-depth characterization. We measured their affinity for both site 2
and site 9 in S and also in a fibrils (Table 7.1). Site 9 radioligand [3H]BF2846,
has similar affinity for aβ fibrils and αS fibrils, allowing it to also be employed in aβ
fibril competition assay. Gratifyingly, we observed that the most potent αS fibril
binders all displayed a preference for αS over aβ fibrils with selectivity ranging from
2- to 7-fold.
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Synthesis and characterization of radioligand
Despite elucidating several important features of the base-scaffold in the
SAR study, the initial compound (6) identified in the in-silico screen remained the
most potent binder, thus we set out to synthesize and further characterize its
iodinated derivative, compound 61, as well as its radiolabeled isotopolog [125I]61.
Synthesis of the [125I]61 compound was performed by Bieneke Janssen as detailed
in Figure 7.12.

Figure 7.12: Synthesis route towards 61 and [125I]61. Reagents and conditions:
(a) 2-chloroacetyl chloride, TEA, CH2Cl2, 0 °C – rt, 20 h (59 67%; 60 65%); (b) 3,4dimethylphenol, Cs2CO3, MeCN, 60 °C, 14-20 h, (28 36%; 61 42%); (c) (SnBu3)2,
Pd(PPh3)4, toluene, 110 °C, 3 h (55%); (d) [125I]NaI, H2O2, AcOH, MeOH, 60 min,
57% radiochemical yield, radiochemical purity >99%, molar activity of 81
GBq·µmol-1.
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Figure 7.13: Characterization of the lead compound. (a,b) Competition binding
curves in αS fibrils with [3H]Tg-190b (a) and in a42 fibrils with [3H]BF2846 (b).
Compounds 61 has a Ki of 1.84 nM and 4.66 nM in αS and a42 fibrils,
respectively. (c,d) Saturation binding curves for [125I]61. Kd and Bmax values were
obtained for αS fibrils (c, Kd = 1.06 nM and Bmax = 1392 fmol/nM of fibrils) and a42
fibrils (d, Kd = 4.56 nM and Bmax = 1058 fmol/nM of fibrils). Data points represent
mean ± s.d. (n=3).

The potential efficacy of this radioligand as an imaging probe was tested by
Zsofia Lengyel-Zhand by in vitro autoradiography studies. Images were obtained
by incubating sagittal brain sections from 17-month old PD mouse model (A53T)
and C6C3F1/J control with [125I]61 and subsequent exposure to storage phosphor
screens. The autoradiograms are shown in Fig 7.14b. and clearly demonstrate that
there is increased signal in A53T mouse brain compared with the control across
the entire brain section. Adjacent brain sections were also stained with PS129 anti410

S antibody (Fig 7.14) and colocalization between the autoradiogram and
fluorescence images was observed in the medulla, pons and midbrain regions
containing the substantia nigra.

Figure 7.14: In vitro autoradiography on mouse brain tissue sections to assess
[125I]61 binding. (a) Immunofluorescence staining of A53T and normal
(B6C3F1/J) mouse brain sections with PS129 anti-S antibody (scale bar: 1000
µm). (b) Autoradiograms showing the binding of [125I]61 in A53T and normal mouse
brain sections. Upper two sections are total binding (TB) and lower two sections
are non-specific binding (NSB), defined using non-labeled Tg-190b (20 µM).
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§ 7.4 Discussion
The development of a PET tracer to image Parkinson’s disease is a high
priority in the field of radiopharmaceutical research, since a radioligand that binds
to S could greatly improve the clinical diagnosis of PD. Despite the progress in
recent years, a radiotracer for imaging S aggregates with high affinity and
selectivity has yet to be developed. In this work, we utilized a combination of
exemplar-based in silico screening and radioligand binding studies to identify
several compounds that bind to S fibrils with nanomolar affinity and moderate
selectivity over aβ. Our approach is unique and represents the first use of this
method in radioligand development; we envision further exploring this method
towards development of a PET tracer targeting αS.
Although we were able to successfully identify a radioligand to image S in
vitro, there are several potential avenues for improving the compound identification
process by modifying the library composition. The current library contained single
rotamers from the ZINC15 commercially available, lead-like library.278 After
identifying similar compounds through the SAR screen which afforded a reduced
base scaffold, and our ultimate radioligand, we looked to see if this scaffold was
contained in our searched database and why this compound series may have been
missed in the initial screen. We verified that this reduced scaffold was indeed
present in the original library and that the single rotamer of this series of
compounds contained in the database did not align favorable with the input
exemplar. Therefore, we envision that the incorporation of more rotamers alone
would likely improve our hit rate and may intrinsically lead to new scaffolds.
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CHAPTER 8: FUTURE DIRECTIONS AND OUTLOOK
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The efforts described in this thesis work have afforded novel computational
and experimental methods for studying disordered and aggregation prone
proteins. Early chapters highlight the developments of minimally perturbing
fluorescence probes, in the form of unnatural amino acids and small scaffold
protein modifications and showcase their employment in protein-based FRET
experiments. Furthermore, this work describes an initial exploration of methods for
predicting which sites are optimal for incorporation of a given unnatural amino acid
probe, laying the groundwork for a predictive algorithm. The latter chapters focus
on using FRET-based experimental methods, alongside experimentally restrained
computational modeling, to gain a better understanding of the disordered
ensemble of α-synuclein. This allowed for the development of new PyRosettabased algorithms which, in tandem, allow for the accurate prediction of ordered
and disordered proteins from sequence. Lastly, the work herein culminates in the
identification of a small molecule probe, using exemplar modeling, which can
selectively bind to α-synuclein fibrils and can be leveraged as a positron emission
tomography imaging probe. Overall, this work has demonstrated the usefulness of
the approaches and tools developed herein, providing new platforms for further
experimentation on α-synuclein and other disordered proteins.

§ 8.1 Identification of Novel Compounds with Improved Therapeutic Potential
via FRET-based Screening
This work has demonstrated that FRET-based fluorescence assays,
alongside experimentally restrained molecular modeling, were able to capture
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differences in the structural ensembles of αS in the presence and absence of 2 M
TMAO. Although this model system may not feature a high degree of physiological
relevance, it provides an important benchmark for the conditions under which
ensemble FRET can be used. Indeed, this method has already been employed to
study the effects of small molecules such as epigallocatechin gallate (EGCG),
nordihydroguaiaretic acid (NDGA) and NDGA derivatives on the structure of αS in
a plate-reader based assay.286 Overall, these efforts demonstrate that highthroughput ensemble FRET-based screens may be useful in identifying new
therapeutic candidates for Parkinson’s Disease.
Since fibrils have long served as the pathological hallmark of PD several
group have attempted to identify compounds that disaggregate αS fibrils.19,

287

Fibrils are notoriously stable, and incomplete dissociating of fibrillar architectures
generally leads to shedding of highly-mobile oligomers, which are still highly
cytotoxic.288 Moreover, the identification of poly-ubiquitinylation and other
degradation markers on fibrillar αS suggests that endogenous cell machinery may
not be sufficient to clear these bulky, insoluble species.289-291 Therefore, in contrast
to clearing fibrils, which appears to be quite difficult, small molecules which hinder
fibrils’ ability to recruit monomer may be a more efficacious route to the
development of a novel therapeutic.286-287, 292-293 This approach could be leveraged
from the fibril end, where a small molecule which targets fibrils prevents fibril ends
from templating naïve monomer, or from the monomer end, where a small
molecule stabilizes the soluble form of αS or lowers the available pools by pushing
monomer towards degradation.287,

292-293
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The former approach appears more

reasonable in light of the myriad of small molecules that have been identified that
target fibrillar architectures and is discussed later in this chapter. 276 However, the
latter approaches present a clear barrier in identifying small molecules that
specifically target the disordered conformation of αS, as described earlier.
The approach of targeting a protein’s disordered state, though still in its
infancy, is not novel to this thesis.294-297 Indeed, others have successfully identified
molecules which are capable of binding to disordered proteins using NMR-based
experimental and MD-based computational approaches.14, 297-298 Furthermore, the
work of Kelley and coworkers with transthyretin supports the notion that a protein’s
soluble form might be stabilized relative to fibril formation. 299 Therefore, the next
major application of the developed ensemble-based FRET approach is to perform
high-throughput screens with the goal of identifying molecules that bind to, and
impact the structural ensemble, of αS. Recently, the National Cancer Institute at
the National Institute of Health has begun to provide natural products libraries to
labs free of charge.300 These libraries contain 150,000 pre-fractioned marine,
microbial and plant extracts and are provided in 384-well plates. Therefore, future
work will be focused on developing the ensemble FRET-based approach,
described herein, into a robust high-throughput strategy aimed at identifying
compounds that modulates the conformational ensemble of αS.

§ 8.2 Continued Exemplar-based Screening
In addition to these clear experimental next steps, further computational
efforts towards the identification of PD probes are underway. The final chapter of
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this thesis work outlined a general workflow for identifying novel molecular
scaffolds that are capable of selectively binding to αS fibrils. Although the
compound identified was sufficient for vetting the validity of this approach, the
selectivity and solubility of the molecule could stand to improve. Therefore, a
second in silico search is currently being prepared, making use of the
improvements noted in that chapter, which will hopefully lead to an improved hit.
Additionally, although the recently identified compound boasts improved specificity
for αS fibrils over other protein fibrils, there is also an ongoing effort to further
enhance compounds selectivity. To solve this problem, exemplars will once again
be employed, and a library of exemplars has been crafted from tau and aβ fibril
structures deposited in the PDB. After a set of potential binders has been identified
using a target exemplar, compounds will be counter screened against this offtarget exemplar library. This method, which has been previously demonstrated by
Karanicolas and coworkers, allows for the rapid removal of non-specific
compounds from a set of potential binders.301 Furthermore, efforts are ongoing for
developing a second tier in silico screening approach to cull false positions from
potential hits identified in the initial screen. The basis of this approach to date has
employed modeling in PyRosetta, along with the development of a custom score
function, to predict experimental binding data. The concept of custom score
functions is discussed later in this chapter. The identification, testing and
development of new compounds is the subject of a recently approved U19 grant
from the NIH which involves the Petersson Lab, along with many others. Overall,
the exemplar-based methods employed in the latter portion of this thesis will be
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employed to generate new lead compounds for αS fibrils from the multitude of cryoEM structures recently deposited in the Protein Data Bank and can be extended
to other fibrillar proteins for identifying targeting compounds.50, 302-303
The final future focus on this topic is on the combination of disordered
ensemble prediction with exemplar-based modeling to identify compounds that
bind disordered proteins. Unlike the previous focus on targeting fibrils, the lack of
static pockets in the disordered state makes pocket identification and thus
exemplar selection difficult. However, the previously described FastFloppyTail
method for generating accurate models of disordered proteins at unparalleled
speeds provides a potential avenue to overcoming this sampling issue. By crafting
composite exemplars from similar protein regions across many structures, one
may be able to capture the necessary three-dimensional architecture and chemical
interactions sufficient for identifying binders. Moreover, the efforts of Nath and
colleagues as well as others suggests that this may be a viable strategy. 298, 304
Lastly, the recent excitement surrounding proteolysis targeting chimera (PROTAC)
further increases the potential utility for small molecules which are capable of
selectively targeting a disordered protein.305 Ultimately this approach could open
the class of disordered proteins to new therapeutic approaches.

§ 8.3 Novel Approaches in Rosetta Targeting Experimental Optimization
Finally, an ongoing computational effort is focused on developing custom
score functions. In the Rosetta Modeling Suite, score functions are utilized
alongside the Metropolis criterion to perform Monte Carlo sampling of protein
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structures.240 Here, custom score functions allow a sequence or molecule to be
scored, post-sampling, to predict experimental measurables. Although these are
comprised of the same energy terms as the canonical Rosetta score functions,
which have been optimized to serve as a surrogate for overall energetics, the
reweighting of these terms is optimized to predict some experiment of interest. This
requires a significant experimental dataset whose fundamental experimental
measurable can be traced to a structural phenomenon. Interestingly, this is not an
approach previously employed within the Rosetta community which has largely
focused on optimizing the core scoring performance of Rosetta (i.e., matching
structural or thermodynamic data).194 A preliminary example of how this may be
employed is demonstrated in this thesis work in the chapter entitled “Systematic
Evaluation of Soluble Protein Expression Using a Fluorescent Unnatural Amino
Acid Reveals No Reliable Predictions of Tolerability.” Following an initial
demonstration that the energetic differences between the mutant and native
proteins as assessed by the canonical Rosetta energy indeed was insufficient for
the prediction of soluble protein fractions, it was demonstrated that individual
components were able to demonstrate some correlative capacity. Therefore, it is
likely that recombination of these terms can afford a score function that is capable
of predicting the soluble fraction of a given mutant provided the initial dataset
utilized for training is sufficient. To this end, further experimentation is underway
with a more extensive library of proteins and unnatural amino acid mutants.
Although the concept of custom score functions was conceived with the goal
of predicting tolerability of unnatural amino acid incorporation, there are many
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opportunities to extend this approach to predict other phenomena of interest.
Exemplar-based modeling provides an efficient platform for identifying potential
lead molecules but, as previously demonstrates, delivers several false-positives.
Therefore, a custom score function is currently in development which utilizes
binding data from the SAR study present herein to generate a second-tier
screening algorithm. This approach docks each compound to the input fibril
structure and uses the resulting structure as the basis for custom score evaluation.
Preliminary efforts, not presented in this work, have shown significant promise in
the capabilities of this method. Lastly, this approach is being extended to other
systems of interest in the Petersson lab which are focused on design. Custom
score functions from peptide proteolysis and logP data are providing algorithms for
designing stabilized peptides while directed evolution data will be used to improve
in silico directed evolution of aminoacyl tRNA synthetase.
Overall, the methods and tools developed herein have been and continue
to be employed towards challenging problems for disordered and aggregation
prone proteins and beyond. This work has focused on developing generalized
approaches and employing these and other methods to elucidate the structural
complexities of disordered proteins. Moreover, this work has extended previously
developed methods to the class of aggregation prone proteins and demonstrated
the efficacy of these approaches. Lastly, these developments are continuing to be
improved and are being leveraged for new protein systems of interest.
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